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Diabetes mellitus is an increasingly prevalent disease amongst Western populations. A serious 
and potentially fatal sequela of diabetes is diabetic ketoacidosis which often relies on post-
mortem examination for diagnosis in the context of unwitnessed deaths. One of the major 
end-organs affected by diabetes is the kidneys, thus, post-mortem examination of the kidneys 
serves as a major diagnostic tool. 
 
Renal tubular vacuolization represents a standard response to a variety of metabolic insults, 
and analysis of vacuole morphology can assist in determining the nature of the underlying 
metabolic derangement. The Armanni-Ebstein phenomenon refers to a pattern of renal tubular 
epithelial cell vacuolization noted in diabetic coma with a demonstrated relationship to the 
extent of hyperglycaemia. It involves a pattern of cytoplasmic clearing by a single large 
vacuole with luminal displacement of nuclei by intra-vacuolar glycogen. In more recent 
literature, the Armanni-Ebstein phenomenon has also been used to describe basal/subnuclear 
vacuoles containing lipids and triglycerides, thus causing confusion. However, there are 
limited studies surrounding basal vacuolization in renal tubular epithelial cells beyond case 
reports, thus, its aetiology remains largely unknown. 
 
This thesis aims to clarify the terminology surrounding patterns of renal tubular vacuolization 
in diabetic ketoacidosis, investigate the aetiology of basal vacuolizations in human and animal 
models, and further define useful markers at autopsy for significant metabolic derangements. 





and improve the linking of specific morphological findings to underlying pathophysiological 








Chapter 1: Clarification of terminology 
1. To clarify the terminology surrounding patterns of renal tubular epithelial cell 
vacuolization in diabetic ketoacidosis. 
 
Chapter 2: Histopathological studies to confirm or refute associations between 
histomorphology and pathological conditions 
2. To investigate the occurrence of basal vacuolizations in non-diabetic causes of 
ketoacidosis. 
3. To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and hyperlipidaemia. 
4. To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and hypothermia. 
5. To investigate if macroscopic renal cortical pallor can be a useful sign for underlying 
metabolic derangements at autopsy. 
6. To investigate if characteristic formalin pigment deposition can be used as a surrogate 
marker for basal vacuolizations. 
 
Chapter 3: Determining incidence and further defining diagnostic utility 
7. To determine the incidence of Armanni-Ebstein lesions and investigate their 
relationship with hyperglycaemia. 







Chapter 4: Establishing and utilizing animal models to facilitate further investigation 
9. To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and terminal hypothermia using an animal model. 
10. To investigate the role of osmotic effect in the aetiology of Armanni-Ebstein lesions. 
11. To develop an isolated perfused kidney model capable of reproducing renal tubular 
epithelial vacuolizations secondary to metabolic derangements. 
a. To utilize the isolated perfused kidney model to reproduce Armanni-Ebstein 
lesions. 








Chapter 1: Clarification of terminology 
1. That Armanni-Ebstein lesions refer to cytoplasmic clearing with luminal displacement 
of nuclei and is a distinct histological change from basal vacuolizations. 
 
Chapter 2: Histopathological studies to confirm or refute associations between 
histomorphology and pathologic conditions 
2. That basal vacuolizations in renal tubular epithelial cells may occur in non-diabetic 
causes of ketoacidosis. 
3. That basal vacuolizations in renal tubular epithelial cells are associated with 
hyperlipidaemia. 
4. That basal vacuolizations in renal tubular epithelial cells are not associated with 
hypothermia per se. 
5. That macroscopic renal cortical pallor at autopsy may be an early indication of basal 
vacuolization of renal tubular epithelial cells. 
6. That formalin pigment deposition in a characteristic basal distribution may be used as 
a surrogate marker for basal vacuolization. 
 
Chapter 3: Determining incidence and further defining diagnostic utility 
7. That Armanni-Ebstein lesions are uncommon in hyperglycaemia and their incidence 
correlates with the degree of glucose elevation. 
8. That basal vacuolizations are common in ketoacidosis and their incidence correlates 






Chapter 4: Establishing and utilizing animal models to facilitate further investigation 
9. That basal vacuolizations in renal tubular epithelial cells are not associated with 
hypothermia. 
10. That Armanni-Ebstein lesions result from the metabolic sequelae of hyperglycaemia 
and not the osmotic effect of glucose. 
11. That the isolated perfused kidney model is a viable ex-vivo model for the investigation 
of renal tubular epithelial vacuolizations, i.e. 
a. That Armanni-Ebstein lesions are reproducible in an isolated perfused kidney 
model. 






















ARMANNI-EBSTEIN LESIONS: A NEED FOR CLARIFICATION 
 
CONTEXTUAL STATEMENT 
AIM: To clarify the terminology surrounding patterns of renal tubular epithelial cell 
vacuolization in diabetic ketoacidosis 
 
HYPOTHESIS: That Armanni-Ebstein lesions refer to cytoplasmic clearing with luminal 
displacement of nuclei and is a distinct histological change from basal vacuolizations. 
 
COMMENTARY: The Armanni-Ebstein phenomenon describes a pattern of cytoplasmic 
clearing with glycogen deposition in renal tubular epithelial cells, noted in deaths due to 
diabetic coma. Its pathogenesis has been firmly established to hyperglycaemia through animal 
studies. In recent literature, Armanni-Ebstein lesions have also been used to describe basal 
vacuolizations which stain positively for lipids with a possible pathogenesis involving 
hyperlipidaemia. Thus, this study was conducted with the aim of clarifying the terminology of 
the ‘Armanni-Ebstein phenomenon’ through a systematic and chronological review of current 
literature.  
 
This manuscript was written in American English to satisfy the publication requirements of 
the Journal of Forensic Sciences. 
 
CONCLUSION: Armanni-Ebstein lesions and basal vacuolizations represent two distinct 
histologic changes in renal tubular epithelial cells and are associated with different metabolic 
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ABSTRACT: Armanni-Ebstein lesions were first described by Luciano 
Armanni, a pathologist at the University of Naples, during autopsy studies undertaken in 
1872, as a unique vacuolar nephropathy associated with poorly controlled diabetes that 
involves selective renal epithelial cell glycogen accumulation. However, within the last two 
decades a broader range of vacuolar changes, including lipid deposition, have also been 
termed Armanni-Ebstein lesions, creating some confusion on possible etiology. We would 
suggest that the term Armanni-Ebstein phenomenon would be best reserved for the original 
clear cell change associated with glycogen deposition, and that this should be clearly 
distinguished from subnuclear lipid vacuolization (“basal vacuolization”). Although there is 
obvious interrelation between these two types of vacuoles, they appear morphologically and 
biochemically distinct from each other. More precise classification may assist in clarifying the 
causal processes and possible diagnostic significance of different types of renal epithelial 
vacuolization at autopsy. 
 
Keywords: forensic science, Armanni-Ebstein, basal vacuolization, renal epithelial cell 






Origins of the Armanni Ebstein lesion 
In the late 1800s, Armanni observed that the morphology of epithelial cells in the 
proximal tubules of the deep cortex and outer medulla of the kidneys had altered; the cells had 
lost their normal polarized cuboidal shapes and were swollen, rounded and transparent, with 
small dark nuclei that were often displaced to the periphery, rather than in their normal central 
position.  This observation was presented to medical students in 1872 and first appeared in 
Italian in Cantani’s textbook Patologia e Terapia del Ricambio Materiale in 1875, with the 
large polygonal cells described on page 257 and illustrated by a sketch in Figure 6 
(reproduced here as Figure 1) (1).  Armanni’s initial study was later published in German in 
1877 (2).  Giordano’s translation of Armanni’s description of large polygonal epithelial cells 
filled with hyaline material appeared in the English literature in 1987 (3).  Ten years after 
Armanni’s initial observations, Ebstein reported similar lesions in the German literature in 
1882, describing edematous cells with remnants of cytoplasm (4). 
 
Contemporary literature 
 One of the first analyses of Armanni-Ebstein lesions in the English literature in 
more recent times was in a study by Ritchie and Waugh in 1957 (5).  These authors described 
the lesions as occurring rarely in poorly controlled diabetic states after the advent of insulin 
therapy, and appearing as markedly swollen epithelial cells with a normal appearing central 
nucleus but with “virtually total conversion of the cytoplasm into a single large vacuole”.  
Affected cells bulged into, and sometimes occluded the tubular lumen.  This was consistent 
with the original descriptions by Armanni and Ebstein, as illustrated in their paper in Figures 
2 and 4 (5).  The lesions principally affected the terminal straight portion of the proximal 





affected area involved mainly the outer medulla with some extension into the inner cortex, but 
did not affect tubules in the middle or outer cortices.  Vacuoles in affected cells stained 
positively for glycogen with no stainable lipids (5).  Of interest, the authors also mentioned 
that fatty vacuolization found in some of their cases was usually basal and present only in the 
upper proximal tubule regions, not in the areas typical of Armanni-Ebstein (5). 
 In 1978, Armanni-Ebstein lesions were described in Meadows’ textbook, Renal 
Histopathology as a rare tubular disorder principally affecting long-term diabetics. The 
lesions appeared as swollen cells that often occluded tubular lumina with vacuoles containing 
abundant glycogen (6) (Figures 2 & 3).  Rasch described Armanni-Ebstein lesions in 
streptozotocin-induced diabetic rats in 1984.  In agreement with the findings of Ritchie and 
colleagues, the lesions were confined to the cortex and outer medulla with abnormal cells 
appearing “empty” or full of PAS-positive material but with an intact nucleus.  Electron 
microscopy showed the cytoplasm of these cells to be filled with glycogen (7).  In 1986, 
Bendon and Hug described typical Armanni-Ebstein lesions in five patients with Fanconi 
Syndrome and commented that the common feature of Fanconi syndrome and diabetes 
mellitus was glycosuria.  The lesions were localized in tubular epithelial cells at the 
corticomedullary junction which were abnormal in being filled with glycogen but which 
retained distinct cell membranes, clear cytoplasm and normal nuclei (8). 
 
Animal models 
 Ishizaki et al noted Armanni-Ebstein lesions in the ascending limbs of the loop of 
Henle in all twenty of their spontaneously diabetic rats, with affected cells characterized by 
the presence of vacuoles filled with glycogen (9).  In the same year, 1987, Orloff et al 





distension of renal tubular cells due to glycogen accumulation, in alloxan-treated diabetic rats 
receiving pancreatic transplants.  In their study, Armanni-Ebstein lesions appeared 1-3 
months after the induction of diabetes with alloxan, and progressively increased over the next 
24 months (10). 
 In 1990, Reyes et al found that cholesterol administration in streptozotocin-induced 
diabetic rats prevented the development of Armanni-Ebstein lesions despite persistent 
hyperglycemia.  As with previous studies, the observed lesions were described as swelling of 
tubular epithelial cells with clear cytoplasm, which were shown by electron microscopy to 
contain diffusely distributed granules characteristic of glycogen (11).  A study by Dobashi et 
al in 1991 on streptozotocin-induced diabetic rats further refined the timeline for the 
development of Armanni-Ebstein lesions by showing that the lesions were not present at two 
weeks after treatment, but had appeared by eight weeks (12). 
 Due to the consistent demonstration of glycogen within vacuoles, Armanni-Ebstein 
lesions have also been referred to as ‘glycogen nephrosis’ (13-16), in keeping with the 
original work in the field linking the condition to hyperglycemia associated with diabetes.  In 
a study of alloxan-diabetic rats, Curtis et al concluded that the appearance of these lesions was 
solely dependent upon the terminal blood glucose level, with Armanni-Ebstein changes 
invariably present with levels above 350mg/100mls and consistently absent below 
300mg/100mls (13). 
 
Broadening of the concept 
 The situation changed somewhat in the mid 1990s with work by Kock and 
Vestergaard expanding the range of lesion phenotypes.  They found eight out of 47 cases of 





Ebstein lesions with two morphological classes of lesions described.  One type of lesion 
consisted of tubular cells that had nuclei “completely surrounded by the vacuolation” that was 
glycogen-positive based on Best’s carmine staining.  Affected cells were located in the outer 
zone of the medulla, consistent with previous descriptions of Armanni-Ebstein lesions. The 
second type of lesion was composed of cells that had basally-located vacuoles with luminally-
displaced nuclei, not characteristic of the classic Amanni-Ebstein phenomenon. PAS staining 
for glycogen was negative (14) (Figure 4). A drawing of these basally-located, non-
glycogenic lesions is shown in Figure 5 and contrasts with the illustration of the original 
Armanni-Ebstein findings shown in Figure 1.  Another contrasting feature of the second 
category was that vacuolization was observed in all regions of the cortex as well as in the 
outer zone of the medulla, although  the middle and outer cortices had been previously 
described as being Armanni-Ebstein “immune” (5).  With mixed data on the presence of 
glycogen and two morphologically distinct patterns of vacuolization, the authors concluded 
that “a combination of glycogen nephrosis and hydropic vacuolization might well have caused 
the widespread changes of the tubular epithelium, which seemed to be more extensive than 
described in the characteristic AE lesions in the literature” (14).  These observations 
effectively expanded the morphological spectrum of Armanni-Ebstein lesions to include PAS-
negative tubular epithelial cells with basal vacuolization that were located in the middle and 
outer cortex. 
 Several years later Thomsen and Hansen described a 47-year-old insulin-dependent 
diabetic woman with Armanni-Ebstein phenomenon where the epithelial vacuoles (which 
were located mainly in the proximal tubules) were PAS-negative but stained strongly for 
neutral lipid (15) (Figure 6).  This led to a new hypothesis that the Armanni-Ebstein 





astride the corticomedullary junction did stain positively for glycogen (15), suggesting in 
retrospect that more than one class of pathology was present.  Neilsen and colleagues further 
described the Armanni-Ebstein phenomenon occurring in vacuolated tubular epithelial cells 
within the renal cortex as being “seen as a line of empty spaces in contact with the peritubular 
basement membrane”.  This again diverged from the original descriptions of cellular 
ballooning with a clear cell change (16).  These authors also reported a tripling of renal 
cortical lipid due to a 60-100 fold increase in triglycerides which suggested that these lesions 
were caused by accumulated lipids.  This supported the proposal of Kock and Vestergaard 
(14) that the Armanni-Ebstein phenomenon encompassed two types of lesions: one in the 
cortex associated with triglyceride accumulation and the other in the outer medulla due to 
glycogen deposition (16) (Figure 7).  In a further study by Thomsen and colleagues, the role 
of the original “glycogen nephrosis” was downplayed further with the statement that “in all 
probability the Armanni-Ebstein phenomenon is caused by the accumulation of lipids in the 
proximal tubules”.  The authors suggested that a more appropriate name would be “fatty 
kidney in diabetics” (17). 
 
Possible association with hypothermia 
 In 2004, Preuβ et al noted similar basal lipid vacuoles in 87% of cases of fatal 
hypothermia, suggesting that these lesions were “a very reliable histologic diagnostic 
criterium in cases of hypothermia”, comparable to Wischnewsky spots (18). Wischnewsky 
spots are superficial gastric lesions characterized histologically by necrosis of the mucosa 
with hematin formation (19), reportedly present in 40-90% of fatal hypothermia cases (20). 
This newly attributed significance of basal lipid vacuolization has subsequently been 







 In our investigations (21-24), we have found evidence of glycogen nephrosis 
consistent with the classic Armanni-Ebstein phenomenon in the tubules of the outer medulla, 
but have concentrated on cases of basal vacuolization of the renal tubular epithelium, which 
we also termed Armanni-Ebstein phenomena. In a retrospective review of deaths with 
terminal hyperglycemia, we observed basal vacuolization in deaths due to diabetic 
ketoacidosis and determined that there was no correlation between the extent of these lesions 
and the degree of terminal hyperglycemia (21).  Similar lesions were observed in 33% of our 
hypothermic cases; however, given the significant number of diabetics in this group it was 
suggested that these changes might have arisen due to underlying metabolic disturbances 
related to diabetes rather than to hypothermia per se (22).  Renal cortical pallor was found to 
be a useful macroscopic marker for the presence of basal vacuolization at autopsy.  
Histologically, numerous subnuclear epithelial cell vacuoles were identified which contained 
lipid on electron microscopy and did not stain with PAS, consistent with the results of other 
work (20).  Finally, we analysed subnuclear vacuolization in deaths due to alcoholic 
ketoacidosis and found this to be a feature of non-diabetic ketoacidosis in the setting of hypo- 
or normoglycemia (23).  Similar findings, again described as Armanni-Ebstein lesions, were 
recently reported in a child who died of ketoacidosis and starvation in the absence of 
hyperglycemia, further strengthening the association between basal (subnuclear) vacuolization 







 It appears, therefore, that there has been broadening of the definition of Armanni-
Ebstein lesions in the more recent literature.  Whereas classical studies described specific 
pathological swelling of cells, loss of shape, clearing of cytoplasm, and accumulation of 
cytoplasmic glycogen that was directly linked to hyperglycemia and subsequent glucosuria, 
the more recent literature includes other conditions of basal vacuolization with preservation of 
cellular integrity, luminal displacement of nuclei, accumulation of lipids and triglycerides 
within vacuoles, and an association with ketoacidosis. 
 How is this disparity best dealt with?  We considered that as the terminology used to 
describe renal tubular epithelial vacuolization has altered over time with changing of original 
definitions, a review of early morphologic descriptions was timely.  Having obtained 
translations of the original nineteenth century texts by Armanni and Ebstein and extensively 
reviewed the literature, we suggest that the term Armanni-Ebstein phenomenon would be best 
reserved for the original clear cell change described in their original work (Figures 1 and 3).  
This is not to suggest that subnuclear lipid vacuolization of renal tubular epithelial cells 
(Figures 2 and 4) is not an important finding at autopsy, as it indicates that there has been a 
significant metabolic derangement.  These vacuoles, however, appear morphologically and 
biochemically distinct from the lesions described by Armanni and Ebstein and might be best 
referred to as “basal vacuolization”. 
 
Conclusion 
 Neilsen et al (2003) and Kock and Vestergaard (1994) were correct in noting that 
tubular epithelial lesions in diabetic ketoacidosis are of two kinds.  For purposes of clarity, it 
would seem logical to refine the nomenclature to distinguish these conditions and to restore 





inadvertently arisen (16,17,20,24). The benefit of clarifying terminology and separating these 
two lesions (i.e Armanni-Ebstein and basal vacuolization) will be in creating greater 
consistency in the reporting of findings which will allow better linking of specific 
morphological findings at autopsy to unique, although possibly related, underlying 
pathophysiological processes and diagnoses.  The elucidation of different types of renal 
vacuolar change with more precise classification should help to further clarify the 
composition, causal processes and possible diagnostic significance of particular types of renal 
epithelial vacuolization at autopsy.  This may then assist in determining possible lethal 
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FIG. 1-A sketch showing typical Armanni Ebstein vacuolization of renal tubular 
epithelial cells, depicted by Luciano Armanni in Cantani’s 1875 textbook Patologia e 
Terapia del Ricambio Materiale, showing swollen polygonal cells with normal nuclei. 
 
 
FIG. 2- Classical Armanni-Ebstein changes in the proximal convoluted tubule, at the 
corticomedullary junction showing markedly swollen epithelial cells with almost total 
conversion of the cytoplasm of individual epithelial cells into a single large vacuole 








FIG. 3-Special staining for glycogen in cases of classical Armanni-Ebstein is positive 
(PAS x 200). 
 
 
FIG. 4- A lesion that has more recently also been called Armanni-Ebstein with orderly 
basal vacuolization of tubular epithelial cells and luminal displacement of nuclei.  








FIG. 5-A sketch depicting vacuolization of the basal portions of renal tubular 
epithelial cells with luminal displacement of nuclei, a change that has been referred to 
in recent times as typical of Armanni-Ebstein. 
 
 
FIG. 6- Positive staining of basal vacuoles in tubular epithelial cells for neutral lipid 












FIG. 7-The corticomedullary junction showing tubules with distinctive basal 
vacuolization next to a glomerulus, with Armanni Ebstein vacuolization in tubules 






















CHAPTER 2: HISTOPATHOLOGICAL STUDIES TO 
CONFIRM OR REFUTE ASSOCIATIONS BETWEEN 










AIM: To investigate the occurrence of basal vacuolizations in non-diabetic causes of 
ketoacidosis. 
 
HYPOTHESIS: That basal vacuolizations in renal tubular epithelial cells may occur in non-
diabetic causes of ketoacidosis. 
 
COMMENTARY:  Basal lipid vacuolization of renal tubular epithelial cells has been 
reported in diabetic ketoacidosis, however, it appears to be a distinct histologic phenomenon 
compared to Armanni-Ebstein lesions which have traditionally been regarded as being 
pathognomonic for diabetes. Thus, the authors wondered whether basal lipid vacuolization 
could be observed in non-diabetic causes of ketoacidosis, such as alcoholic ketoacidosis, in 
which there is no elevation in glucose levels. 
 
Literature review establishing the field of knowledge is discussed within the paper.  
 
This manuscript preceded the manuscript titled “Armanni-Ebstein lesions: a need for 
clarification” in chapter 1, therefore, the terminology of “Armanni-Ebstein” 
lesions/phenomenon was still used to refer to these basal vacuolizations. The manuscript was 
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ABSTRACT:  Subnuclear renal tubular epithelial cell vacuolization is a marker for 
diabetic ketoacidosis.  Whether it is because of hyperglycemia or of ketoacidosis is unclear. 
To examine the effect of ketoacidosis on renal cells in isolation, five cases of lethal alcoholic 
ketoacidosis without hyperglycemia were examined (vitreous humor β-hydroxybutyrate: 6.42-
8.75 mM, mean 7.66 mM; glucose: 0.1-4.2 mM, mean 1.46 mM). Microscopic examination 
of the kidneys revealed basal vacuoles in three cases (60%). Seven control cases with acute 
alcohol toxicity without ketoacidosis (blood alcohol: 0.18-0.43%, mean 0.31%; and β-
hydroxybutyrate: 0.12-0.42 mM, mean 0.21 mM) did not have these changes. In this study, 
basal epithelial vacuolization was found only in cases with significant ketoacidosis.   
Although the numbers are small, the finding of basal renal tubular epithelial vacuolization in 
normoglycemic cases with elevated β-hydroxybutyrate levels provide further evidence that 
disordered lipid metabolism may be involved in the pathogenesis this phenomenon. 
 
Keywords: Forensic science, alcoholic ketoacidosis, intoxication, Armanni Ebstein 







The term “Armanni-Ebstein phenomenon”, first described in 1877 by Luciano 
Armanni, has been used to refer to subnuclear vacuolization of renal tubular epithelial cells, 
which when severe enough may present macroscopically as renal cortical pallor.  First 
recognized in poorly controlled diabetic states, it was initially thought to be a direct effect of 
hyperglycemia causing cytoplasmic glycogen accumulation (1-5).  However there is now 
evidence that the intracellular vacuoles contain lipid (6-8).  A recent study also failed to 
demonstrate a significant correlation between the degree of hyperglycemia and these 
morphological changes, suggesting a more complicated etiology possibly involving the effect 
of ketoacidosis or lipiduria on tubular cells (9).  Although this subnuclear vacuolization has 
been reported in cases of lethal hypothermia, it appears that in at least some of these cases it 
may be related to underlying diabetic ketoacidosis, that is, basal epithelial vacuolization in 
these cases may be merely a marker of diabetic metabolic derangement rather than to 
hypothermia per se (10,11).  To examine the effect of ketoacidosis on renal cells in isolation, 
without concomitant hyperglycemia, a series of deaths because of alcoholic ketoacidosis were 
reviewed.  A control group consisted of cases with significantly elevated blood alcohol levels, 
but no evidence of ketoacidosis. 
 
Materials and methods 
Case files over a 7-year-period from 2004 to 2010 at Forensic Science SA, Adelaide, 
South Australia, were retrospectively reviewed for all cases of nontraumatic deaths where 
alcohol was listed as a direct cause of death.  Cases where deaths were attributed to alcoholic 
ketoacidosis or where acute alcohol intoxication had played a role were then selected.  All 





ketoacidosis was diagnosed when the vitreous humor β-hydroxybutyrate was > 5 mM with 
normoglycemia or hypoglycemia (vitreous glucose ≤ 11 mM), in conjunction with a history of 
alcohol abuse and/or autopsy findings suggestive of chronic alcoholism.  Alcohol toxicity was 
taken as a blood alcohol level of >0.15%.  Cases where vitreous humor biochemistry and full 
toxicology had not been performed were excluded.  Case files were summarized and all 
available microscopic slides of the kidneys were then blindly reviewed for basal epithelial 
vacuolization; there were no histologic sampling differences between the alcoholic 
ketoacidosis and the acute alcohol toxicity group, with one section per kidney being reviewed.  
Cases where the kidneys were too autolysed for accurate assessment were also excluded. 
 
Results 
 A total of 26 cases were identified, consisting of 12 deaths because of alcoholic 
ketoacidosis, and 14 because of acute alcohol toxicity.  Of the 12 cases of alcoholic 
ketoacidosis, six were excluded due to incomplete vitreous humor biochemical evaluations, 
and one was excluded due to insufficiently raised β-hydroxybutyrate (<5 mM).  Of the 14 
deaths where alcohol toxicity had contributed to the lethal episode, five were excluded 
because of lack of vitreous biochemistry, and two were excluded because of insufficiently 
raised blood alcohol concentrations (<0.15%). 
 All five cases where death was because of alcoholic ketoacidosis had a history of 
chronic alcohol abuse, two with hepatomegaly, four with steatosis and periportal fibrosis, and 
one with splenomegaly.  The age range was from 51 to 72 years (mean 61 years) and all were 
men.  Vitreous humor β-hydroxybutyrate levels ranged from 6.42 to 8.75 mM (mean 7.66 
mM) with no elevation in glucose levels (range 0.10-4.20 mM; mean 1.46 mM).  In one case, 





post-mortem interval in which samples were drawn ranged from 4 to 8 days, with a mean of 
5.6 days.  No cases showed evidence of significant putrefaction.   Microscopic examination of 
the kidneys revealed basal epithelial vacuolization in three cases (Fig. 1).  There was no 
history of diabetes mellitus in any of these cases. 
 A total of seven cases with acute alcohol toxicity without ketoacidosis were studied; 
six had a history of chronic alcohol abuse with hepatomegaly at autopsy in four cases, marked 
cirrhosis in one case, early cirrhotic changes in four cases, mild steatosis in one case, and 
splenomegaly in four cases.  The ages ranged from 37 to 68 years (mean 51.1 years).  The 
male to female ratio was 3:4.  In one case there was a medical history of insulin-dependent 
diabetes mellitus.  Blood alcohol concentrations ranged from 0.18 to 0.43% (mean 0.31%).  β-
hydroxybutyrate levels ranged from 0.12 to 0.42 mM (mean 0.21 mM).  Vitreous glucose was 
tested in three cases and ranged from 0.1 to 1.3 mM (mean 0.5 mM).  The post-mortem 
interval in which samples were withdrawn ranged from 2 to 6 days, with a mean of 3.9 days.  
No cases showed evidence of significant putrefaction.  None of the cases exhibited basal 
epithelial vacuolization in the kidneys (Fig. 2). 
 
Discussion 
 Ethanol is a commonly used substance, the excessive consumption of which can have 
a variety of effects on the body with forensic repercussions.  Ethanol readily crosses the 
blood-brain-barrier into the cerebral extracellular fluid, and has a direct depressant effect on 
neurons.  Chronic excessive alcohol intake is associated with many significant conditions 
including malnutrition, cirrhosis with liver failure, esophageal varices, chronic pancreatitis, 





excessive alcohol consumption associated with aspiration of gastric contents and a variety of 
unnatural deaths that include drowning, falls, burns, and other forms of trauma (13). 
 Alcoholic ketoacidosis has been reported in 7-10% of alcoholic patients suffering 
sudden death (14).  β-hydroxybutyrate levels >2.5 mM are considered lethal (15), and a 
typical episode involves binge drinking with subsequent reduced caloric intake (16).  Ethanol 
levels are frequently low or absent (<10 mg/dL) at autopsy, as the victims have often stopped 
drinking after the onset of symptoms (17,18).  Alcoholic ketoacidosis accounts for up to 25% 
of cases of ketoacidosis (19), occurring once for every four cases of diabetic ketoacidosis 
(17).   It results from low protein and carbohydrate stores, and/or alcoholic liver disease with 
subsequent hepatic glycogen depletion, a situation that causes a fall in blood glucose 
concentrations with suppression of insulin secretion (14,19).  Volume depletion caused by 
vomiting, decreased fluid intake, and/or diaphoresis, can lead to hypotension and a 
sympathetic response, further decreasing insulin production and increasing catecholamines, 
cortisol, growth hormone, and glucagon levels (14,18).  Starvation and hypothermia may also 
lead to an elevation in these hormone levels, which in conjunction with the direct affect of 
ethanol, promotes lipolysis, and increases the supply of fatty acids to the liver (14).  When 
this exceeds the rate of oxidation, a surplus of acetyl-CoA results and is converted to 
acetoacetate (20).  In addition, ketogenesis is favoured by the inhibition of gluconeogenesis 
and decreased pyruvate levels. Subsequent accumulation results, as clearance of ketoacids is 
also impaired by volume depletion and low plasma insulin (17). 
 In the present series, typical basal epithelial vacuolization in renal tubular epithelial 
cells was found in three of the five cases (60%) of alcoholic ketoacidosis that fulfilled the 
criteria for the study.  In addition, these so-called Armanni-Ebstein changes were present only 





While vitreous glucose levels decline after death, in our experience markedly elevated levels 
can still be detected for many days after death (10), and thus the glucose levels in the three 
cases with basal vacuolizations were not considered to have been significantly raised prior to 
death.  In addition, there was no history of diabetes mellitus in any of these victims.  Although 
the numbers are small, the detection of renal tubular epithelial vacuolization in cases where β-
hydroxybutyrate levels were elevated in the absence of hyperglycemia may provide further 
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FIG. 1-Typical vacuolization in the basal portions of renal tubular epithelial cells in a case of 




FIG. 2-Normal renal tubular epithelial cells in a case of acute alcoholic toxicity (Blood 







SEPTIC KETOACIDOSIS – A POTENTIALLY LETHAL ENTITY WITH RENAL 
TUBULAR EPITHELIAL VACUOLIZATION 
 
CONTEXTUAL STATEMENT 
AIM: To investigate the occurrence of basal vacuolizations in non-diabetic causes of 
ketoacidosis. 
 
HYPOTHESIS: That basal vacuolizations in renal tubular epithelial cells may occur in septic 
ketoacidosis. 
 
COMMENTARY:  Basal lipid vacuolization of renal tubular epithelial cells has been 
reported in diabetic, alcoholic, and starvation ketoacidosis, suggesting a possible relationship 
to elevated ketones. Therefore, the same pattern of vacuolization should also be observed in 
ketoacidosis secondary to sepsis or severe infections. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
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ABSTRACT:   Fatal ketoacidosis due to diabetes mellitus, alcoholism and starvation 
may produce characteristic basal vacuolization of renal tubular epithelial cells (RTEC). Septic 
ketoacidosis has recently been recognized clinically as a distinct condition in which 
septicemia can lead to elevation of ketones and various anions unrelated to  diabetes mellitus, 
alcoholism, or caloric deprivation. We report four lethal cases with significantly elevated 
vitreous ketones secondary to sepsis and/or severe localized infection in individuals with no 
history of diabetes mellitus, alcoholism, or starvation. Three of four cases exhibited typical 
basal vacuolization of RTEC. We suggest that septic ketoacidosis is an appropriate cause of 
death in the forensic setting where sepsis or severe localized infection is found with 
significant ketoacidosis (β-hydroxybutyrate>5mmol/l) - in the absence of diabetes mellitus, 
alcoholism, starvation, or other states associated with accelerated ketogenesis. The finding of 
basal vacuolization of RTEC in such cases provides morphological support for the underlying 
metabolic derangement. 
 
Keywords: Forensic science, ketoacidosis, sepsis, basal vacuolization, subnuclear 







Ketoacidosis can lead to death via many mechanisms including severe extracellular 
volume contraction, electrolyte disturbances such as hypokalemia, cerebral edema, and 
sudden cardiac arrest (1,2). The cause of ketoacidosis is most commonly diabetes mellitus, 
but it may also be related to alcohol abuse, starvation, non-insulin mediated hypoglycemia 
(including inherent errors of fatty acid metabolism), and drugs (e.g. those that inhibit insulin 
release or acetyl-CoA carboxylase activity)(1). Septic ketoacidosis has recently been 
recognized in clinical settings as a separate pathological condition which can lead to marked 
ketoacidosis independent of diabetes mellitus, alcoholism, starvation, and drugs (3); it is, 
therefore, logical that sepsis or severe localized infections causing ketoacidosis could be a 
cause of death in forensic cases. 
The post-mortem diagnosis of ketoacidosis relies heavily on detecting elevations in 
vitreous β-hydroxybutyrate and acetoacetate, as often there is no gross pathology present at 
autopsy. Basal vacuolizations in renal tubular epithelial cells and characteristic formalin 
pigment deposition in the region of the basal vacuoles are, however, useful histological 
observations supporting significant ketoacidosis (4). These vacuoles have been reported in 
ketoacidosis due to diabetes mellitus, alcoholism, and starvation. We report characteristic 
basal vacuolizations found at autopsy in three of four cases of lethal septic ketoacidosis. 
 
Materials and methods 
Case files over a 5-year-period from 2010 to 2014 at Forensic Science SA, Adelaide, 
South Australia were retrospectively reviewed for all cases of sepsis and/or where death had 





complete forensic autopsies. Cases with a history of diabetes mellitus, alcoholism, recent 
starvation, or autopsy findings supporting any of these conditions were excluded. Septic 
ketoacidosis was diagnosed when vitreous humor β-hydroxybutyrate > 5mmol/l with 
normoglycemia or hypoglycemia (vitreous glucose ≤ 11mmol/l), in conjunction with positive 
bacterial cultures and autopsy findings of localized infection. Cases with insufficiently raised 
β-hydroxybutyrate levels, elevated glucose levels (>11mmol/l), or where vitreous humor 
biochemistry had not been performed were excluded. Case files were summarized and 
microscopic slides of the kidneys were then blindly reviewed for basal vacuolization of renal 
tubular epithelial cells. Cases where autolysis precluded accurate histological assessment 
were also excluded. 
 
Case reports 
Case 1: A 41–year-old Caucasian male with a history of Human Immunodeficiency Virus 
(HIV) and hepatitis C positivity was found dead lying face down outdoors. There were reports 
of him suffering from poor concentration and a change in behavior leading up to death. He 
had no history of diabetes mellitus, alcoholism, or recent starvation. At autopsy, he appeared 
adequately nourished with a BMI of 22; bilateral pneumonia was found in the lungs with 
Streptococcus pneumoniae, Staphylococcus aureus, Moraxella catarrhalis, Penicillium, and 
Mycobacterium heckeshornense identified on culture. The heart was unremarkable with no 
significant coronary artery disease, and the liver was also normal with no steatosis or 
cirrhosis. Subnuclear vacuolization of renal tubular epithelial cells was present in the kidneys, 
with no evidence of diabetic nephropathy. Vitreous biochemistry showed significant 
ketoacidosis with a β-hydroxybutyrate concentration of 13.32 mmol/l and lactate of 7.63 





detected acetone in the blood but was otherwise unremarkable. Staphylococcus aureus was 
also cultured from the spleen, thus, death was attributed to Staphylococcus aureus sepsis 
arising from pneumonia, with HIV as a likely significant underlying factor predisposing to 
infection. 
Case 2: A 78-year-old Caucasian male (BMI = 21.5) with a past medical history of epilepsy, 
dementia, and mobility problems was found dead lying supine on a concrete floor at his home 
address. His medications include lamotrigine, aspirin, and ostelin. There was no history of 
diabetes mellitus, alcoholism, or starvation. At autopsy, extensive acute bilateral confluent 
bronchopneumonia was present on a background of chronic obstructive pulmonary disease. 
Post-mortem bronchial swab and lung tissue showed a mixed growth of Klebsiella oxytoca, 
Citrobacter sp., Hemophilus influenzae, and Streptococcus pneumoniae. Examination of the 
heart revealed severe triple vessel coronary artery disease with left ventricular hypertrophy 
and myocardial scarring; no acute changes were identified. Sections of the kidneys showed 
mild to moderate generalized nephrosclerosis and subnuclear vacuolization of renal tubular 
epithelial cells. Scattered mucosal erosions were noted in the lower stomach consistent with 
hypothermic changes. Neuropathological changes of Alzheimer’s disease were present in the 
brain, with no evidence of acute trauma or ischemic injury. Multiple minor areas of bruising, 
abrasions, and underlying right rib fractures (8th, 9th, and 10th) were present, likely relating to 
a fall around the time of death. Vitreous biochemistry showed significant ketoacidosis with a 
β-hydroxybutyrate level of 8.13 mmol/l and no hyperglycemia (glucose < 0.6 mmol/l). Blood 
toxicology was unremarkable. Death was attributed to multi-organ failure, ketoacidosis, 






Case 3: A 78-year-old Caucasian male (BMI = 22) was found dead on the floor of his 
residence. He had no history of diabetes mellitus, alcoholism or starvation. Acute 
bronchopneumonia was found at autopsy and post-mortem lung swabs grew mixed organisms 
including Hemophilus influenzae. The heart was unremarkable with no significant coronary 
artery disease. Wischnewsky-type mucosal hemorrhages were present in the stomach and 
proximal small intestine. The liver showed moderate steatosis. There was no evidence of 
diabetic nephropathy or subnuclear vacuolization in the kidneys. There was a fractured left 
humerus with extensive bruising around the left shoulder most likely due to a fall associated 
with the terminal episode. There was no other evidence of trauma. Vitreous biochemistry 
showed a raised β-hydroxybutyrate level of 8.07 mmol/l with normoglycemia (1.4 mmol/l). 
Acetone was found in the blood on toxicology. Death was attributed to acute 
bronchopneumonia complicated by hypothermia with ketosis and fracture of the left humerus. 
Case 4: A 72-year-old underweight Caucasian female (BMI = 14) was found dead on the 
floor of her lounge room. It appeared that she had collapsed striking her chin. She had a 
history of breast carcinoma 20 years previously, arthritis, and possible overuse of analgesics. 
She did not have a history of diabetes mellitus, alcoholism, or starvation. At autopsy, florid 
suppurative meningitis was found with chronic inflammatory cells suggesting that the process 
had been present for some time. Streptococcus agalactiae was cultured from the brain. 
Bacterial endocarditis involved the mitral valve, and abrasions were present on her chin and 
limbs consistent with terminal collapse. Examination of the heart showed mild (up to 30%) 
stenosis of the epicardial coronary arteries but no evidence of recent or old ischemic changes. 
The liver was unremarkable with no steatosis or cirrhosis. Histopathological examination of 
the kidneys showed bacterial overgrowth and focal collections of chronic inflammatory cells, 





evidence of diabetic nephropathy. Vitreous biochemistry showed ketoacidosis (β-
hydroxybutyrate 6.26 mmol/l) but no hyperglycemia (glucose <0.6 mmol/l). Blood toxicology 




 Ketoacidosis is a form of metabolic acidosis which is known to be a complication in 
diabetics, alcoholics, and those with prolonged starvation. Recently, septic ketoacidosis has 
been suggested as a separate pathological condition in the clinical setting by Nakamura and 
colleagues who reported a case of significant ketoacidosis (β-hydroxybutyrate 9.86 mmol/l, 
acetoacetate 2.55 mmol/l) caused by Klebsiella pneumonia sepsis due to acute obstructive 
cholangitis in a non-diabetic and non-alcoholic patient with no history of starvation (3). 
Previous studies have also shown that the septic state is associated with a decreased arterial 
ketone body ratio (acetoacetate/hydroxybutyrate)(5), as is seen in diabetic and alcoholic 
ketoacidosis (6,7). Although post-mortem blood cultures were not undertaken in our cases, 
the pathological findings, in conjunction with the available microbiological results in case 1 
and 4, would be in keeping with disseminated sepsis. In cases 2 and 3, it was clear that a 
severe burden of infection was present as both were complicated by hypothermia and 
ketoacidosis, and case 2 was complicated by multi-organ failure, however, as only the post-
mortem lung tissue or lung swab was submitted for microbiology, disseminated sepsis was 
not confirmed. 
 The mechanism by which sepsis causes ketoacidosis is likely multifactorial. Sepsis is 
associated with a relative increase in the level of glucagon and impairs the actions of insulin 





deficiency. (3,8). Sepsis can also lead to ketogenesis through acetic acid overload from 
bacterial metabolism in the gastrointestinal tract, and inhibition of acetyl CoA carboxylase by 
adrenalin which is elevated during sepsis. The latter can lead to ketogenesis even without 
relative or absolute insulin deficiency (1,9). Furthermore, sepsis, particularly in its early 
stages, is associated with a hypermetabolic state, thus there is a relative increase in 
carbohydrate demands compared to normal individuals (10,11). This can contribute to and 
exaggerate ketogenesis by inducing a relative state of starvation with increased lipolysis, 
increased circulating free fatty acids presented to the liver, and subsequent increase in hepatic 
ketone production (12). Approximately half of the ketoacids produced are removed by 
oxidation in the brain and one quarter by oxidation in the kidneys (1). Other mechanisms of 
ketone removal include urinary excretion, conversion to acetone, and oxidation in the 
gastrointestinal tract (1). Sepsis is a known cause and precipitant of multi-organ failure, as in 
Case 2, and can therefore also significantly impair the removal of circulating ketones by 
affected organs. 
 On retrospective review of autopsy reports, the cause of ketoacidosis in all four cases 
had been presumed to be dehydration and inadequate food intake in the pre-terminal period of 
the infective illnesses. However, although fasting may result in mild to moderate ketosis, it is 
not known to cause a marked elevation of ketoacids to the levels seen in diabetics and 
alcoholics. This may be because although low, plasma insulin levels are still consistently 
detectable in the fasted state (12), whereas diabetic ketoacidosis is associated with absolute 
insulin deficiency. Diets with over 100g of carbohydrates a day are sufficient to prevent 
ketosis (β-hydroxybutyrate < 0.1 mmol/l), and an intake of approximately 20-40g of glucose 
per day is associated with a β-hydroxybutyrate level of around 1 mmol/l (13). The average 





days of starvation (12), and levels between 4-7 mmol/l after 2 weeks of fasting (13). There 
have, however, been two case reports of starvation ketoacidosis after approximately 3 days, 
with β-hydroxybutyrate levels of 4.5 and 5.21 mmol/l, respectively (1,14). In comparison, 
obese individuals take longer (10 to 14 days) to reach a β-hydroxybutyrate level of 2.5-4.5 
mmol/l (12). Similarly, only mild ketosis has been reported in animal studies with small 
rodents achieving a β-hydroxybutyrate level of 2-3 mmol/l with starvation, and most rodents 
having levels < 1 mmol/l (13,15). Starvation ketoacidosis with β-hydroxybutyrate levels of 
>5mmol/l may be seen in children, possibly related to the increased rate of carbohydrate 
utilization by extrahepatic tissues and lower glycogen stores compared to adults (16). 
 As there is also accelerated hepatic ketogenesis in pregnancy and lactation, 
(pregnancy is a diabetogenic state associated with relative insulin resistance, increased 
lipolysis, and elevated free fatty acids), a shorter period of starvation may precipitate 
ketoacidosis (17). For example, a report of a 22-year-old woman at 32 weeks gestation 
revealed a blood ketone level of 4.0 mmol/l after only 24 hours of starvation (18); the highest 
reported β-hydroxybutyrate level of 7.1 mmol/l associated with starvation ketoacidosis was in 
a 32-year-old lactating woman 10 days after commencing a low carbohydrate, high fat diet, 
with an estimated carbohydrate intake of less than 20g per day (19). The only case report of 
starvation ketoacidosis in a forensic setting was of a 3-year-old girl who had been starved by 
her parents for over two days with a vitreous β-hydroxybutyrate level of 3.97 mmol/l (20). 
Thus, starvation rarely causes ketoacidosis of >5mmol/l in adults, particularly in the absence 
of pregnancy and/or lactation. Furthermore, as even small amounts of glucose, such as 7.5g, 
can decrease ketone production (13), it may be incorrect to attribute significant ketoacidosis 
to starvation in the absence of known absolute or prolonged fasting, or conditions that 





 In our cases, the β-hydroxybutyrate levels ranged from 6.26 to 13.32 mmol/l (mean = 
8.95 mmol/l). None of these cases had a history of diabetes mellitus, alcohol abuse, prolonged 
fasting, or were pregnant/lactating. Vitreous glucose was not elevated in any case. Three cases 
had normal BMIs of 21.5 to 22 and only Case 4 having a low BMI of 14. Although the 
decedent in Case 4 was underweight, a comment was made in the autopsy report that “she 
appeared thin but in good general condition and well kept”. While starvation as a cause of 
ketoacidosis is an important differential diagnosis to consider, the observed degree of 
ketoacidosis in these cases is beyond that which can be accounted for by fasting alone. In 
contrast, sepsis in the absence of fasting, has been reported to show severe ketoacidosis with 
β-hydroxybutyrate of 9.86 mmol/l (3). Cases 2 and 3 also had evidence of hypothermia in the 
form of Wischnewsky ulcers (21,22). This could have been contributory to ketogenesis, as 
ketoacidosis can be aggravated by hypothermia (23), and hypothermia is a known 
complication of sepsis and severe infections associated with increased mortality (24-26). 
Therefore, the combination of an absence of documented fasting and the presence of sepsis or 
a severe burden of infection at autopsy makes septic ketoacidosis a more likely diagnosis in 
the reported cases.  
 Postmortem diagnosis of ketoacidosis can be a challenge as there are often little or 
no significant findings at autopsy. The diagnosis has traditionally relied upon detection of 
raised β-hydroxybutyrate levels on vitreous biochemistry, although vitreous humor may not 
always be available for analysis. Histological examination of the kidneys may also help in 
diagnosing ketoacidosis when characteristic basal vacuolizations in renal tubular epithelial 
cells are identified. These vacuoles contain lipid, and appear as a single row beneath the 
nucleus in contact with the basement membrane, with possible luminal displacement of 





Armanni-Ebstein lesion (27), to which they have previously been referred (28). Their 
presence has been reported in diabetic, alcoholic, and starvation ketoacidosis (20,29,30).  
 In the current study, we observed characteristic basal vacuolization (Figure 1) in 3 
out of 4 cases, which is in keeping with the association between these vacuoles and 
ketoacidotic states. Importantly, however to the best of our knowledge this is the first report 
of renal epithelial tubular basal vacuolization occurring in the setting of lethal septic 







1. Davids MR, Segal AS, Brunengraber H, Halperin ML. An unusual cause for 
ketoacidosis. Q J Med 2004;97:365-76. 
2. Yanagawa Y, Sakamoto T, Okada Y. Six cases of sudden cardiac arrest in alcoholic 
ketoacidosis. Intern Med 2008;47:113-7. 
3. Nakamura K, Inokuchi R, Doi K, Fukuda T, Tokunaga K, Nakajima S, Noiri E, 
Yahagi N. Septic ketoacidosis. Intern Med 2014;53:1071-3. 
4. Zhou C, Gilbert JD, Byard RW. Basal epithelial formalin pigment deposition in the 
kidneys – a useful marker for ketoacidosis at autopsy. J Forensic Leg Med 
2013;20:305-7. 
5. Levy B, Sadoune LO, Gelot AM, Bollaert PE, Nabet P, Larcan A. Evolution of 
lactate/pyruvate and arterial ketone body ratios in the early course of catecholamine-
treated septic shock. Crit Care Med 2000;28:114-9. 
6. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of 
monitoring to diabetes. Diabetes Metab Res Rev 1999;15:412-26. 
7. Koay ESC, Walmsley N. A primer of chemical pathology. Singapore: World 
Scientific Publishing;1996. 
8. Chambrier C, Laville M, Rhzioual Berrada K, Odeon M, Boulétreau P, Beylot M. 
Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) 
2000;99:321-8. 
9. Hahn PY, Wang P, Tait SM, Ba ZF, Reich SS, Chaudry IH. Sustained elevation in 





10. Wu C, Wang X, Yu W, Tian F, Liu S, Li P, Li J, Li N. Hypermetabolism in the initial 
phase of intensive care is related to a poor outcome in severe sepsis patients. Ann Nutr 
Metab 2015;66:188-95. 
11. Frankenfield DC, Omert LA, Badellino MM, Wiles CE 3rd, Bagley SM, Goodarzi S, 
Siegel JH. Correlation between measure energy expenditure and clinically obtained 
variables in trauma and sepsis patients. JPEN J Parenter Enteral Nutr 1994;18:398-
403. 
12. Grey NJ, Karl I, Kipnis DM. Physiologic mechanisms in the development of 
starvation ketosis in man. Diabetes 1975;24:10-6. 
13. Cahill GF Jr. Fuel metabolism in starvation. Annu Rev Nutr 2006;26:1-22. 
14. Owen D, Little S, Leach R, Wyncoll D. A patient with an unusual aetiology of a 
severe ketoacidosis. Intensive Care Med 2008;34:971-2. 
15. Drynan L, Quant PA, Zammit VA. The role of changes in the sensitivity of hepatic 
mitochondrial overt carnitine palmitoyltransferase in determining the onset of the 
ketosis of starvation in the rat. Biochem J 1996;318:767-70. 
16. Nitzan M, Kowadlo-Silbergeld A, Doron M, Laron Z. Metabolic substrates and 
hormones during starvation ketosis in children. Am J Clin Nutr 1968;21:1268-73. 
17. Sinha N, Venkatram S, Diaz-Fuentes G. Starvation ketoacidosis: a cause of severe 
anion gap metabolic acidosis in pregnancy. Case Rep Crit Care 2014;2014:906283. 
18. Frise CJ, Mackillop L, Joash K, Williamson C. Starvation ketoacidosis in pregnancy. 
Eur J Obstet Gynecol Reprod Biol 2013;167:1-7. 
19. Von Geijer L, Ekelund M. Ketoacidosis associated with low-carbohydrate diet in a 





20. Milroy CM, Parai JL. Armanni-Ebstein lesion, ketoacidosis and starvation in a child. 
Forensic Sci Med Pathol 2011;7:213-6. 
21. Bright F, Winskog C, Byard RW. Wischnewski ulcers and hypothermia – sensitive, 
specific or serendipitous? Forensic Sci Med Pathol 2013; 9: 88-90. 
22. Bright F, Winskog C, Walker M, Byard RW. Why are Wischnewski spots not always 
present in lethal hypothermia? The results of testing a stress-reduced animal model. J 
Forensic Leg Med 2013; 20: 785-787. 
23. Gale EA, Tattersall RB. Hypothermia: a complication of diabetic ketoacidosis. Br 
Med J 1978;2:1387-9. 
24. El Ghoussein H, Hegazi MO. Hypothermia with pneumonia: a rare presentation of 
brucellosis. Med Princ Pract 2011;20:485-7. 
25. Tiruvoipati R, Ong K, Gangopadhyay H, Arora S, Carney I, Botha J. Hypothermia 
predicts mortality in critically ill elderly patients with sepsis. BMC Geriatr 
2010;10:70. 
26. Drewry AM, Fuller BM, Skrupky LP, Hotchkiss RS. The presence of hypothermia 
within 24 hours of sepsis diagnosis predicts persistent lymphopenia. Crit Care Med 
2015;43:1165-9. 
27. Zhou C, Yool AJ, Nolan J, Byard RW. Armanni-Ebstein lesions: a need for 
clarification. J Forensic Sci 2013;58 Suppl 1:S94-8. 
28. Thomsen JL, Felby S, Theilade P, Nielsen E. Alcoholic ketoacidosis as a cause of 
death in forensic cases. Forensic Sci Int 1995;75:163-71. 
29. Zhou C, Gilbert JD, Byard RW. How useful is the Armanni-Ebstein phenomenon as a 





30. Zhou C, Byard RW. Basal renal tubular epithelial cell vacuolization and alcoholic 








FIG. 1- Characteristic basal vacuolizations of renal tubular epithelial cells in a 72 year old 






RENAL TUBULAR EPITHELIAL VACUOLES – A MARKER FOR BOTH 
HYPERLIPIDEMIA AND KETOACIDOSIS AT AUTOPSY 
 
CONTEXTUAL STATEMENT 
AIM: To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and hyperlipidaemia. 
 
HYPOTHESIS: That basal vacuolizations in renal tubular epithelial cells are associated with 
hyperlipidaemia. 
 
COMMENTARY:  Basal vacuolization of renal tubular epithelial cells has been reported in 
diabetic, alcoholic, septic and starvation ketoacidosis, suggesting a possible relationship to 
elevated ketones. However, the constituents of these vacuoles have been consistently 
demonstrated to contain lipids by methods including the Oil-Red-O stain and electron 
microscopy. Therefore, the authors wondered if hyperlipidaemia in the absence of 
ketoacidosis could produce basal lipid vacuolizations. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
 
CONCLUSION: Basal lipid vacuolizations in renal tubular epithelial cells are caused by 
hyperlipidaemic conditions such as nephrotic syndrome, however, the vacuoles appear to be 
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ABSTRACT:  Review of 15 cases of nephrotic syndrome found that eight had 
significant hyperlipidemia with serum cholesterol levels ranging between 10.59 and 18.60 
mmol/L (mean 12.88) and serum triglyceride levels between 2.30 and 9.92 mmol/L (mean 
4.58); all of these cases displayed basal lipid vacuolization. Seven of the 15 study cases had 
normal–mild hyperlipidemia with serum cholesterol levels ranging between 4.71 and 7.54 
mmol/L (mean 6.02) and serum triglyceride levels between 0.65 and 4.1 mmol/L (mean 
1.57). Six of the seven cases had basal lipid vacuoles (86%). Of these, five cases were 
hyperlipidemic and one case had borderline hyperlipidemia with a serum cholesterol level of 
4.71 mmol/L. Although hyperlipidemia was associated with renal tubular epithelial 
vacuolization, the vacuoles appeared morphologically different to those found in 
ketoacidosis. This study has shown that while hyperlipidemia in isolation may result in 
basal lipid vacuolization within renal tubular epithelial cells, the phenotype differs from that 
observed in ketoacidosis. 
 
Keywords: forensic science, hyperlipidemia, renal tubular epithelial vacuoles, 







A variety of metabolic derangements cause pathological changes in renal tubular 
epithelial cells. Very recently, Armanni–Ebstein phenomenon and basal vacuolization have 
been distinguished from each other due to different morphologies and probable distinct 
etiologies (1). While the pathogenesis of Armanni–Ebstein lesions has been clearly 
attributed to hyperglycemia (2,3), the exact cause of basal vacuolization remains unclear; 
basal lipid vacuolization has been reported in ketoacidosis due to diabetes, alcoholism, and 
starvation (4–7). These vacuoles stain positively with Oil-red O, contain lipids on electron 
microscopy (8,9), and demonstrate formalin pigment artifact deposition (10). In addition, 
their pathogenesis appears to be independent of glucose levels (4–7), suggesting that their 
etiology instead involves elevation of serum lipid levels (8,9). This study reviewed renal 
biopsies in cases of nephrotic syndrome to test the hypothesis that hyperlipidemia, in the 
absence of hyperglycemia and ketoacidosis, could result in the basal vacuolization similar to 
that observed in ketoacidotic states. 
 
Materials and methods 
A search of renal biopsy reports was retrospectively conducted over an 8-year period 
from 2005 to 2012 at the Department of Histopathology at the Women’s and Children’s 
Hospital, Adelaide, South Australia, where the clinical summary contained the keyword 
‘nephrotic’. Patients who did not have lipid studies, 24-h urine collection, serum 
biochemistry, or an acid-base profile within 1 month from the date of renal biopsy were 
excluded from the study. 
Hospital case notes and blood/urine test results were then reviewed. Inclusion criteria 





weight gain, pleural effusion, ascites, etc.), proteinuria (total urinary protein >0.16 g/L, 
protein/creatinine ratio >20, and albumin/creatinine ratio >3), hypoalbuminemia (<35 g/L), 
and hyperlipidemia as defined by the American Academy of Pediatrics (borderline ≥4.40 
mmol/L, high ≥5.17 mmol/L) (11). Cases that did not satisfy these criteria were excluded 
from the study. Ketoacidosis was excluded based on an absence of suggestive clinical 
signs and symptoms (e.g., history of diabetes, polyuria/polydipsia, alcohol intake, altered 
mental state, coma, Kussmaul breathing), the absence of urinary glucose and ketones, and 
normal acid– base profile. 
Study cases were then divided into two groups: those with significant 
hyperlipidemia (serum cholesterol ≥6.5 mmol/L and hypertriglyceridemia ≥2.3 mmol/L) 
and those with normal–mild elevation in lipid profiles (serum cholesterol <6.5 mmol/L or 
triglycerides <2.3 mmol/L). 
Renal biopsy slides stained with hematoxylin and eosin were then reviewed for 
vacuolization of tubular epithelial cells and graded “mild-moderate”, where vacuoles were 
limited to a basal involvement, and “marked” if one or more tubules had epithelial cells 
completely effaced by vacuoles. Lipid was confirmed within the vacuoles by Oil-Red O 
staining when frozen sections of renal biopsies were available, or by electron microscopy in 
the other cases. The severity of lipid vacuolization was then plotted against the level of 
hyperlipidemia and hypertriglyceridema to determine if a relationship existed. 
Approval was obtained from the Women’s and Children’s Hospital Human Research 







A total of 15 cases of nephrotic syndrome fulfilling the above criteria were found. 
The age range was 2–15 years (mean 8.3 years) with a male to female ratio of 8:7. The 
interval between the date of renal biopsy and lipid studies ranged from 0 to 29 days 
(mean 9.9 days), 24-h urine collection ranged from 0 to 12 days (mean 2.7 days), and 
serum biochemistry including acid–base profile ranged from 0 to 12 days (mean 3.9 days). 
Eight of the 15 study cases had significant hyperlipidemia. The age range was 2–14 years 
(mean 7.1) with a male to female ratio of 1:1.  Serum cholesterol levels ranged from 10.59  
to 18.6 mmol/L (mean 12.88) and serum triglyceride levels from 2.30 to 9.92 mmol/L 
(mean 4.58). The patients were all clinically edematous, severely proteinuric with a total 
urinary protein of 2.60–31.18 g/L (mean 9.16), protein/creatinine ratio of 295–2006 (mean 
1191.6), albumin/creatinine ratio of 15.1–1863.7 (mean  986.7),  and  hypoalbuminemic  
with  a  serum  albumin range of 13–30 g/L (mean 19.8). Three patients had no treatment 
prior to biopsy; three patients were treated with prednisolone, one with tacrolimus, and 
one with tacrolimus and prednisolone. Basal epithelial cell vacuolization was present in all 
cases including three graded as mild–moderate and five graded as severe. Basal vacuolization 
ranged from clusters of basally located vacuoles (Fig. 1A) to cases where vacuoles occupied 
virtually the entire cytoplasm of the affected cells (Fig. 1B). Oil- red O staining was 
undertaken in five cases, all of which showed positive staining for lipids (Fig. 2). Three 
cases were reviewed by electron microscopy, and intravacuolar lipid was identified in all of 
these (Fig. 3). 
Seven of the 15 study cases had normal–mild hyperlipidemia. The age range was 5–
15 years (mean 9.7) with a male to female ratio of 4:3. Serum cholesterol ranged from 4.71 
to 7.54 mmol/L (mean 6.02) and serum triglycerides from 0.65 to 4.1 mmol/L (mean 





done for incomplete remission, two for relapse after initial remission, and the other two to 
monitor response to treatment and drug toxicity. Total urinary protein in these cases ranged 
from 0.06 to 27.93 g/L (mean 7.02), protein/creatinine ratio ranged from 50 to 1961 (mean 
715.4), albumin/creatinine ratio ranged from 25.8 to 1693.3 (mean 514.2), and serum 
albumin ranged from 15 to 36 g/L (mean 24.6). One patient was not on treatment, two 
were on prednisolone, two were on tacrolimus, one was on prednisolone and tacrolimus, 
and one was on a combination of prednisolone, tacrolimus, and mycophenolate. Basal 
epithelial cell vacuolization was absent in one case and present in six cases; two were 
graded as mild– moderate and four graded as severe. Of these six cases, five cases were 
hyperlipidemic and one case had borderline hyperlipidemia with a serum cholesterol level 
of 4.71 mmol/L 10 days after the date of renal biopsy. Oil-red O staining was performed on 
one case which stained positively for lipids. Electron microscopy demonstrated 
intravacuolar lipid in all three cases where material was available. 
Plotting the degree of hypercholesterolemia and hypertriglyceridemia against the 
severity of lipid vacuolization revealed no significant relationship.  
 
Discussion 
Renal tubular epithelial cells display varying patterns of vacuolization in response to 
different metabolic stimuli. Although basal vacuolization has been referred to as “Armanni-
Ebstein” lesions due to the association with diabetic ketoacidosis, the two entities should be 
separated as they most likely have different constituents and etiology (1). The pathogenesis of 
Armanni-Ebstein lesions due to hyperglycemia has been clearly established in animal models 
(12); however, the pathogenesis of basal vacuolization remains unclear. Typically, basal 





blood glucose levels. The vacuoles stain positively with Oil-Red O, and intravacuolar lipids 
have been demonstrated on electron microscopy (13). Because of this observation, Thomsen 
et al. (9) have suggested that hyperlipidemia, lipiduria, and subsequent reabsorption in the 
renal tubules are the causes of these vacuoles. The association between ketoacidosis and 
hyperlipidemia, which has also been demonstrated in previous studies (14-17), lends support 
to this hypothesis. In the current study, patients with nephrotic syndrome were chosen for 
evaluation as hyperlipidemia occurs without a concurrent rise in serum ketones or glucose 
thus, enabling determination as to whether hyperlipidemia, independent of hyperglycemia and 
ketoacidosis, could result in basal lipid vacuolization. A limitation of this study was the time 
interval between lipid studies and the date of renal biopsy, and so a dose-response relationship 
could not be confidently established. 
Hyperlipidemia is a feature of nephrotic syndrome with elevated concentrations of  
serum  cholesterol,  triglycerides,  and phospholipids confined to lipoproteins that contain 
apoprotein B (18). One study of 207 adults with nephrotic syndrome due to nondiabetic 
renal disease showed a mean total cholesterol concentration of 203 mg/dL (7.8 mmol/L) 
(19), and another study with 100 patients revealed total serum cholesterol concentrations 
>200 mg/dL (5.2 mmol/L) in 87%, 300 mg/dL (7.8 mmol/L) in 53%, and 400 mg/dL (10.3 
mmol/L) in 25% (20). The pathogenesis of hyperlipidemia is directly related to low plasma 
oncotic pressure secondary to proteinuria and hypoalbuminemia. There is an inverse 
relationship between serum albumin concentration, plasma oncotic pressure, and serum 
lipid concentrations (18,21). Furthermore, it has also been demonstrated that an increase in 
oncotic pressure secondary to albumin or dextran reverses these changes in vitro and 
decreases lipid levels (22). Decreased oncotic pressure leads to a compensatory increase in 





transcription (22). Clearance of lipoproteins from the circulation may also be reduced in 
nephrotic syndrome as hypoalbuminemia causes decreased removal of free fatty acids and 
lysolecthin, which in turn leads to reduced activity of lipoprotein lipase and lectothin 
acyltransferase, respectively (24). 
Although intracellular lipid  vacuoles  were  observed  in  the patients with nephrotic 
syndrome, they appeared morphologically different  to  the  typical  lipid  vacuoles  found  in  
ketoacidosis. Aggregated lipid in hyperlipidemia appeared as collections of circular 
vacuoles within the cytoplasm with well-defined rims that began basally and then spread to 
involve  the  entire  cell (Fig. 1), whereas those in ketoacidosis tended to be purely basally 
located (Fig. 4) as a single large vacuole under the nucleus against the basement 
membrane. The numerous small subnuclear vacuoles in hyperlipidemia were also not 
necessarily in contact with the basement membrane. On light microscopy, vacuoles in 
ketoacidosis appeared more opaque than the translucent vacuoles in pure hyperlipidemia. 
As basal lipid vacuolization was found in fourteen of the 15 study cases, it can be 
concluded that hyperlipidemia in the absence of hyperglycemia and ketoacidosis can be 
related to this type of change in renal tubular epithelial cells. However, as the vacuoles 
appeared morphologically different to those found in ketoacidosis, future studies will be 
needed to determine whether hyperlipidemia, independent of increased permeability in 
nephrotic syndrome, can result in lipid vacuoles that are similar structurally to those 
associated with ketoacidosis, or whether the synergistic effect of elevated serum ketones 
and lower pH is required to cause this particular phenotype. Despite these disparities, the 
differential diagnosis of renal tubular epithelial cell vacuolization detected in postmortem 







1. Zhou C, Yool A, Nolan J, Byard RW. Armanni-Ebstein: a need for clarification. J 
Forensic Sci 2013; 58(Suppl 1): S94-98. 
2. Ritchie S, Waugh D. The pathology of Armanni-Ebstein diabetic nephropathy. Am J 
Pathol 1957; 33: 1035-57. 
3. Kock KF, Vestergaard V. Armanni-Ebstein lesions of the kidney: diagnostic of death 
in diabetic coma? Forensic Sci Int 1994; 67: 169-74. 
4. Zhou C, Gilbert JD, Byard RW. How useful is basal renal tubular epithelial 
vacuolization as a marker for hyperglycemia at autopsy? J Forensic Sci 2011;56:1531-
3. 
5. Zhou C, Byard RW. Basal renal tubular epithelial cell vacuolization and alcoholic 
ketoacidosis. J Forensic Sci 2012;57:126-8. 
6. Parai JL, Kodikara S, Milroy CM, Pollanen MS. Alcoholism and the Armanni-Ebstein 
lesion. Forensic Sci Med Pathol. 2012; 8: 19-22. 
7. Milroy CM, Parai JL. Armanni-Ebstein lesion, ketoacidosis and starvation in a child. 
Forensic Sci Med Pathol 2011; 7: 213-6. 
8. Thomsen JL, Hansen TP. Lipids in the proximal tubules of the kidney in diabetic 
coma. Am J Forensic Med Pathol 2000; 21: 416-8. 
9. Thomsen JL, Kristensen IB, Ottosen PD. The histological demonstration of lipids in 
the proximal renal tubules of patients with diabetic coma. Forensic Sci Med Pathol 
2006; 2: 249-52. 
10. Zhou C, Gilbert JD, Yool A, Byard RW. Basal epithelial formalin pigment deposition 
in the kidneys – a useful marker for ketoacidosis in decomposed bodies. J Forensic 





11. American Academy of Pediatrics. National cholesterol education program: report of 
the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 
1992; 89: 525-84. 
12. Rasch R. Tubular lesions in streptozotocin-diabetic rats. Diabetologia 1984; 27: 32-7. 
13. Zhou C, Byard RW. Armanni-Ebstein phenomenon and hypothermia. Forensic Sci Int 
2011; 206: e82-84. 
14. Fulop M, Eder HA. Plasma triglyceride and cholesterol in diabetic ketosis. Arch Intern 
Med 1989; 149: 1997-2002. 
15. Fulop M, Eder HA. Severe hypertriglyceridemia in diabetic ketosis. Am J Med Sci 
1990; 300: 361-5. 
16. Wasada T. Type V hyperlipidemia associated with diabetic ketoacidosis. Intern Med 
1997; 36: 535. 
17. Potter JL, Stone RT. Massive hyperlipidemia in diabetic ketoacidosis. The clinical 
importance of laboratory recognition. Clin Pediatr (Phila) 1975; 14: 412-3. 
18. Joven J, Villabona C, Vilella E, Masana L, Albertí R, Vallés M. Abnormalities of 
lipoprotein metabolism in patients with the nephrotic syndrome. N Engl J Med 1990; 
323: 579-84. 
19. Kronenberg F, Lingenhel A, Lhotta K, Rantner B, Kronenberg MF, König P, et al. 
Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic 
syndrome: Impact on lipid-lowering therapy? Kidney Int 2004; 66: 348-54. 
20. Radhakrishnan J, Appel AS, Valeri A, Appel GB. The nephrotic syndrome, lipids, and 





21. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the 
nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and 
viscosity. N Engl J Med 1985;312:1544-8. 
22. Yamauchi A, Fukuhara Y, Yamamoto S, Yano F, Takenaka M, Imai E, et al. Oncotic 
pressure regulates gene transcriptions of albumin and apolipoprotein B in cultured rat 
hepatoma cells. Am J Physiol 1992; 263: C397-404. 
23. Wuethrich RP, Marti HP. Abnormal renal function. In: Siegenthaler W. Differential 
diagnosis in internal medicine: From symptom to diagnosis. 1st Ed. New York. 
Thieme Publishing Group; 2007;836-91. 
24. Groggel GC, Border WA. Nephrotic syndrome. In: Suki WN, Massry SG. Therapy of 










Fig 1-Vacuolization of renal tubular epithelial cells in a case of nephrotic syndrome with 
hypercholesterolemia and hypertriglyceridemia demonstrating multiple basally oriented 
vacuoles (A). Vacuolization in a case of nephrotic syndrome with severe 
hypercholesterolemia and hypertriglyceridemia, demonstrating the progression of vacuoles 









Fig 2-Positive lipid staining with Oil-Red O in hyperlipidemic basal vacuoles of nephrotic 







Fig 3-Electron microscopy of basal vacuoles in nephrotic syndrome demonstrating 
intravacuolar lipid close to, but separate from the basement membrane (A). Filling of the 
entire cell with vacuoles (B) (Magnifications x 8000, x 6000). 
 
 





ARMANNI-EBSTEIN PHENOMENON AND HYPOTHERMIA 
 
CONTEXTUAL STATEMENT 
AIM: To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and hypothermia. 
 
HYPOTHESIS: That basal vacuolizations in renal tubular epithelial cells are not associated 
with hypothermia per se. 
 
COMMENTARY:  Basal vacuolization of renal tubular epithelial cells has been suggested 
by Preuβ et al as “a very reliable histologic diagnostic criterium in cases of hypothermia, 
comparable to the significance of Wischnewsky ulcers” (1). Therefore, the authors conducted 
a retrospective analysis of hypothermic deaths in an attempt to elucidate any possible 
underlying metabolic conditions which may be contributed to the development of basal lipid 
vacuoles in this context. 
 
Literature review establishing the field of knowledge is discussed within the paper. 
 
This manuscript preceded the manuscript titled “Armanni-Ebstein lesions: a need for 
clarification” in chapter 1, therefore, the terminology of “Armanni-Ebstein” 
lesions/phenomenon was still used to refer to these basal vacuolizations. The manuscript was 







CONCLUSION: Basal vacuolizations in renal tubular epithelial cells can be seen in deaths 
due to hypothermia, but the aetiology in some cases may be a manifestation of underlying 
metabolic derangements predisposing to the development of hypothermia, rather than to the 
hypothermia on its own. 
 
1. Preuβ J, Dettmeyer R, Lignitz E, Madea B. Fatty degeneration in renal tubule epithelium 
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ABSTRACT  Retrospective review was undertaken of 46 cases of lethal hypothermia 
for the presence of subnuclear vacuolization of renal tubular epithelial cells.  Fifteen of the 46 
cases (33%) had renal tubular vacuolization typical of the Armanni-Ebstein phenomenon.  
The age range was 30-87 years (average 59 years) with a male to female ratio of 6:9.  Nine of 
the 15 cases with Armanni-Ebstein changes (60%) had a history of diabetes mellitus, and in 
seven of these, vitreous humour biochemical analyses were performed, all of which revealed 
diabetic ketoacidosis (vitreous glucose levels = 32.9-85.3 mmol/L; β-hydroxybutyrate = 7.4-
20 mmol/L).  This study has confirmed the association between hypothermia and renal tubular 
epithelial vacuolization, but in addition raises the prospect that this may be contributed to in 
some cases by underlying diabetic ketoacidosis.  Hypothermic deaths should, therefore, raise 
the possibility of diabetes mellitus and initiate postmortem biochemical measurement of 
vitreous humor glucose and β-hydroxybutyrate levels. 
 
Keywords: Armanni-Ebstein phenomenon, renal tubular vacuolization, hypothermia, 






Armanni-Ebstein is the term used to describe subnuclear vacuolization of renal tubular 
epithelial cells that is most often seen in poorly controlled diabetic states.  Debate has 
occurred as to whether the accumulated material consists of glycogen or lipid, with recent 
data supporting the latter [1-3].  In addition to diabetes mellitus, renal tubular vacuolization 
has also been reported in cases of lethal hypothermia.  The following study was undertaken to 
further investigate this association. 
 
Materials and methods 
Case files from Forensic Science SA, Adelaide, Australia were retrospectively 
reviewed over a six-year period from April 2004 to March 2010 for cases where deaths were 
due to, or contributed to, by hypothermia.  All cases had undergone full police and coronial 
investigations with complete autopsy examinations being performed.  Hypothermia had been 
diagnosed when there was a recorded antemortem core temperature less than 30°C, or if 
erosive gastritis with so-called Wischnewsky spots was found at autopsy in an individual who 
had been alone for some time in a cool environment. 
Autopsy reports were reviewed and the age, gender and pathological findings were 
summarized.  Specific details of diabetic status, blood alcohol concentration and the results of 
vitreous biochemistry if performed, were recorded.  Histological sections of the kidneys were 
then examined for the presence of Armanni-Ebstein lesions. Cases where putrefaction and 







A total of 62 cases with terminal hypothermia were identified, 16 of which were 
excluded due to poor renal preservation.  Of the remaining 46 cases, Wischnewsky spots were 
present in 44 (96%) and antemortem core temperatures were taken in 7 cases (ranging from 
22.5 to 29.7oC).  Blood alcohol levels were measured in 31 cases ranging from 0 to 0.19%, 
with a mean of 0.02%.  Fifteen of the 46 cases (33%) had renal tubular vacuolization typical 
of the Armanni-Ebstein phenomenon (Fig. 1).  PAS/PAS-D staining did not reveal glycogen, 
although oil-red O staining and electron microscopy (Fig. 1 inset and Fig. 2) demonstrated 
lipid droplets.  The age range was 30-87 years (average 59 years) with a male to female ratio 
of 6:9.  Blood alcohol levels were measured in five of these cases and were negative.  Nine of 
the 15 cases with Armanni-Ebstein changes (60%) had a documented medical history of 
diabetes mellitus; in the remaining six cases the clinical history was unknown and vitreous 
humour biochemical analyses had not been performed.  Of the nine cases with a known 
history of diabetes mellitus, five had nodular glomerulosclerosis and seven had vitreous 
humour biochemical analyses performed, all of which revealed diabetic ketoacidosis (vitreous 
glucose levels = 32.9-85.3 mmol/L; β-hydroxybutyrate = 7.4-20 mmol/L); this was not tested 
for in the remaining two cases (Fig. 3).  The postmortem interval when vitreous humor was 
withdrawn ranged from 2 to 6 days, mean 5.2 days. 
A total of 31 of the 46 cases (67%) did not have Armanni-Ebstein lesions.  The ages 
ranged from 38 to 89 years (average 69.23 years) with a male to female ratio of 13:18.  A 
history of diabetes mellitus had been documented in four cases (13%) and was unknown in 
the remaining 27 cases.  Diabetic ketoacidosis had not been tested for at autopsy. 
Only one of the victims who had antemortem core temperatures taken (indicating 
survival for some time) had Armanni-Ebstein changes, and this was a woman who had died of 





hydroxybutyrate (8.87 mmol/L) levels, and no detectable blood alcohol (Brief details of this 
case have been previously reported [4]).  Deaths in the remaining six cases were due to: 
ischemic heart disease and dementia, ischemic heart disease, subdural hemorrhage, epilepsy 
and cardiomegaly, and bronchopneumonia (N = 2). 
 
Discussion 
 Hypothermia results from the body core temperature falling to less than 35°C and 
occurs when counter-regulatory mechanisms such as vasoconstriction and heat production are 
exceeded by heat loss to the environment [5,6].  Hypothermia is a significant event and has 
been associated with greater than 70% mortality when the core temperature drops to 30°C, 
and 90% at 26°C.  Lethal mechanisms include ventricular fibrillation or asystole, contributed 
to by myocardial ischemia, hypoxia, electrolyte abnormalities, and elevated catecholamine 
levels [5]. 
 The most common cause of severe hypothermia is accidental exposure to low ambient 
temperatures associated with a number of exacerbating factors such as damp conditions, air 
movement, inadequate or wet clothing, low muscle mass, alcohol ingestion and alcoholism, 
certain medications and drugs, trauma, open injuries, immobility, neurological, endocrine and 
cardiovascular disorders, and psychiatric illness [7].  Children and the elderly are at highest 
risk [5]. 
 Erosive gastritis or Wischnewsky spots are present in 40-90% of fatal hypothermia 
cases, but this may be artificially high if this finding has been used as a diagnostic parameter, 
as in the current series.  The lesions consist of superficial gastric erosions characterized 
histologically by necrosis of the mucosa with acid hematin formation.  Acute pancreatitis with 





 Fatty changes on routine histology have been associated with fatal hypothermia, with 
vacuolization of hepatocytes and cardiac myocytes occasionally being documented [6].  In 
terms of renal tubules, Preuβ et al demonstrated basal vacuolization of tubular epithelial cells 
in 87% of cases of terminal hypothermia leading to the conclusion that these changes 
represented “a very reliable histologic diagnostic criterium in cases of hypothermia, 
comparable to the significance of Wischnewsky ulcers” [8].  The vacuoles stain positively for 
lipids and are morphologically similar to Armanni-Ebstein lesions that are strongly associated 
with poorly controlled diabetic states and deaths due to diabetic ketoacidosis [9,10].  While 
the vacuoles in Armanni-Ebstein lesions complicating diabetes were initially thought to 
contain to glycogen [9-13], recent studies have demonstrated positive staining for lipids, 
suggesting that the vacuoles consist of accumulated triglycerides [1-3].  Occasionally the 
vacuolization may be so profound that it can be observed macroscopically as cortical pallor 
[4].  In our series, a case of hypothermia and diabetic ketoacidosis demonstrated lipid on both 
histological staining and on electron microscopy (Figs 1 and 2). 
. Although it has been asserted that “fatty degeneration of renal tubules cannot be 
regarded as a sign of diabetes” [8], it is unclear from this study what the levels of glucose and 
β-hydroxybutyrate were.  Certainly while many individuals with a history of diabetes mellitus 
do not manifest Armanni-Ebstein phenomenon, due to lack of terminal ketoacidosis, others do 
[1-3,9-13,14].  Thus, as the renal tubular vacuoles in hypothermia and in diabetic ketoacidosis 
appear similar in morphology and composition, the current study was undertaken to ascertain 
whether there might be a relationship between cases of hypothermia with Armanni-Ebstein 
phenomenon, and diabetes mellitus, as has been suggested in a case report that was not 





 The diagnosis of Armanni-Ebstein phenomenon at autopsy may be difficult if there 
has been significant putrefaction and/or autolysis, as this may cause nonspecific cytoplasmic 
vacuolization and artefactual separation of proximal tubular epithelial cells from the basement 
membrane, features that resemble Armanni-Ebstein lesions.  This may be predisposed to in 
hypothermic deaths when there has been social isolation and delay in finding the victim, as 
this may enhance putrefactive changes [16]. 
 The present study has shown that more than half of the cases of terminal hypothermia 
where Armanni-Ebstein change was observed (60%) had an established history of diabetes 
mellitus.  This may well be a significant underestimation, as a history of diabetes mellitus 
may not have been volunteered in the remaining cases, and so vitreous biochemical testing 
was not routinely undertaken.  Significantly, of the nine known diabetic victims with 
Armanni-Ebstein lesions, all who were tested (N = 7) had biochemical evidence of diabetic 
ketoacidosis.  This suggests that renal tubular epithelial vacuolization in cases of hypothermia 
may have a significant association with diabetic ketoacidosis. 
 In turning to the literature, there is certainly a recognized association between diabetes 
mellitus and hypothermia, with diabetic individuals being more susceptible to dropping their 
core temperature [7] resulting in hospital admissions for hypothermia being more common 
among diabetic patients compared to the general population [17,18].  This may be influenced 
by the greater frequency of pathological conditions that are associated with an increased risk 
of hypothermia among the diabetic population, such as other endocrinopathies [18].  
Autonomic neuropathy, which is a common complication of diabetes mellitus, also places 
individuals at increased risk of developing hypothermia due to impaired physiologic 





 Metabolic complications of diabetes mellitus can cause secondary hypothermia.  For 
example, hypoglycaemia may result in increased heat loss from sweating, inhibition of 
shivering, and peripheral vasodilation [17-19].  Hypothermia may also be a cause and a 
complication of diabetic ketoacidosis [21] with Gale and Tattersall reporting diabetic 
ketoacidosis as the basis for 11.8% of all hospital admissions for severe hypothermia; a rate 
higher than that for hypothyroidism (8%) [22]. Acidosis can interfere with thermoregulation 
and cause peripheral vasodilation with a reduced ability to maintain core body temperature 
when exposed to cold ambient temperatures [23,24].  Insulin deficiency in diabetic 
ketoacidosis also decreases the uptake of glucose into muscles and adipose tissue, leading to 
decreased substrate availability for heat production and impaired chemical thermogenesis [7, 
21,23]. 
A reverse relationship between hypothermia and diabetes mellitus also exists as 
primary hypothermia can worsen a decompensated diabetic state.  When the core temperature 
decreases below 32°C, insulin activity and release are both markedly reduced, resistance to 
exogenous insulin develops, and peripheral utilization of glucose declines.  Additionally, 
there is also increased secretion of catecholamines and cortisol during hypothermic states, 
which exacerbate diabetic ketoacidosis [7,22,24]. Consequently, concurrent hypothermia and 
diabetic ketoacidosis may initiate a vicious metabolic cycle associated with a high mortality 
rate exceeding 30% [25]. 
 Although in the current study, Armanni-Ebstein lesions were found in only 
approximately a third of cases with terminal hypothermia, considerably less than other studies 
[8], the association between renal tubular epithelial vacuolization and hypothermia was 
confirmed.  While the numbers in the study are relatively small and the review was 





those with Armanni-Ebstein changes, and all of those from this group who were tested 
exhibited biochemical evidence of diabetic ketoacidosis.  Thus, we concur with other authors 
that Armanni-Ebstein lesions are a feature of hypothermic deaths [5,6,8], but would also 
suggest that in some cases this may occur due to an association with diabetic ketoacidosis, 
rather than as a result of a significant reduction in body temperature per se.  Thus when 
hypothermia is suspected at autopsy, specific enquiry should be made regarding a possible 
history of diabetes mellitus and vitreous humour should be tested for elevated glucose, β-
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FIG. 1-Characteristic subnuclear vacuolization of renal tubular epithelial cells in a case of 
hypothermia and ketoacidosis (Hematoxylin & eosin x 100).  Inset shows patchy oil-red O 
staining of lipid droplets within tubular epithelial cells (x 60) 
 
 








FIG. 3-An analysis of 46 cases with hypothermia showing the number of cases with Armanni-
Ebstein phenomenon and the relationship to diabetes mellitus and ketoacidosis (DKA) on 






RENAL CORTICAL PALLOR – A USEFUL MACROSCOPIC MARKER FOR 
METABOLIC DERANGEMENTS AT AUTOPSY 
 
CONTEXTUAL STATEMENT 
AIM: To investigate if macroscopic renal cortical pallor can be a useful sign for underlying 
metabolic derangements at autopsy. 
 
HYPOTHESIS: That macroscopic renal cortical pallor at autopsy may be an early indication 
of basal vacuolization of renal tubular epithelial cells. 
 
COMMENTARY:  The authors have previously reported a case of diabetic ketoacidosis 
where marked pallor of the renal cortices was associated with underlying prominent basal 
vacuolization of the proximal convoluted tubules (1). Following on from this, a retrospective 
review of cases demonstrating macroscopic renal cortical pallor was conducted to further 
define the usefulness of this sign at autopsy. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
 
CONCLUSION: Macroscopic renal cortical pallor is a useful marker for significant 
metabolic derangements and the underlying spectrum of histologic changes includes basal 





autopsy should prompt measurement of vitreous humour glucose and β-hydroxybutyrate 
levels. 
 
1. Zhou C, Gilbert JD, Byard RW. Early diagnosis of Armanni-Ebstein phenomenon at 
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ABSTRACT  Renal cortical pallor was studied as a potential marker at autopsy of 
diabetic ketoacidosis in 23 cases, hyperglycemic non-ketotic coma in eight cases, and 
alcoholic ketoacidosis in five cases (vitreous humor glucose >11.1 mM; β-hydroxybutyrate 
>5 mM).  Renal cortical pallor was noted on macroscopic examination in 10 of 23 cases of 
lethal diabetic ketoacidosis (43.5%), three of eight cases of fatal hyperglycemic non-ketotic 
coma (37.5%) and in two of five cases of alcoholic ketoacidosis (40%).  Histological 
examination revealed basal vacuolization of renal tubular epithelial cells in 12 cases, 
Armanni-Ebstein lesions in 10, and osmotic nephrosis in three.  Although renal cortical pallor 
did not appear to be a particularly sensitive marker for hyperglycemia or ketoacidosis, and did 
not correlate with the severity of these parameters, it may still represent a useful macroscopic 
marker for underlying metabolic conditions at autopsy and should therefore prompt 
measurement of vitreous humor glucose and β-hydroxybutyrate levels. 
 
Keywords: Forensic science, renal cortical pallor, ketoacidosis, diabetes mellitus, alcoholism, 







In previous studies we have investigated the histologic manifestations of ketoacidosis 
and hyperglycemia in the tubular epithelium of the kidney, where it appears that at least two 
distinct changes may occur involving basal vacuolization and Armanni-Ebstein change (1,2). 
Although there has been some confusion in the literature regarding terminology, swelling of 
cells with loss of normal shape, clearing of cytoplasm, and accumulation of cytoplasmic 
glycogen represent the classical changes first described by Armanni and Ebstein due to 
glycogen nephrosis associated with hyperglycemia and glucosuria (3).  In addition, basal 
vacuolization due to lipid accumulation with luminal displacement of nuclei may be present, 
and linked to ketoacidosis (3).  Osmotic nephrosis is another change that may occur in tubular 
epithelial cells exposed to high solute concentrations with diffuse intracytoplasmic 
vacuolization.  One of the associated changes that we observed macroscopically in some of 
these cases was marked renal cortical pallor (4,5).  The following study was undertaken to 
determine how useful this feature is at the time of autopsy dissection as a marker of 
underlying metabolic disturbance, and whether it is of value in the assessment of lethal 
diabetic ketoacidosis, hyperglycemic non-ketotic coma, and alcoholic ketoacidosis. 
 
Materials and Methods 
Case files over a 6-year period from 2004 to 2009 at Forensic Science SA, Adelaide, 
South Australia, were retrospectively reviewed for all cases in which the cause of death was 
listed as diabetic ketoacidosis, hyperglycemic non-ketotic coma, or alcoholic ketoacidosis.  
All cases had full coronial and police investigations with complete forensic autopsies.  
Significant diabetic ketoacidosis was recorded when the vitreous humor glucose was >11.1 





vitreous hyperglycemia (>11.1 mM) with no elevation of β-hydroxybutyrate levels.  
Significant alcoholic ketoacidosis was diagnosed when the vitreous humor β-hydroxybutyrate 
was >5 mM with normo- or hypoglycemia (vitreous glucose ≤11 mM) in conjunction with a 
history of alcohol abuse and/or autopsy findings suggestive of chronic alcoholism.  Cases that 
did not meet these criteria, those with an incomplete vitreous humor biochemical screen, and 
those in which kidneys were autolysed to a level that prevented accurate histological 
assessment were excluded from the series. 
 The autopsy reports of the study cases were then reviewed with special attention to the 
documentation of renal cortical pallor.  When pallor was present, histological slides of the 
kidneys were examined. Statistical analysis was conducted using unpaired Student’s t-test, 
and statistical significance was defined as p<0.05. 
 
Results 
 A total of 36 study cases were identified with 23 deaths due to diabetic ketoacidosis, 
eight due to hyperglycemic non-ketotic coma, and five due to alcoholic ketoacidosis. 
 The 23 cases of lethal diabetic ketoacidosis consisted of 13 men and 10 women (age 
range 21-80 years; mean 47.6 years).  Ten had renal cortical pallor documented at autopsy 
(43.5%; age range 21-80 years; mean 43.4 years; M:F = 1:1; Fig. 1).  In this group, vitreous 
humor glucose ranged from 32.9 to 71.8 mM (mean 47.33 mM) and β-hydroxybutyrate 
ranged from 8.85 to 20.40 mM (mean 13.15 mM).  The remaining 13 cases did not have 
pallor of the kidneys documented.  These consisted of eight men and five women, whose age 
ranged from 25 to 80 years (mean 50.8 years).  Their vitreous glucose levels ranged from 22.2 
to 91.9 mM (mean 54.73 mM) and β-hydroxybutyrate levels ranged from 6.3 to 20.0 mM 





and β-hydroxybutyrate levels (p = 0.53) between the cases with renal cortical pallor and those 
without.  Seven cases with renal cortical pallor showed superficial gastric erosions, or 
Wischnewsky spots, indicating that hypothermia played a role in the terminal episodes. 
 The eight cases of fatal hyperglycemic non-ketotic coma were aged between 14 and 60 
years (mean 43.1 years; M:F = 5:3).  Three of these cases had pallor of the renal cortices 
(37.5%; age range 37-60 years; mean 50.3 years; all were men).  The vitreous glucose levels 
ranged from 19.7 to 35.8 mM (mean 28.3 mM), with normal levels β-hydroxybutyrate (range 
0.2-2.55 mM; mean 1.25).  The remaining five cases that did not have noticeably pale renal 
cortices were aged from 14 to 52 years (mean 38.8 years; M:F = 2:3) with vitreous glucose 
levels ranging from 17.0 to 49.7 mM (mean 28.88 mM), and β-hydroxybutyrate levels 
ranging from 0.02 to 1.65 mM (mean 0.7 mM).  There was no statistically significant 
difference in the glucose (p = 0.95) and β-hydroxybutyrate levels (p = 0.41) between the cases 
with and without renal cortical pallor. 
 All five cases where death was due to alcoholic ketoacidosis had a history of 
chronic alcohol abuse, two with hepatomegaly, three with steatosis and periportal fibrosis, 
and one each with macrovesicular steatosis and splenomegaly.  The age ranged from 51 to 72 
years (mean 61 years), and all were men.  Two cases had renal cortical pallor (40%), both 
were men aged 63 and 51 years, respectively.  Vitreous humor glucose levels were 2.6 and 4.2 
mM, and β-hydroxybutyrate levels were 7.40 and 6.42 mM, respectively.  The remaining 
three cases without pallor of the kidneys were aged from 51 to 72 years (mean 63.7 years).  
There was no elevation in glucose levels (range 0.1-0.3 mM; mean 0.17), with elevated β-
hydroxybutyrate levels ranging from 7.55 to 8.75 mM (mean 8.17).  Given the low numbers 
of these cases, statistical evaluations were not performed.  One case with renal cortical pallor 





 Histological examination of slides from the cases with diabetic ketoacidosis and 
cortical pallor revealed basal vacuolization of tubular epithelial cells in all 10 cases (Fig. 2), 
with Armanni-Ebstein changes in seven (Fig. 3).  In the three cases of hyperglycemic non-
ketotic coma and cortical pallor, there were two cases with Armanni-Ebstein change and no 
cases with basal vacuolization.  Both cases of alcoholic ketoacidosis had basal vacuolization 
with one case having Armanni-Ebstein changes.  In this case, there was demonstrable 
pancreatic fibrosis with a 4-day post mortem interval.  Three cases had diffuse vacuolization 
and swelling typical of osmotic nephrosis. 
 
Discussion 
 Pallor of the kidneys involving both the cortex and medulla may be observed in 
situations of acute blood loss.  Differential pallor of the cortex compared to the medulla is, 
however, suggestive of a more specific and localized effect, which may be a marker for local 
cell necrosis.  For example, pallor of the renal cortices is a feature of renal cortical necrosis, in 
which coagulative necrosis results in the development of patchy or diffuse sharply demarcated 
zones of pallor with hyperemic rims (6,7).  It may also be seen in acute tubular necrosis (8,9) 
and has been reported in cases of severe asphyxia (10) and septicemia (11,12).  Cortical pallor 
may also be a feature of acute renal failure, possibly due to the redistribution of blood flow 
away from cortical glomeruli (13). Renal cortical pallor may also be observed in cases where 
death involves diabetic ketoacidosis and hypothermia, due to underlying metabolic 
derangements that may merely alter the composition and structure of renal tubular epithelial 
cells, rather than inducing necrosis (4,5). 
 Three different metabolic disorders commonly seen in the forensic context were 





and alcoholic ketoacidosis.  Diabetic ketoacidosis arises when counterregulatory hormone 
excess in conjunction with insulin deficiency leads to increased gluconeogenesis, increased 
glycogenolysis, and decreased glyconeogenesis. Ketogenesis also occurs as oxaloacetate is 
directed to gluconeogenesis, resulting in a relative lack of oxaloacetate for use in the Krebs 
cycle, and a corresponding rise in acetyl-CoA, which would otherwise have been consumed.  
Consequently, acetyl-CoA is used for the production of ketones (14,15), and elevated levels 
of both glucose and β-hydroxybutyrate may be detected in the vitreous humor at autopsy.  
 In contrast, ketoacidosis does not occur in most type 2 diabetics with metabolic 
decompensation; instead, they progress to a hyperglycemic hyperosmolar nonketotic state.  
This is most likely due to the presence of residual pancreatic function with secretion of small 
amounts of insulin that depress the release of counter-regulatory hormones and the 
mobilization of free fatty acids, thus inhibiting ketogenesis (16).  The vitreous biochemistry 
profile in these cases is, therefore, one of elevated glucose levels in the absence of elevated β-
hydroxybutyrate. 
 Alcoholic ketoacidosis tends to occur in malnourished, chronic alcoholics who have 
low protein and carbohydrate stores, and/or alcoholic liver disease with subsequent hepatic 
glycogen depletion (17,18).  This, in addition to volume depletion caused by vomiting, 
decreased fluid intake, and/or diaphoresis, leads to a fall in blood glucose levels, the 
suppression of insulin, and a sympathetic response causing increases in catecholamines, 
cortisol, growth hormone, and glucagon levels (17,19).  These hormones, in conjunction with 
the direct effect of ethanol, promote the mobilization of free fatty acids to the liver (17).  
When the supply exceeds the rate of oxidation, a surplus of acetyl-CoA results, which is 
converted into acetoacetate (20).  Additionally, alcohol dehydrogenase preferentially uses 





lactate to pyruvate, with subsequent decreased production of oxaloacetate required for 
gluconeogenesis; thus gluconeogenesis is inhibited.  Alcoholic ketoacidosis can be identified 
on post mortem vitreous biochemistry by an elevated β-hydroxybutyrate levels in the setting 
of hypo- or normoglycemia. 
 Macroscopic pallor of the renal cortices was found in all three of these metabolic 
disorders, specifically in 43.5% of those with diabetic ketoacidosis, in 37.5% of those with 
hyperglycemic nonketotic coma, and in 40% of those with alcoholic ketoacidosis (Table 1).  
In the cases of diabetic ketoacidosis and those dying from hyperglycemic nonketotic coma, no 
statistically significant difference could be demonstrated between the cases that had renal 
cortical pallor, and those that did not, in the glucose (p = 0.35 and 0.95, respectively) and β-
hydroxybutyrate levels (p = 0.53 and 0.41, respectively).  Thus, the presence of macroscopic 
pallor did not appear to correlate with the severity of the underlying metabolic disturbance. 
 Histologic investigation was also carried out in those cases with pale renal cortices to 
identify corresponding morphological abnormalities.  Subnuclear vacuolization of tubular 
epithelial cells, as described by Thomsen et al. (20,21), was found in all of the cases of 
diabetic and alcoholic ketoacidosis (N = 12), in keeping with the effects of ketoacidosis.  
Characteristic Armanni-Ebstein changes were seen in the tubules of 70% (7/10) of those who 
had died of diabetic ketoacidosis, and in 67% (2/3) of those who had died from 
hyperglycemic nonketotic coma whose kidneys displayed renal cortical pallor.  This would be 
in keeping with the effects of hyperglycemia.  It is apparent, therefore, that renal cortical 
pallor may be caused by different subcellular morphological abnormalities. 
 An unusual finding was that of Armanni-Ebstein change in renal tubular epithelial 
cells in a case of alcoholic ketocacidosis without an elevated glucose level.  However, in this 





was a post mortem interval of 4 days.  The presence of pancreatic fibrosis could be further 
evidence to suggest that there may have been an underlying disturbance in pancreatic 
function.  
 A potential problem with this study is its retrospective nature, in that not all cases of 
renal cortical pallor may have been documented.  However, alternatively this also means that 
at the time of assessment of renal color there was no skewing by potential observer bias. 
 An interesting observation made during the study was that concurrent hypothermia 
was present in seven out of the 10 individuals who died from diabetic ketoacidosis with renal 
cortical pallor.  It was also present in the single case of alcoholic ketoacidosis with pallor.  
Although it has been proposed that one of the substrates of cortical pallor, renal epithelial 
subnuclear vacuolization, may be caused by hypothermia in isolation (22), we consider that it 
is more likely to involve a more complex interaction between both diabetic ketoacidosis and 
reduced body core temperature (23).  The concurrence of the two in the present study may 
suggest that hypothermia may add to the underlying metabolic disturbance, and therefore 
could contribute to the development of macroscopic pallor. 
 In conclusion, this study has shown that renal cortical pallor in cases of suspected 
ketoacidosis or hyperglycemia represents a marker for significant metabolic derangement in 
only 37.5-43.5% of cases.  Once observed at autopsy, however, full biochemical screening 
may provide further useful information.  The histologic basis for pallor was underlying 
glycogen nephrosis (Armanni-Ebstein phenomenon), subnuclear lipid vacuolization, and/or 
osmotic nephrosis.  The presence of renal cortical pallor did not appear to be a reflection of 
the severity of the underlying metabolic derangement and may have been contributed to by 
hypothermia.  The sensitivity and specificity of renal cortical pallor in the general autopsy 
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FIG 1-Typical pallor of the renal cortex relative to the medulla that may be observed in cases 
of diabetic ketoacidosis, hyperglycemic nonketotic coma and alcoholic ketoacidosis. 
 
FIG 2- Diffuse basal subnuclear vacuolization of renal tubular epithelial cells in a case of 







FIG 3- Armanni-Ebstein lesions of renal tubules with ballooning of epithelial cells in a case 









BASAL EPITHELIAL FORMAIN PIGMENT DEPOSITION IN THE KIDNEYS – A 
USEFUL MARKER FOR KETOACIDOSIS AT AUTOPSY 
 
CONTEXTUAL STATEMENT 
AIM: To investigate if characteristic formalin pigment deposition can be used as a surrogate 
marker for basal vacuolizations. 
 
HYPOTHESIS: That formalin pigment deposition in a characteristic basal distribution may 
be used as a surrogate marker for basal vacuolization. 
 
COMMENTARY:  Formalin pigment deposition is an artefact seen on histologic sections 
which is not known to have any diagnostic utility. However, occasionally they have been 
noted to deposit in a characteristic basal distribution in the area corresponding to basal 
vacuolizations. Therefore, a retrospective review of ketoacidotic deaths was conducted to 
further define the usefulness of this sign. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic and Legal Medicine. 
 
CONCLUSION: Formalin pigment deposition in a characteristic basal distribution is a useful 
surrogate marker for basal vacuolization, especially in cases where significant putrefaction or 
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ABSTRACT  Basal vacuolization of renal epithelial cells occurs in diabetic and 
alcoholic ketoacidosis, hypothermia and starvation.  The vacuoles contain triglycerides.  
Following a case where formalin pigment deposition within these vacuoles led to the 
identification of ketoacidosis, a retrospective review of a further 31 cases with ketoacidosis, 
was undertaken.  There were 24 diabetics and 7 alcoholics (age range 21-80 yrs; mean 
50.9yrs; M:F ratio = 2:1.  The post-mortem interval was 1-12 days (mean – 4.5 days).  
Characteristic basally-located pigment surrounding vacuoles was found in 16 cases (51.6%) 
(14 diabetic ketoacidosis; 2 alcoholic ketoacidosis).  Fifteen cases had no formalin pigment 
deposition.  No relationship could be found between the intensity of staining and the 
postmortem interval, degree of putrefaction, or level of vitreous humor β-hydroxybutyrate.  
No staining was demonstrated in control cases matched for postmortem interval.  Although 
formalin pigment deposition occurred in only 51.6% of cases with proven ketoacidosis at 
autopsy, it appeared to be a highly specific phenomenon.  As these deposits were identifiable 
after recognizable cellular morphology had been lost due to autolysis and putrefaction, this 
artefact of fixation may be of particular use in suggesting the possibility of ketoacidosis in 
decomposed bodies with compromised histology. 
 








The aetiology of basal vacuolization of epithelial cells of the proximal convoluted 
tubules of the kidney in the cortex and outer medulla remains unclear1.  Cases have been 
reported in association with diabetic and alcoholic ketoacidosis, hypothermia and starvation2-
12, and may be identified macroscopically at autopsy by renal cortical pallor13,14.  Vacuoles 
have been shown to contain the neutral lipid, triglyceride3,4.  As this could be the only 
indication of ketoacidosis at autopsy, this may be a very significant diagnostic finding.  
Unfortunately, cellular morphology is progressively lost after death; a process which may be 
exacerbated by the high glucose levels in diabetics15, resulting in almost complete loss of 
microscopic detail in badly decomposed bodies.  One of the authors (JDG) has observed, 
however, that formalin pigment preferentially deposits in the areas of basal vacuolization.  
The results of the following case and study are reported to demonstrate the usefulness of this 
finding as a marker of basal vacuolization from ketoacidosis, particularly when tissue 
preservation is suboptimal. 
 
Case report 
A case of unexpected death is reported in an adult male who was found dead in bed at 
his home address.  At autopsy there were moderate putrefactive changes.  Toxicology did not 
reveal any lethal drugs or poisons.  There were no injuries present.  Although extensive 
putrefactive changes hindered accurate assessment of the histology (postmortem interval = 6 
days), the pancreas showed patchy lobular atrophy and fibrosis and the liver focal severe 
steatosis, in keeping with alcohol related damage.  In addition, deposits of birefringent 
formalin pigment were noted outlining subnuclear basal spaces in proximal convoluted 





of the authors (JDG) in cases of ketoacidosis, biochemical analysis of vitreous humor was 
undertaken.  This showed a markedly elevated glucose level of (51.3 mmol/L) and a raised 
level of β-hydroxybutyrate (8.33 mmol/L).  Death was therefore attributed to diabetic 
ketoacidosis.  Subsequent information indicated that the deceased had been complaining of 
polyuria and polydipsia in the week preceding death and had a family history of diabetes 
mellitus. 
 
Materials and methods 
In view of these results, case files were retrospectively reviewed at Forensic Science 
SA, Adelaide, South Australia, over a six-year period from 2004 to 2009 for other cases of 
diabetic and alcoholic ketoacidosis.  All cases had full coronial and police investigations with 
complete forensic autopsies.  Ketoacidosis was diagnosed when the vitreous humor β-
hydroxybutyrate was > 5 mmol/L.  Postmortem interval was noted.  A control group matched 
for post-mortem interval was randomly selected from case files from the same time period for 
comparison.  All cases had renal tissue routinely sampled at autopsy and fixed in 10% 
buffered formalin solution for 24-48 h prior to processing for histology. 
 A single renal slide stained with haematoxylin and eosin from each case was evaluated 
blind for basal vacuolization and the presence of characteristic formalin pigment deposition: 
i.e. along the base of epithelial cells and outlining basal vacuoles within the proximal 
convoluted tubules of the kidney in the cortex and outer medulla.  Cases were graded as 0 if 
there was no evidence of this type of basal tubular epithelial cell formalin pigment deposition, 
1+ if there was mild focal deposition, 2+ if there was moderate-severe focal, or diffuse mild 
deposition, and 3+ if there was moderate to marked diffuse deposition.  Cases were also 





putrefaction, 1+ mild, 2+ moderate and 3+ marked, the latter with complete loss of normal 
cellular detail. 
 The amount of formalin pigment deposition was compared between the cases with 
ketoacidosis and the controls, and was also plotted against postmortem interval, degree of 
autolysis/putrefaction and β-hydroxybutyrate levels. 
 
Results 
A total of 31 cases were found with ketoacidosis, consisting of 24 individuals with 
diabetes mellitus and seven with alcoholism.  The age range was 21-80 years (mean 50.9 
years) with a male to female ratio of 20:11.  The post-mortem interval ranged from 1 to 12 
days (mean – 4.5 days).  A frequent feature of basal epithelial cell formalin pigment 
deposition was geographic variation, with no staining in some areas of the cortex contrasting 
with marked staining in other areas in the same case (Fig. 2).  Formalin pigment was found in 
16 cases (51.6%) (in 14 cases of diabetic ketoacidosis [58.3%] and in 2 cases of alcoholic 
ketoacidosis [28.6%] [Fig. 3]). The number of cases without formalin pigment deposition was 
15. There were 13 cases with no signs of decomposition, 7 cases with 1+ decomposition, 11 
cases with 2+ decomposition.  Staining was intense (>2+) in cases with short postmortem 
intervals and no autolysis/putrefaction (Fig. 4), and also in cases with long postmortem 
intervals and marked autolysis/putrefaction, as in the reported case.  No staining was 
demonstrated in any of the 31 control cases.   
 Plotting the degree of formalin pigment deposition against postmortem interval 
revealed no significant relationship.  Similarly, no relationship could be demonstrated 
between the degree of autolytic/putrefactive changes and degree of formalin pigment 






A variety of different types of vacuoles occur in renal tubules.  Clear cell change of 
the proximal tubular epithelium may be caused by hyperglycemia and is known as glycogen 
nephrosis or Armanni Ebstein change16-18.  Ketoacidosis from a variety of causes may result 
in basal vacuolization of tubular cells, with displacement of nuclei towards the lumina2,3.  The 
detection of these changes on postmortem histology should raise the suspicion of an 
underlying metabolic disturbance and initiate biochemical analysis of vitreous humor to test 
for this possibility14.  However, renal tubular epithelium quickly degrades after death due to 
the combined effects of autolysis and putrefaction.  Thus, basal vacuolization may be 
obscured by cytoplasmic degeneration and lifting of cells away from the basement membrane.  
In the absence of a history or other indications of underlying metabolic derangements, such as 
alcohol abuse or diabetes mellitus, these diagnoses may go undiscovered.  
 Formaldehyde is used as a tissue preservative in most histology laboratories, and is 
commonly utilized in buffered preparations at 10% concentration.  This fixative has been 
known to produce an artefact known as ‘formalin pigment’ or ‘acid formaldehyde haematin’, 
which appears as dark brown to black, finely granular, birefringent microcrystals19-21. These 
pigments are iron-free derivatives of haemoglobin, and are formed when blood-rich tissues 
are fixed with aqueous solutions of formaldehyde at pH less than 6.020,22.  Historically, these 
pigments have been deemed an artefact with no pathologic significance, and many techniques 
have been described for their prevention and removal19,23-25. 
 In 1971, Holmes reported an affinity of formalin pigment for fat, noting that it was 
often localized to cells which contained fat before processing of tissues in solvents. These 
included fatty vacuoles within cells of the liver, kidneys, and lungs21. The current study has 





kidney during fixation in areas of accumulated triglyceride.  This striking aggregation of 
formalin pigment to the areas of triglycerides may occur because of the breakdown of 
triglycerides into component fatty acids, providing a localized area of reduced pH that 
provokes pigment deposition. 
 The observation that formalin pigment preferentially deposits in the vacuolated 
epithelial cells of the renal tubules in cases of ketoacidosis (either diabetic or alcoholic) may 
be significant as this may enhance the postmortem detection of metabolic disturbances.  As 
pigment deposition may be very focal in nature, it may be useful to examine multiple areas of 
the cortex and outer medulla.  The reason for the lack of correlation with postmortem interval 
and degree of decomposition is unclear, but may be related to factors that were not controlled 
for in this study such as minor differences in concentration of the formalin solution, amount 
of buffer, or time of fixation.  While formalin deposition does not appear to be a particularly 
sensitive marker of ketoacidotic basal vacuolization (occurring in only 51.6% of cases), it 
does appear to be highly specific (100%).  Given that these deposits are present even after 
autolysis and putrefaction have destroyed recognizable cellular morphology, this finding may 
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FIG. 1-Prominent formalin pigment deposition in the reported case with a prolonged 
postmortem interval (6 days) and marked loss of cellular detail demonstrating the usefulness 




FIG. 2-Characteristic basal vacuolization of the epithelial cells of the proximal convoluted 
tubules of the kidney in the cortex in a case of diabetic ketoacidosis with no formalin pigment 
deposition (A), contrasting with adjacent areas where there was prominent deposition of 








FIG. 3- Characteristic basal vacuolization of the epithelial cells of the proximal convoluted 
tubules of the kidney in the cortex in a case of alcoholic ketoacidosis with prominent formalin 
pigment deposition (H&E x 100). 
 
 
FIG. 4- Prominent formalin pigment deposition in a case with a short postmortem interval (1 
















CHAPTER 3: DETERMINING INCIDENCE AND 






ARMANNI-EBSTEIN LESIONS IN TERMINAL HYPERGLYCEMIA 
 
CONTEXTUAL STATEMENT 
AIM: To determine the incidence of Armanni-Ebstein lesions and investigate their 
relationship with hyperglycaemia. 
 
HYPOTHESIS: That Armanni-Ebstein lesions are uncommon in hyperglycaemia and their 
incidence correlates with the degree of glucose elevation. 
 
COMMENTARY:  Armanni-Ebstein lesions refer to a phenomenon of cytoplasmic clearing 
due to glycogen accumulation within renal tubular epithelial cells. Prior animal studies have 
demonstrated a direct relationship between glucose levels and the appearance of Armanni-
Ebstein lesions. Therefore, a retrospective review of all cases with terminal hyperglycaemia 
(≥11.1 mmol/l) was conducted to determine if the results of previous animal studies translated 
to humans. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
 
CONCLUSIONS:  
1. Armanni-Ebstein lesions are present in 38% of cases with terminal hyperglycaemia 
(≥11.1 mmol/l). 
2. There is no significant difference in vitreous glucose levels between cases with and 





3. Cases with Armanni-Ebstein lesions have a significantly higher level of β-
hydroxybutyrate compared to cases without, suggesting that ketoacidosis may 
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ABSTRACT:  Armanni-Ebstein lesions (AEL) occur in deaths related to uncontrolled 
diabetes mellitus. To investigate the relationship between AEL and terminal hyperglycemia, 
we retrospectively reviewed 71 cases with vitreous glucose levels ≥11.1mmol/l; 27 (38%) 
cases had AEL (vitreous glucose 14.0-77.3mmol/l) and 44 cases (62%) did not (vitreous 
glucose 11.1-91.9mmol/l). There was no significant difference (p=0.271) in vitreous glucose 
levels between the cases with AEL (mean 39.2, SD 16.7mmol/l) and those without (mean 
34.2, SD 19.8mmol/l). Similarly, there was no difference in the degree of dehydration, renal 
failure, or osmolality. However, there was a significantly higher level of β-hydroxybutyrate 
among the cases with AEL compared to those without (p=0.007), suggesting that ketoacidosis 
may facilitate the development of AEL. Given the possible synergistic role of β-
hydroxybutyrate, the correlation between AEL and terminal hyperglycemia in animal studies 
may not be applicable to humans. AEL may also possibly occur with sub-lethal elevations in 
glucose. 
 
Keywords: Forensic science, Armanni Ebstein phenomenon, glycogen nephrosis, diabetes 







 The Armanni-Ebstein phenomenon refers to a pattern of renal tubular epithelial 
vacuolization which has been regarded as pathognomonic for hyperglycemia in diabetes 
mellitus (1). It is characterized by markedly swollen epithelial cells with clear cytoplasm, 
representing virtual total conversion of the cytoplasm into a single large vacuole filled with 
PAS-positive material (1). Microdissection studies have localized this lesion to the 
corticomedullary junction, mainly in the outer medulla, with the middle and outer cortex 
being spared (1). Electron microscopy has confirmed β-glycogen as the constituent of these 
vacuoles (2-4), hence the alternative name of glycogen nephrosis (5). Curtis et al. 
demonstrated that the presence of Armanni-Ebstein lesions in the kidneys in alloxan-induced 
diabetic rats depended solely upon the degree of terminal hyperglycemia, with lesions 
invariably present at levels above 350 mg/dl (19.4 mmol/l), and consistently absent at levels 
below 300mg/dl (16.7 mmol/l) (5). No relationship was demonstrated between the presence of 
Armanni-Ebstein lesions and the initial blood glucose level after induction of diabetes, or with 
the maximum glucose level attained by the rats (5).  
 Although there have been numerous animal studies in diabetic rats (3,5-8), there 
are limited reports of Armanni-Ebstein lesions in a forensic context, and none that have 
investigated its correlation with terminal glucose levels. The phenomenon was originally 
observed in autopsy studies performed by Armanni in 1872 and appeared in Cantani’s 
Textbook of Internal Medicine in 1875 only as an observation without correlations to glucose 
levels at death (9,10). Ritchie and Waugh conducted microdissection studies on the kidneys of 
five selected autopsy cases of diabetic decedents with Armanni-Ebstein lesions in order to 
localize these lesions, but the terminal blood glucose level was only reported in 3 out of the 5 





diabetic vacuolization of the iris pigment in 57 postmortem cases, and incidentally found 19 
cases with terminal blood glucose levels > 200mg/100ml (11.1 mmol/l) that displayed 
Armanni-Ebstein lesions in the kidneys, however, the degree of hyperglycemia in these cases 
was not reported (11). Armanni-Ebstein lesions have also been reported in 5 autopsy cases of 
severe Fanconi syndrome with glucosuria and death in infancy, however, again the blood 
glucose levels were not presented (2). Additionally, many of the more recent forensic studies 
and case reports of Armanni-Ebstein lesions refer to basal lipid vacuolization of renal tubular 
epithelial cells (12-18), which we now recognize as distinct from the Armanni-Ebstein 
phenomenon (19). Therefore, the current study was undertaken to investigate the incidence of 
traditional Armanni-Ebstein lesions in terminal hyperglycemia, its correlation with vitreous 
glucose levels, and to identify potential factors which may have contributed to its 
pathogenesis. 
 
Materials and methods 
All case files which included vitreous humor analysis over an 11-year-period from 
2004 to 2014 at Forensic Science SA, Adelaide, South Australia were retrospectively 
reviewed for cases with terminal hyperglycemia, defined as vitreous glucose ≥11.1 mmol/l 
(199.8 mg/dl). All available microscopic slides of the kidneys in study cases were then blindly 
reviewed with respect to Armanni-Ebstein lesions, and cases where autolysis and putrefaction 
precluded accurate histological assessment were excluded from the study. All cases had full 
coronial and police investigations with complete forensic autopsies.   
Cases were then classified into two groups based on the presence or absence of 
Armanni-Ebstein lesions. Vitreous glucose, β-hydroxybutyrate, urea, creatinine and sodium 





statistically significant difference existed. This was done via F-tests for the equality of 
variances followed by the appropriate two-tailed t-test (with or without equal variance).  
 
Results 
A total of 71 cases with terminal hyperglycemia fulfilling the study criteria were 
identified. Their ages ranged from 14 to 80 (mean 47.5) years with a male to female ratio of 
43:28. Vitreous glucose levels ranged from 11.1 to 91.9 mmol/l (199.8-1654.2 mg/dl) with a 
mean of 36.1 mmol/l (649.8 mg/dl), and β-hydroxybutyrate ranged from 0.1 to 29.35 mmol/l 
(1.04-305.7 mg/dl) with a mean of 9.09 mmol/l (94.7 mg/dl).  
Twenty-seven out of 71 cases (38%) had Armanni-Ebstein lesions of classic 
morphology (Figure 1) and PAS-positive material was demonstrated within vacuoles in 
representative cases (Figure 2). Their ages ranged from 17 to 63 (mean 39.9) years with a 
male to female ratio of 14:13. Postmortem interval ranged from 1 to 13 (mean 4.3) days. 
Vitreous glucose levels ranged from 14.0 to 77.3 mmol/l (252.0-1391.4 mg/dl) with a mean of 
39.2 mmol/l (705.6 mg/dl) and β-hydroxybutyrate ranged from 0.1 to 23.18 mmol/l (1.04-
241.5 mg/dl) with a mean of 12.33 mmol/l (128.4 mg/dl). Twenty-one out of the 27 cases 
(77.8%) had elevated ketone levels of > 5 mmol/l (52.1 mg/dl). Nineteen cases had vitreous 
sodium levels between 118 and 159 (mean 134.1) mmol/l (mEq/l), sixteen cases had urea 
levels ranging from 5.4 to 44.4 mmol/l (32.5-267.5 mg/dl) with a mean of 17.1 mmol/l (103.0 
mg/dl), thirteen cases had creatinine levels ranging from 32 to 332 µmol/l (0.36-3.76 mg/dl) 
with a mean of 143.9 µmol/l (1.63 mg/dl), and ten cases had osmolality ranging from 319 to 
495 (mean 391.1) mosmol/l. Causes of death were diabetic ketoacidosis (n=21), ischemic 
heart disease (n=3), cardiomegaly (n=1), pulmonary thromboembolism (n=1), and hanging 





1), 2 cases had a history of diabetes but it was unclear which type or if they required insulin 
therapy, 2 cases were type 2 diabetics on oral hypoglycemic agents, and 6 cases had no 
known history of diabetes.  
Forty-four out of 71 cases (62%) did not have Armanni-Ebstein lesions. Their ages 
ranged from 14 to 80 (mean 52.3) years with a male to female ratio of 29:15. Postmortem 
interval ranged from 1 to 11 (mean 3.8) days. Vitreous glucose levels ranged from 11.1 to 
91.9 mmol/l (199.8-1654.2 mg/dl) with a mean of 34.2 mmol/l (615.6 mg/dl), and β-
hydroxybutyrate levels ranged from 0.1 to 29.35 mmol/l (1.04-305.7 mg/dl) with a mean of 
7.09 mmol/l (73.85 mg/dl). Twenty-one out of the 44 cases (47.7%) had elevated ketone 
levels of > 5 mmol/l (52.1 mg/dl). Twenty-nine cases had vitreous sodium levels between 112 
and 188 (mean 137.7) mmol/l (mEq/l), twenty-seven cases had urea levels ranging from 5.1 to 
45.3 mmol/l (30.7-272.9 mg/dl) with a mean of 17.6 mmol/l (106.0 mg/dl), twenty-five cases 
had creatinine levels ranging from 27 to 360 µmol/l (0.31-4.07 mg/dl) with a mean of 138.6 
µmol/l (1.57 mg/dl), and twelve cases had osmolality ranging from 318 to 425 (mean 372) 
mosmol/l. Causes of death included diabetic ketoacidosis (n=21), ischemic heart disease 
(n=9), drug toxicity (n=3), drowning (n=2), multiple injuries (n=2), congestive cardiac failure 
(n=1), myocarditis (n=1), pericarditis and hemopericardium complicating stab wounds (n=1), 
dehydration and hyperglycemia (n=1), hypothermia (n=1), acute subdural hemorrhage (n=1), 
and upper gastrointestinal hemorrhage (n=1). Twenty-four decedents had been insulin-
dependent diabetics (six known to be type 1), 8 cases were type 2 diabetics, 5 cases had a 
history of diabetes recorded but it was unclear which type, and 7 cases had no previous 
history of diabetes.  
F-tests indicated that the variances in the post-mortem interval (F=1.55, p=0.100), 





(F=0.547, p=0.092), urea (F=1.080, p=0.418), creatinine (F=1.049, p=0.440), and osmolality 
(F=2.49, p=0.078) of the cases with and without Armanni-Ebstein lesions were not different. 
There was also no statistically significant difference between the post-mortem interval 
(p=0.433), vitreous glucose (p=0.271), sodium (p=0.355), urea (p=0.900), creatinine 
(p=0.853), and osmolality (p=0.359) of the cases with and without Armanni-Ebstein lesions. 
However, there were significantly higher levels of ketoacidosis in the cases with Armanni-
Ebstein lesions compared to those without (p=0.007). The quantitative comparison of the 




 In the recent literature, the term Armanni-Ebstein phenomenon has been expanded 
to include basal vacuolization as well as the traditional cytoplasmic clear-cell change, 
however, a recent review by our group has suggested that basal vacuolization is a separate and 
distinct entity from the originally described Armanni-Ebstein lesion, based on morphology, 
constituents, and etiology (19). For example, in contrast to Armanni-Ebstein lesions, basal 
vacuoles contain lipids instead of glycogen, and are associated with a variety of ketoacidotic 
states (19). It appears that basal vacuolizations were included under the umbrella of the 
“Armanni-Ebstein lesion” after a study by Ritchie and Waugh in 1957 which noted fine basal 
fat droplets in the cytoplasm of proximal tubular epithelial cells not involved by the Armanni-
Ebstein lesion (1,19). Thus, many of the recent reports on the Armanni-Ebstein phenomenon 
in a forensic context have referred to this type of basal lipid vacuolization, rather than to the 
originally described clear-cell change (12-18,20). Similarly, the only prior study investigating 





vacuolizations rather than to cytoplasmic glycogen accumulation, and concluded that no 
relationship existed between terminal hyperglycemia and basal vacuolization (12). 
 The etiology of the traditional Armanni-Ebstein phenomenon is thought to involve 
hyperglycemia and glucosuria (1), however, results of the current study suggest that 
underlying mechanisms may be more complicated. To our knowledge, there has only been 
one study which investigated the relationship of Armanni-Ebstein lesions to terminal blood 
glucose levels which used alloxan to induce diabetes in 207 rats, of which 62 survived and 
met the study criteria (5). The authors observed that lesions were invariably present with 
glucose levels above 350 mg. per cent (19.4 mmol/l) and that no lesions were present with 
levels below 300 mg. per cent (16.7 mmol/l). However, the upper threshold level and a direct 
relationship with the level of hyperglycemia were not observed in our study, as only 31 out of 
the 44 cases (70.5%) without Armanni-Ebstein lesions had a glucose level above 19.4 mmol/l 
(349.2 mg/dl). Additionally, there was no significant difference in the degree of terminal 
hyperglycemia between the cases with and without Armanni-Ebstein lesions (p=0.271), and 
the case with the highest observed glucose level of 91.9 mmol/l (1654.2 mg/dl) did not have 
typical vacuoles. It is unclear why the direct relationship observed in rats was not observed in 
human subjects. A possible explanation may be that animal studies tend to be conducted on 
healthy rats of a selected breed, similar age, and with similar environmental parameters, with 
diabetes being induced in a uniform manner with a set dose of the same drug (i.e. alloxan or 
streptozotocin). In contrast, human cases in a forensic environment have more varied 
demographics, and often have other significant illnesses, impairments, and/or metabolic 
derangements. For example, 6 out of the 27 cases (22.2%) with Armanni-Ebstein lesions had 





the variable appearance of Armanni-Ebstein lesions at similar glucose values may reflect 
other complex organic factors. 
 Ketoacidosis may, therefore, be contributory to the development of Armanni-
Ebstein lesions. In this study, 21 out of the 27 cases (77.8%) exhibiting Armanni-Ebstein 
lesions had concurrent ketoacidosis demonstrated by elevations in vitreous β-
hydroxybutyrate. Although Armanni-Ebstein lesions also occurred in cases with 
hyperglycemia without elevations in ketones (n=6), an overall significantly higher level of β-
hydroxybutyrate was seen in the cases exhibiting Armanni-Ebstein lesions compared to those 
that did not (p=0.007). 
 The exact mechanism for the development of Armanni-Ebstein lesions is unclear, 
but it is thought to represent excess reabsorption of glucose in the distal tubules secondary to 
hyperglycemia (3). However, injury to the pars recta has also been proposed as a mechanism 
for glycogen accumulation (2), as well as excessive glycogenesis or defective glycogenolysis 
as a result of cellular dysfunction (1). Ketoacidosis can contribute to this as it may cause renal 
tubular dysfunction and injury, evidenced by significantly increased urinary excretion of 
proximal tubular marker alpha 1-microglobulin and distal tubular marker Tamm-Horsfall 
protein compared to metabolically stable controls (21). The toxic effects of ketone bodies on 
renal tubular cells were also shown by Asami and colleagues with significantly elevated 
urinary beta-D-N-acetyl glucosamine and beta 2-microglobulin in patients with non-diabetic 
ketoacidosis (22). Thus, it is possible that the resultant tubular dysfunction in ketoacidosis 
may facilitate the intracellular accumulation of glycogen.  
 Higher levels of glucose in the current post-mortem study were observed 
compared to previous animal studies. A number of diabetic rat models have demonstrated 





were treated with alloxan or streptozotocin (3,5-8,23-29). Serum glucose levels reported in 
these rats ranged from 13.9 to approximately 40.0 mmol/l (250.2-720.0 mg/dl) (3,5-8,23-29) 
with only one study reporting a glucose level of 66.7 mmol/l (1200.6 mg/dl) in one rat (5). In 
contrast, the highest vitreous glucose level associated with Armanni-Ebstein lesions in the 
current study was 77.3 mmol/l (1391.4 mg/dl), and 10 out of the 27 cases (37%) with 
Armanni-Ebstein lesions had a vitreous glucose level of >40 mmol/l (720 mg/dl). This may be 
because of more severe metabolic derangements in forensic cases.  
 A major limitation in attempting to correlate the presence of Armanni-Ebstein 
lesions with terminal glucose levels is the reduction in glucose after death due to continued 
consumption by cells. Therefore, the true terminal glucose level will be higher than the 
vitreous level obtained at the time of autopsy by an amount that depends on the post-mortem 
interval. For example, in a series of 3076 cases by Zilg et al, the post-mortem vitreous glucose 
level was observed to drop by approximately 3 mmol/l (54.0 mg/dl) in the very early post-
mortem period with levels remaining relatively stable for up to 4 days (30). This was 
attributed to initial survival of hyalocytes and inner retinal cells with gradual equilibration 
thereafter (30). Therefore, the observations made in this study are likely to be valid as the 
majority (65%) of our cases had a post-mortem interval of 4 days or less, and there was no 
significant difference in post-mortem interval between cases with and without Armanni-
Ebstein lesions (p=0.433). Furthermore, exclusion of the 25 cases (35%) with a postmortem 
interval of greater than 4 days leaves 18 cases with Armanni-Ebstein lesions [vitreous glucose 
mean 39.5 mmol/l (711.0 mg/dl), standard deviation 16.6 mmol/l (298.8 mg/dl)] and 28 cases 
without [vitreous glucose mean 31.6 mmol/l (568.8 mg/dl), standard deviation 15.6 mmol/l 
(280.8 mg/dl)]. Repeating the quantitative analysis similarly shows no statistically significant 





 In summary, in the present series typical Armanni-Ebstein lesions were found in 
38% of all cases with terminal hyperglycemia, and no significant differences in vitreous 
glucose levels could be demonstrated between cases with or without these lesions (p=0.271). 
Additionally, the threshold glucose level for the invariable appearance of Armanni-Ebstein 
lesions established in animal studies did not correspond to the current human data, as 70.5% 
of cases without Armanni-Ebstein lesions had glucose levels exceeding 19.4mmol/l (349.2 
mg/dl). However, a significantly greater degree of ketoacidosis was present among cases with 
Armanni-Ebstein lesions (p=0.007), suggesting that ketoacidosis may facilitate its 
development. Additional available biochemical parameters, including vitreous sodium, urea, 
and creatinine levels, and osmolality, were also compared between cases with and without 
Armanni-Ebstein lesions and no significant differences were present. Although Armanni-
Ebstein lesions can be used as a marker for terminal hyperglycemia at autopsy, its presence 
does not appear to correlate with the level of glucose as it can be seen with mild sub-lethal 
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FIG. 1- Typical Armanni-Ebstein vacuolization in a case of diabetic ketoacidosis 
(Hematoxylin and eosin x400). 
 
 






FIG. 3- Scatterplot histogram summarizing the vitreous glucose levels in cases with and 






FIG. 4- Scatterplot histogram summarizing the vitreous β-hydroxybutyrate in cases with and 








BASAL VACUOLIZATION IN RENAL TUBULAR EPITHELIAL CELLS AT 
AUTOPSY AND THEIR RELATION TO KETOACIDOSIS 
 
CONTEXTUAL STATEMENT 
AIM: To determine the incidence of basal vacuolizations and investigate their relationship 
with ketoacidosis. 
 
HYPOTHESIS: That basal vacuolizations are common in ketoacidosis and their incidence 
correlates with the degree of ketone elevation. 
 
COMMENTARY:  Basal vacuolization in renal tubular epithelial cells has been reported in 
diabetic, alcoholic, septic, and starvation ketoacidosis. Although it can be seen along with 
Armanni-Ebstein lesions in diabetic ketoacidosis, their presence in other normo-glycaemic 
ketoacidotic conditions strongly suggest a relationship with elevated ketones, and no 
relationship to serum glucose levels. To prove this, a retrospective review of all deaths 
featuring elevated β-hydroxybutyrate of >1mmol/l was conducted to investigate the incidence 
and relationship of basal vacuolizations to ketoacidosis and hyperglycaemia. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 







1. Basal vacuolizations in renal tubular epithelial cells are present in 43% of cases with 
terminal ketoacidosis (>1mmol/l). 
2. Basal vacuolizations are associated with ketoacidosis, and their incidence increases 
with the degree of ketone elevation. 
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ABSTRACT:  Basal vacuolization of renal tubular epithelial cells is a useful post-
mortem marker for ketoacidosis. To investigate its incidence and relationship to the severity 
of ketoacidosis, 158 autopsy cases with elevated β-hydroxybutyrate (>1mmol/l) over a 7-year-
period were retrospectively reviewed. Sixty-eight cases (43%) exhibited basal vacuolizations 
(vitreous β-hydroxybutyrate: 1.16-29.35mmol/l, mean 10.28mmol/l) and 90 cases (57%) did 
not (vitreous β-hydroxybutyrate: 1.03-13.7mmol/l, mean 2.84mmol/l). Quantitative analysis 
revealed on average a four-fold elevation in β-hydroxybutyrate in cases with basal 
vacuolizations compared to those without. 10.3% of cases with β-hydroxybutyrate 
concentrations between 1.01-2.00mmol/l had basal vacuolizations, and this incidence 
increased to 33.3% with concentrations between 4.01-6.00mmol/l. A marked increase in 
incidence to >70% was observed with concentrations >6.00mmol/l, and basal vacuoles were 
invariably present (100%) with concentrations >14.01mmol/l. This study demonstrates that 
basal vacuolizations are a sensitive marker for significant ketoacidosis, and reaffirms its use 
as an indicator for likely cases of fatal ketoacidosis at autopsy. 
 
Keywords: Forensic science, basal vacuolization, diabetic ketoacidosis, starvation 








 Basal vacuolizations of renal tubular epithelial cells appear as a row of clear 
spaces beneath the nucleus in close proximity to the basement membrane. Intravacuolar lipids 
have been demonstrated on Oil-Red O staining and electron microscopy (1-3). Recently, this 
pattern of vacuolization has been referred to as the ‘Armanni-Ebstein phenomenon’ (1,2,4-9), 
possibly after a report on autopsy cases of diabetics with Armanni-Ebstein lesions by Ritchie 
and Waugh who mentioned fine basal fat droplets in the cytoplasm of proximal tubules not 
affected by the Armanni-Ebstein lesion in 2 out of their 5 cases (10). However, a recent 
review of the literature showed that the originally reported Armanni-Ebstein lesion instead 
represented a clear-cell change with intra-cytoplasmic glycogen accumulation in 
hyperglycemic states, therefore suggesting that basal vacuolizations should be recognized as a 
distinct entity from the Armanni-Ebstein lesion on the basis of different morphology, 
constituents, and etiology (11).  
 Basal vacuolizations have been reported in deaths due to diabetic, alcoholic, 
starvation, and septic ketoacidosis (4,6,12,13). They have also been put forward as a marker 
for hypothermia (3,14), although, a review of hypothermic deaths suggested that a significant 
proportion of cases had underlying metabolic derangements which may have been the cause 
of the basal vacuolizations rather than simply decreased core temperature in isolation (15). 
This concept was supported by an animal model inducing fatal hypothermia in rats where 
none of the cases demonstrated basal vacuolizations (16). However, to date there have been 
no studies investigating the overall incidence of basal vacuolizations in ketoacidosis or its 
relationship to the degree of ketosis. 
 





All case files which included vitreous humor analysis over a 7-year-period from 2008 
to 2014 at Forensic Science SA, Adelaide, South Australia were retrospectively reviewed for 
cases featuring ketosis, defined as β-hydroxybutyrate ≥ 1 mmol/L (10.3 mg/dl); the cause of 
ketoacidosis was determined in each case. Cases were classified as diabetic ketoacidosis if 
concurrent hyperglycemia (vitreous glucose ≥11.1 mmol/l or 200mg/dl) was present. 
Alcoholic ketoacidosis was diagnosed if there was a previous history combined with signs of 
chronic alcoholism at autopsy and normoglycemia. Starvation was considered the cause of 
ketosis when a documented history of decreased oral intake was present in the absence of 
elevated glucose concentrations or alcoholism. Septic ketoacidosis was diagnosed when 
proven sepsis or severe infection was present at autopsy in the absence of raised glucose 
concentrations or a history of alcoholism, diabetes, or starvation. The cause of ketosis in the 
remainder of cases was unclear and may have been due to a combination of the above factors. 
All available microscopic slides of the kidneys were blindly screened for basal 
vacuolizations of renal tubular epithelial cells and/or formalin pigment deposition around 
basal vacuolar spaces (17). Cases exhibiting significant autolysis precluding accurate 
histological assessment were excluded from the series. All cases had full coronial and police 
investigations with complete forensic autopsies.  Study cases were divided into two groups 
based on the presence or absence of characteristic basal vacuolizations. The vitreous β-
hydroxybutyrate concentrationss of the two groups, as well as other biochemical parameters 
such as glucose, urea, creatinine, and sodium levels, and osmolality, were compared to 
determine if a statistically significant difference existed. This was done by F-tests for the 
equality of variances followed by the appropriate t-test (with or without equal variance). The 









A total of 158 cases fulfilling the study criteria were identified, including 44 cases of 
diabetic ketoacidosis, 17 cases of alcoholic ketoacidosis, 5 cases of starvation ketoacidosis, 5 
cases of septic ketoacidosis, and 87 cases where the cause of ketosis was unclear and a single 
causative mechanism could not be determined. 
Sixty-eight out of the 158 study cases (43%) displayed characteristic basal 
vacuolization of the renal tubular epithelial cells (Figure 1). Their ages ranged from 15 to 92 
(mean 54.2) years and they comprised of 40 males and 28 females. The post-mortem interval 
ranged from 1 to 13 (mean 4.7) days. The cause of ketosis was diabetic in 36 cases, alcoholic 
in 11 cases, septic in 3 cases, starvation in 1 case, and a single cause of ketosis could not be 
identified in 17 cases. Vitreous β-hydroxybutyrate concentrations ranged from 1.16 to 29.35 
(mean 10.28) mmol/l and vitreous glucose concentrations ranged from 0.1 to 91.9 (mean 
23.3) mmol/l. Thirty-two of the 68 cases (47.1%) also displayed characteristic basal formalin 
pigment deposition in the vicinity of the vacuoles (17).  
Ninety out of the 158 study cases (57%) did not have characteristic basal 
vacuolization of renal tubular epithelial cells. Their ages ranged from 5 to 94 (mean 64.1) 
years and they comprised of 58 males and 32 females. Postmortem intervals ranged from 1 to 
12 (mean 4.3) days. The cause of the ketosis was diabetic in 8 cases, alcoholic in 6 cases, 
starvation in 4 cases, and septic in 2 cases. A single cause for the elevation in ketones could 
not be determined in the remainder of the 70 cases. Vitreous β-hydroxybutyrate ranged from 









 The F-test indicated that the variances in the vitreous β-hydroxybutyrate 
concentrations (F=7.731, p<0.001) and postmortem interval (F=1.540, p=0.034) in cases 
exhibiting basal vacuolizations were not equivalent to cases without basal vacuolizations. 
Subsequent t-tests assuming unequal variances demonstrated a statistically significantly 
higher vitreous β-hydroxybutyrate concentration (p<0.001) in cases with basal vacuolizations 
compared to those without, with no significant difference in the postmortem interval (p=0.22). 
The quantitative comparisons of vitreous β-hydroxybutyrate concentrations between cases 
with and without basal vacuolizations are summarized in Figure 2. 
The incidence of characteristic basal vacuolizations observed at different β-
hydroxybutyrate concentrations is summarized in Table 1 and Figure 3. The incidence of 
basal vacuolizations markedly increased when β-hydroxybutyrate concentration exceeded 6.0 
mmol/l from 33.3% to above 70%. Basal vacuolizations were seen in >80% of cases with β-
hydroxybutyrate concentration >10.0 mmol/l and were invariably present (100%) with 
concentrations > 14.0 mmol/l. The incidence of basal vacuolizations among different causes 
of ketoacidosis was 81.8% in diabetic, 64.7% in alcoholic, 60% in septic, and 20% in 
starvation ketoacidosis. Basal vacuolizations were present in 19.5% of the cases in which the 
exact cause of ketoacidosis was unclear or multi-factorial. 
 Data sets were each fitted with a Gaussian distribution function using GraphPad Prism 
software; plotting this data on a frequency histogram (Figure 4) demonstrates that cases 





whilst cases with basal vacuolizations were widely distributed over a broad range. 
Additionally, cases exhibiting basal vacuoles had on average a four-fold elevation in β-
hydroxybutyrate concentration (mean 5.91 +/- 4.64 mmol/l) compared to cases lacking basal 
vacuoles (mean 1.43 +/- 0.10 mmol/l). 
 
Discussion 
 Lethal ketoacidosis encountered in the forensic context is most commonly due to 
decompensated diabetes mellitus, but elevations in ketones may also occur in alcohol abusers, 
and in cases of starvation, sepsis, non-insulin mediated hypoglycemia, drug abuse, or in cases 
involving a combination of these factors (18,19). The mechanism in which ketoacidosis may 
lead to death includes extracellular volume contraction, electrolyte disturbances (including 
hypokalemia), sudden cardiac arrest, and cerebral edema (18,20). In the current study, basal 
vacuolizations were seen in all categories of ketoacidosis including diabetic, alcoholic, septic, 
starvation-induced, and in cases where the cause of ketoacidosis was unclear or multi-
factorial. 
 Most prior studies have reported on vitreous acetone rather than β-
hydroxybutyrate concentrations. However, β-hydroxybutyrate is the major ketone body 
produced in ketosis accounting for approximately 78% of total ketones, with acetoacetate 
(20%) and acetone (2%) produced in much smaller amounts (21). The ratio of β-
hydroxybutyrate to acetoacetate is normally 1:1, however, this ratio can increase to as high as 
10:1 in diabetic and alcoholic ketoacidosis (22,23). Additionally, β-hydroxybutyrate 
concentrations have also been shown to correlate more closely than serum ketones with the 
degree of anion gap elevation in ketoacidotic states (21), therefore making it the ideal 





previous retrospective review of basal vacuolizations in alcoholic ketoacidosis which reported 
β-hydroxybutyrate concentrations ranging from 6.42 to 8.75 mmol/l (12), and one case report 
on starvation ketoacidosis which had a vitreous β-hydroxybutyrate of 3.966 mmol/l (6). In the 
current study, basal vacuolizations were seen at a β-hydroxybutyrate level of 1.16 mmol/l 
with the highest level being 29.35 mmol/l, representing a wider range than previously 
reported. Three prior studies reported on vitreous acetone levels which ranged from 0.5 to 
12.8mmol/l in decedents with basal vacuolization who died of starvation and diabetic 
ketoacidosis (4,7,9). At Forensic Science SA, acetone can be detected in the blood on 
toxicological screening but it does not appear as a quantitative measurement. An acetoacetate 
screen is also occasionally conducted on vitreous humor biochemistry which appears in a 
semi-quantitative manner as ‘small’, ‘moderate’, or ‘large’. Therefore, these measurements 
were not reported in the current study.  
 Basal vacuolizations are a useful marker for lethal ketoacidosis, with the 
incidence increasing with the extent of metabolic derangement. A large retrospective review 
of 1795 forensic cases recommended that β-hydroxybutyrate levels < 0.4 mmol/l should be 
interpreted as normal, 0.41-1.2 mmol/l to be slightly elevated and rarely (<1%) of concern, 
1.21-2.0 mmol/l to be moderately elevated and less rarely (2.5%) of concern, 2.01-6.0 mmol/l 
to be significantly elevated and frequently (12-48%) of concern, and concentrations above 6.0 
mmol/l to indicate life-threatening conditions (24). In this study, we divided the cases 
according to incremental increases in vitreous β-hydroxybutyrate levels and found that the 
lowest β-hydroxybutyrate concentration in which basal vacuolizations could be identified was 
1.16mmol/l. Above this concentration, and regardless of the cause of ketoacidosis, the 
incidence of basal vacuolizations increased with greater elevations in β-hydroxybutyrate 





concentration in this study, above which the incidence of basal vacuolizations more than 
doubled from 33.3% to over 70%. The incidence of basal vacuolizations was >80% with β-
hydroxybutyrate concentrations of 10.0-14.0 mmol/l, and 100% when levels exceeded 14.0 
mmol/l. Therefore, basal vacuolizations were certainly found to be sensitive markers for fatal 
ketoacidosis. 
 In the current study, the incidence of basal vacuolizations in diabetic ketoacidosis 
was slightly lower than previously reported figures, whereas the incidence in alcoholic 
ketoacidosis is slightly higher. Basal vacuolizations have been reported in 30.8% of deaths in 
individuals with a history of diabetes (4) and 84-100% of deaths due to diabetic ketoacidosis 
(1,9), whereas it was noted in 81.8% in the present series. Two previous studies on alcoholic 
ketoacidosis reported basal vacuolizations in 47.8-60.0% of cases (7,12), whereas it was seen 
in 64.7% in the present study. There have been no previous reports on the incidence of basal 
vacuolizations in septic or starvation ketoacidosis, which in this study, was found to be 60% 
and 20% respectively. The higher incidences found in diabetic, alcoholic, and septic 
ketoacidosis is likely a reflection of the typically higher degrees of ketone elevation seen in 
these conditions compared to starvation (19,25). 
 Vitreous humor has been proven as a reliable alternative to blood for the 
determination of β-hydroxybutyrate levels (26-28). Additionally, studies suggest that 
decompositional changes are not associated with β-hydroxybutyrate production, therefore the 
concentration detected at autopsy can be considered a reflection of concentrations at the time 
of death (29,30). This includes a study by Iten and Meier demonstrating no statistically 
significant increase in serum β-hydroxybutyrate concentration with increasing post-mortem 
interval (30), and another study by Palmiere et al whom observed lower concentrations of 





cases that did not (31). These observations are supported in the present study as no 
statistically significant difference in post-mortem interval could be demonstrated between 
cases with and without basal vacuolizations (p=0.22). The exact role that micro-organisms 
play in β-hydroxybutyrate metabolism after death is unclear, however, it seems that vitreous 
humor is a relatively protected environment from post-mortem microbiological contamination 
(32), and has an inherent antibacterial capacity in vitro which does not support bacterial 
growth (33). Therefore, any potential alterations micro-organisms may have on β-
hydroxybutyrate concentrations would be reduced in vitreous humor compared to blood.  
 The current study is limited by its retrospective nature. Although selection bias 
was eliminated by conducting a search for all cases containing keywords “vitreous humor” 
biochemistry and “vitreous biochemistry” rather than specific causes of ketosis, it is possible 
that a small number of cases may have been missed if these keywords were not used in a 
report. Cases with β-hydroxybutyrate concentrations <1.0 mmol/l were not reviewed in the 
present study. Review of these cases in the future may, however, be useful to establish 
whether basal vacuolization can occur with normal ketone concentrations, although there have 
been no reports of this in the literature to date. Review of larger numbers of cases would also 
assist in more accurately quantifying the incidence of basal vacuolization in septic and 
starvation ketoacidosis as the current study had relatively low case numbers due to the 
infrequent nature of these conditions leading to death. 
 In conclusion, this study has demonstrated that basal vacuolization in renal tubular 
epithelial cells may be found in autopsy material from all categories of ketoacidosis including 
diabetic, alcoholic, septic, and starvation. It is also present in both minor and severe ketosis, 
with β-hydroxybutyrate concentrations ranging from 1.16 to 29.35 mmol/l. Additionally, the 





increase in incidence to >70% at β-hydroxybutyrate concentrations of >6.0 mmol/l, and 
vacuoles invariably (100%) present at concentrations >14.0 mmol/l. Therefore, basal 
vacuolization in renal tubular epithelial cells in autopsy tissues is a very useful marker for 
ketosis, even in putrefied and/or autolytic kidneys. Once it has been identified it should 
initiate investigation into the quite diverse potential underlying causes, with full vitreous 






1. Thomsen JL, Kristensen IB, Ottosen PD. The histological demonstration of lipids in 
the proximal renal tubules of patients with diabetic coma. Forensic Sci Med Pathol 
2006;2:249-52. 
2. Thomsen JL, Hansen TP. Lipids in the proximal tubules of the kidney in diabetic 
coma. Am J Forensic Med Pathol 2000;21:416-8. 
3. Turk EE. Hypothermia. Forensic Sci Med Pathol 2010;6:106–15. 
4. Kock KF, Vestergaard V. Armanni-Ebstein lesions of the kidney: diagnostic of death 
in diabetic coma? Forensic Sci Int 1994;67:169-74. 
5. Zhou C, Gilbert JD, Byard RW. How useful is basal renal tubular epithelial cell 
vacuolization as a marker for significant hyperglycemia at autopsy? J Forensic Sci 
2011;56:1531-3. 
6. Milroy CM, Parai JL. Armanni-Ebstein lesion, ketoacidosis and starvation in a child. 
Forensic Sci Med Pathol 2011;7:213-6. 
7. Parai JL, Kodikara S, Milroy CM, Pollanen MS. Alcoholism and the Armanni-Ebstein 
lesion. Forensic Sci Med Pathol 2012;8:19-22. 
8. Palmiere C, Teresiński G, Hejna P. Postmortem diagnosis of hypothermia. Int J Legal 
Med 2014;128:607-14. 
9. Kodikara S, Paranitharan P, Pollanen MS. The role of the Armanni-Ebstein lesion, 
hepatic steatosis, biochemical analysis and second generation anti-psychotic drugs in 
fatal diabetic ketoacidosis. J Forensic Leg Med 2013;20:108-11. 






11. Zhou C, Yool AJ, Nolan J, Byard RW. Armanni-Ebstein lesions: a need for 
clarification. J Forensic Sci 2013;58 Suppl 1:S94-8. 
12. Zhou C, Byard RW. Basal renal tubular epithelial cell vacuolization and alcoholic 
ketoacidosis. J Forensic Sci 2012;57:126-8. 
13. Zhou C, Byard RW. Septic ketoacidosis – a potentially lethal entity with renal tubular 
epithelial vacuolization. J Forensic Sci 2017. In press. 
14. Preuβ J, Dettmeyer R, Lignitz E, Madea B. Fatty degeneration in renal tubule 
epithelium in accidental hypothermia victims. Forensic Sci Int 2004;141:131-5. 
15. Zhou C, Byard RW. Armanni-Ebstein phenomenon and hypothermia. Forensic Sci Int 
2011;206:e82-4. 
16. Zhou C, Bright F, Winskog C, Yool AJ, Byard RW. Lethal hypothermia in an animal 
model, not associated with basal renal epithelial vacuolization. J Forensic Leg Med 
2014;21:14-6. 
17. Zhou C, Gilbert JD, Byard RW. Basal epithelial formalin pigment deposition in the 
kidneys – a useful marker for ketoacidosis at autopsy. J Forensic Leg Med 
2013;20:305-7. 
18. Davids MR, Segal AS, Brunengraber H, Halperin ML. An unusual cause for 
ketoacidosis. Q J Med 2004;97:365-76. 
19. Nakamura K, Inokuchi R, Doi K, Fukuda T, Tokunaga K, Nakajima S et al. Septic 
ketoacidosis. Intern Med 2014;53:1071-3. 
20. Yanagawa Y, Sakamoto T, Okada Y. Six cases of sudden cardiac arrest in alcoholic 





21. Sena SF. Beta-hydroxybutyrate: new test for ketoacidosis. Technically Speaking 
2010;4(8). Available from: 
www.stanbio.com/media/pdf/bhb/Danbury%20Hospital%20PDF%2012-21-11.pdf. 
22. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of 
monitoring to diabetes. Diabetes Metab Res Rev 1999;15:412-26. 
23. Koay ESC, Walmsley N. A primer of chemical pathology. Singapore: World 
Scientific Publishing;1996. 
24. Heninger M. Postmortem vitreous beta-hydroxybutyrate: interpretation in a forensic 
setting. J Forensic Sci 2012;57:1234-40. 
25. Grey NJ, Karl I, Kipnis DM. Physiologic mechanisms in the development of 
starvation ketosis in man. Diabetes 1975;24:10-6. 
26. Palmiere C, Mangin P, Werner D. Postmortem distribution of 3-beta-hydroxybutyrate. 
J Forensic Sci 2014;59:161-6. 
27. Pounder DJ, Stevenson RJ, Taylor KK. Alcoholic ketoacidosis at autopsy. J Forensic 
Sci 1998;43:812-6. 
28. Osuna E, Vivero G, Conejero J, Abenza JM, Martínez P, Luna A et al. Postmortem 
vitreous humor beta-hydroxybutyrate: its utility for the postmortem interpretation of 
diabetes mellitus. Forensic Sci Int 2005;153:189-95. 
29. Palmiere C. Postmortem diagnosis of diabetes mellitus and its complications. Croat 
Med J 2015;56:181-93. 
30. Iten PX, Meier M. Beta-hydroxybutyric acid--an indicator for an alcoholic 






31. Palmiere C, Sporkert F, Werner D, Bardy D, Augsburger M, Mangin P. Blood, urine 
and vitreous isopropyl alcohol as biochemical markers in forensic investigations. Leg 
Med 2012;14:17-20. 
32. Harper DR. A comparative study of the microbiological contamination of postmortem 
blood and vitreous humour samples taken for ethanol determination. Forensic Sci Int 
1989;43:37-44. 
33. Egger SF, Buxbaum A, Georgopoulos M, Scholda C, Vecsei VP, Huber-Spitzy V et 







FIG. 1- Characteristic basal vacuolizations in renal tubular epithelial cells in a case of 
diabetic ketoacidosis (Hematoxylin and eosin x400). 
 
FIG. 2- Scatterplot histogram summarizing the vitreous β-hydroxybutyrate in cases with and 
without basal vacuolizations. [Horizontal bars indicate mean +/- standard error of the mean 






FIG. 3- Plotting the incidence of basal vacuolizations in renal tubular epithelial cells against 
incremental increases in vitreous β-hydroxybutyrate levels in 158 autopsy cases with ketosis 
(β-hydroxybutyrate > 1.0 mmol/l). 
 
 
FIG. 4- Frequency histogram summarizing vitreous β-hydroxybutyrate in cases with and 






TABLE. 1- The incidence of basal vacuolizations in renal tubular epithelial cells at different 
















CHAPTER 4: ESTABLISHING AND UTILIZING 







LETHAL HYPOTHERMIA IN AN ANIMAL MODEL, NOT ASSOCIATED WITH 
BASAL RENAL EPITHELIAL VACUOLIZATION 
 
CONTEXTUAL STATEMENT 
AIM: To investigate the relationship between basal vacuolizations in renal tubular epithelial 
cells and terminal hypothermia using an animal model. 
 
HYPOTHESIS: That basal vacuolizations in renal tubular epithelial cells are not associated 
with hypothermia. 
 
COMMENTARY:  Basal vacuolization of renal tubular epithelial cells has been suggested 
by Preuβ et al as “a very reliable histologic diagnostic criterium in cases of hypothermia, 
comparable to the significance of Wischnewsky ulcers” (1). However, our retrospective 
review of hypothermic deaths (see Chapter 2) revealed that a significant percentage of these 
cases had a documented history of diabetes and all cases in which vitreous biochemistry was 
done showed diabetic ketoacidosis. Therefore, it remains unclear if low core body 
temperature alone, in the absence of underlying metabolic derangements, can cause basal 
vacuolizations. Therefore, an animal model was employed to investigate the effects of 
hypothermia in isolation. 
 
Literature review establishing the field of knowledge is discussed within the paper. 
 
CONCLUSION: Basal vacuolizations in renal tubular epithelial cells are not associated with 
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ABSTRACT  A rodent model was used to evaluate the association between 
hypothermia and basal vacuolization in renal tubular epithelial cells. 28 Sprague Dawley rats 
were anaesthetized in non-stressful conditions and placed two at a time into a cooling 
chamber. Body core temperatures dropped to a minimum of 7-10°C, causing death under 
anaesthesia at times varying from 120 to 240 minutes. The animals were then subjected to 
necropsy; the kidneys were removed and placed in 10% buffered formalin. Examination of 
haematoxylin and eosin-stained renal sections failed to reveal basal vacuolization of renal 
tubular epithelial cells in any of the 28 animals. In this model, no evidence of subnuclear lipid 
vacuolization of renal tubular cells could be demonstrated despite significant and eventually 
lethal hypothermia. These results lend support to the hypothesis that the basal vacuolization in 
hypothermia may be a manifestation of a more complex pathophysiological pathway rather 
than being due simply to low body core temperatures. 
 







Deaths from hypothermia are encountered in forensic mortuaries in both temperate 
and cold climates1. Unfortunately the findings at autopsy, although characteristic, are not 
diagnostic, and their underlying pathophysiology is poorly understood2. Typical features 
include Wischnewsky spots of the gastric mucosa in 40-90% of cases, pinkish discoloration of 
the skin over larger joints, and acute pancreatitis with haemorrhage and surrounding fat 
necrosis3,4. Microscopic findings have included vacuolization of hepatocytes, cardiac 
myocytes and renal tubular epithelial cells4,5. It has been suggested that basal lipid 
vacuolization in renal epithelial cells could serve as a potential diagnostic tool for identifying 
hypothermic deaths, as it has an “equal value of diagnostic sensitivity compared to that of 
Wischnewski-ulcers”5. 
However, basal vacuolization of renal tubular epithelial cells may be also caused by 
underlying metabolic derangements, rather than by the direct effects of hypothermia6-9.  A 
recent study by the authors demonstrating basal vacuolization in 15 out of 46 cases of 
hypothermia (33%), revealed that 9 of the 15 cases (60%) had a documented history of 
diabetes mellitus (which is known to be associated with basal vacuolization)6. Vitreous 
humour biochemical analyses were performed in seven of these cases, all of which 
demonstrated diabetic ketoacidosis6. Based on these findings we suggested that diabetic 
ketoacidosis may be a more significant factor in the generation of basal vacuolization than 
hypothermia in isolation6. We also noted that hypothermia might, in fact, be both a cause and 
a complication of diabetic ketoacidosis, which accounts for 11.8% of hospital admissions of 
all patients with markedly low core temperatures6,10. The same may apply to alcoholic 
ketoacidosis, which is also known to be associated with the formation of renal basal 





of cases the subjects were long-term alcoholics, and that 65% had detectable levels of ethanol 
in the blood and/or urine11. 
We chose to use a rat model to specifically test whether basal vacuolization of renal 
tubular epithelial cells could be caused by lethal hypothermia in isolation. 
 
Materials and methods 
A model using male Sprague Dawley rats was developed to assess the effects of 
hypothermia in anaesthetized, minimally-stressed animals12. Twenty–eight rats were given an 
acclimatization period of one week with free access to food, water, and social interaction to 
reduce psychological and physiological stress. They were then sequentially anaesthetised with 
isoflurane at a flow rate of 3-5% and an oxygen flow rate of 1-2ml/min prior to placement 
into a cooling chamber. The isoflurane flow rate was decreased to 1-2% during the procedure 
to avoid significant respiratory depression whilst maintaining deep sleep. Constant monitoring 
of body core temperatures was achieved using a rectal temperature probe until death occurred. 
Core temperatures dropped over time to a minimum of 7-10°C which resulted in death of the 
animals under anaesthesia at times ranging from 120 to 240 minutes after placement in the 
cooling chamber. The animals were then subjected to necropsy and the kidneys removed and 
immediately placed in 10% buffered formalin. Routine haematoxylin and eosin stained slides 
were then prepared and examined. This study was fully approved by the Animal Ethics 
Committee at The University of Adelaide. 
 
Results 
Microscopic examination of coronal sections through each kidney from all 28 animals 





Although occasional sections displayed areas of non-specific, irregular cytoplasmic 
vacuolization, sections of the kidneys were generally unremarkable. (The latter vacuolization 
was thought to represent an artefact due to delayed fixation of deeper tissues.) 
 
Discussion 
Although lipid-containing vacuoles have been found in the basal portions of renal 
tubular epithelial cells in cases of hypothermia in humans5,6 the  pathophysiology remains 
uncertain. It appears likely that such deposits may occur when there has been a significant 
metabolic disruption resulting in lipid mobilization from tissue stores, as occurs with 
ketoacidosis arising from a number of different conditions including diabetes mellitus, 
alcoholism and starvation13-16. Over the last decade, the term “Armanni-Ebstein phenomenon” 
has been applied broadly to include descriptions of subnuclear lipid vacuolizations of renal 
tubular epithelial cells in the outer medulla; however, a recent review has clarified the precise 
use of the Armanni-Ebstein term, indicating that this classification should refer specifically to 
clear cell changes of swollen, rounded and transparent cells having peripherally displaced 
nuclei associated with hyperglycemia17. 
 In the present study there was no evidence of Armanni-Ebstein changes, nor of 
subnuclear lipid vacuolization of tubular cells, despite the imposition of significant and 
eventually lethal hypothermia. The rats used in this study had been subject to minimal 
psychological and physiological stress, and had been in good physical condition, therefore 
creating a suitable model to study the effect of hypothermia in isolation12. 
 A possible limitation of this study is that the rat model might not develop the 
subnuclear vacuolization phenotype.  However, studies have shown that rats exposed to 





hypothermia such as Wischnewsky spots of the gastric mucosa18-22. Sprague Dawley rats have 
also been successfully used in previous studies to manifest other renal histological changes 
such as Armanni-Ebstein lesions23-26. These studies suggest the rat is a valid animal model for 
exploring renal sequelae of pathophysiological conditions. A second possible limitation is that 
the time of cold exposure may have been too short to allow for the development of subnuclear 
vacuolization; however some animals did survive for hours with extremely low core 
temperatures. Of note, the rats in this study also did not develop Wischnewsky spots, which 
could be directly related to the role that stress may have in the pathological manifestations of 
hypothermia12. 
 This study suggests that basal renal tubular cell vacuolization may not be caused 
solely by lethal hypothermia. In cases where renal pathology is observed following significant 
hypothermia, additional studies testing for underlying metabolic disturbances, perhaps 
involving lipid mobilization due to ketoacidosis, will be required to determine the potential 
role of disturbances of glucose metabolism associated with lowered core temperatures, in 
creating this phenotype. 
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HYPEROSMOLARITY INDUCES ARMANNI-EBSTEIN-LIKE RENAL TUBULAR 
EPITHELIAL SWELLING AND CYTOPLASMIC VACUOLIZATION 
 
CONTEXTUAL STATEMENT 
AIM: To investigate the role of osmotic effect in the aetiology of Armanni-Ebstein lesions. 
 
HYPOTHESIS: That Armanni-Ebstein lesions result from the metabolic sequelae of 
hyperglycaemia and not the osmotic effect of glucose. 
 
COMMENTARY:  Armanni-Ebstein lesions have been reported in hyperglycaemic 
conditions including diabetic ketoacidosis and hyperglycaemic hyperosmolar nonketotic 
coma. The vacuoles in Armanni-Ebstein lesions contain accumulated glycogen, which 
suggests that their pathogenesis is related to glucose metabolism. However, glucose 
molecules are also osmotically active, and hyperglycaemia also causes serum hyperosmolarity 
which alone, is known to cause vacuolization in renal tubular epithelial cells (termed “osmotic 
nephrosis”). Therefore, this study uses intravenous mannitol to simulate the osmotic effect of 
glucose and determine if Armanni-Ebstein lesions are on the spectrum of changes induced by 
hyperosmolarity, or whether the phenomenon is specific to glucose metabolism. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript is written in American English to satisfy the publication requirements of the 






CONCLUSION: Armanni-Ebstein lesions were not reproducible by simulating the osmotic 
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ABSTRACT:  Armanni-Ebstein lesions have been considered pathognomonic for 
diabetes mellitus, and appear as markedly swollen renal tubular epithelial cells with 
cytoplasmic clearing and glycogen accumulation. However, the extent to which 
hyperosmolarity contributes to the Armanni-Ebstein phenotype is unclear. Ten sheep were 
injected intravenously with 20% mannitol at 11mOsm/kg and subsequent histological 
evaluation of the kidneys showed variable degrees of osmotic nephrosis and cytoplasmic 
clearing of renal tubular epithelial cells similar to that seen with Armanni-Ebstein lesions. 
However, although morphological changes similar to Armanni-Ebstein lesions could be 
produced, no intracytoplasmic glycogen was demonstrated with periodic-Acid-Schiff (PAS) 
stain. This suggests that while hyperosmolarity may contribute to the development of an 
Armanni-Ebstein phenotype, glycogen accumulation may result from the more complex 
metabolic effects of glucose on renal tubular epithelial cells. Thus, when Armanni-Ebstein-
like vacuolizations are seen at autopsy, a confirmatory PAS stain is recommended because of 
the potential effect of hyperosmolar states. 
 








The Armanni-Ebstein phenomenon refers to markedly swollen renal tubular epithelial 
cells with small dark nuclei that are often peripherally displaced, and almost complete 
conversion of the cytoplasm into a single large vacuole filled with glycogen (1,2). These 
lesions occur in poorly controlled diabetic states such as diabetic ketoacidosis. Although their 
pathogenesis has been consistently attributed to hyperglycemia and subsequent glucosuria in 
both autopsy and animal studies (2-5), it is unclear whether the vacuoles occur secondary to 
the osmotic effect exerted by glucose, or whether the pathogenesis is specific to the chemical 
properties of glucose molecules. To investigate this, serum hyperosmolarity was induced in a 
sheep model using mannitol, a structurally similar osmotic agent to glucose, with subsequent 
histological analysis of the kidneys to look for the presence of Armanni-Ebstein lesions. 
 
Materials and methods 
This project used scavenged sheep kidneys from a study approved by the local animal 
ethics committees of SA Pathology and The University of Adelaide, South Australia (6). 
Animal studies were performed according to the guidelines established by the National Health 
and Medical Research Council (NHMRC). 
As part of a neurotrauma study (6), a subgroup of ten anesthetized male merino sheep 
were intravenously administered 20% mannitol (11 mOsm/kg) over a 10-15min period and 
euthanized by barbiturate overdose 4 hours later for tissue analysis. Animals were initially 
anesthetized by intravenous injection of thiopentone before intubation and ventilation 
(4L/min) with oxygen enriched (30-35%) air containing 2.5% isoflurane. Ventilation 
parameters were adjusted as necessary on the basis of arterial blood gases sampled at regular 





catheter, and an intravenous infusion of ketamine (4mg/kg/h) was initiated for ongoing 
anesthesia. Mean arterial blood pressure was continuously monitored via a femoral arterial 
catheter using a MacLab data acquisition system, while core body temperature was 
maintained using a thermostatically controlled heating pad.  
After 4 hours, animals were euthanized by barbiturate overdose. Sheep were then 
intravenously perfused with 10% buffered formalin for 15 minutes before the kidneys were 
surgically removed and immediately immersed in 10% formalin for fixation. Representative 
sections of the kidneys were taken, and routinely processed, embedded in paraffin blocks, 
sectioned, and stained with hematoxylin and eosin (H&E). Periodic Acid-Schiff (PAS) stain 
for glycogen was done in representative cases. 
 
Results 
 Histological examination of the kidneys showed variable degrees of osmotic 
nephrosis with a uniform degree of non-specific vacuolization of renal tubular epithelial cells 
(Figure 1). There was also an associated variable degree of cytoplasmic clearing of tubular 
epithelial cells in all cases ranging from incomplete clearing with undisplaced central and 
normal appearing nuclei (Figure 2), to complete cytoplasmic clearing with small dark 
peripherally displaced nuclei (Figure 3) suggestive of Armanni-Ebstein lesions. PAS staining 
in two cases with Armanni-Ebstein-like lesions did not show any PAS-positive material 
within the affected tubules (Figure 4). 
 
Discussion 
 The Armanni-Ebstein phenomenon refers to vacuolated renal tubular epithelial cells, 





loss of their normal cuboidal shapes, are markedly swollen with small dark nuclei that were 
often peripherally displaced, and have almost complete conversion of the cytoplasm into a 
single large vacuole (1,2). Affected cells often bulge into and occlude the tubular lumen (2). 
Intravacuolar glycogen accumulation can be demonstrated on periodic Acid-Schiff (PAS) 
staining and on electron microscopy (3). Microdissection studies have shown that Armanni-
Ebstein lesions were consistently localized astride the corticomedullary junction, and 
principally affect the terminal straight portion of the proximal convoluted tubule (2). These 
lesions have been reported in poorly controlled diabetic states such as diabetic ketoacidosis 
(2,8), with a demonstrated correlation with hyperglycemia in animal studies (3-5,9). Thus, 
their presence has been deemed pathognomonic for diabetes (2). It is proposed that 
vacuolizations reflect marked glucosuria and the excessive reabsorption of glucose (8), 
however, the extent to which hyperosmolarity contributes to the development of these lesions 
is unclear.  
 The current study used scavenged sheep kidneys from a neurotrauma study 
investigating the effects of substance P antagonists as agents to reduce intracranial pressure 
(ICP) following traumatic brain injury (6). Four study groups were involved including 
uninjured controls, and injured animals that were administered intravenous normal saline, 
20% mannitol (11 mOsm/kg), or 2.5mg/kg n-acetyl-tryptophan (substance P antagonists). ICP 
monitoring revealed significantly increased ICP (p<0.05) to approximately 20 mmHg by 30 
minutes after traumatic brain injury compared to the uninjured controls (ICP 7 ± 2 mmHg). 
The authors found a continued increase in ICP in saline treated animals, and a reduction in 
ICP following administration of mannitol or substance P antagonist, concluding that 





injury (6).  The kidneys from the group administered with 20% intravenous mannitol were 
analyzed in this study. 
 This study is subject to limitations as a result of the scavenged nature of the tissues. 
Kidneys from the uninjured control group or the group administered with saline were not 
obtained at the time of the experiments, therefore there is an absence of a control group to 
compare the histological changes induced by mannitol. In hindsight, this would have been 
greatly beneficial to the study. Serum osmolarity was not measured in the sheep post 
administration of mannitol as it was not deemed relevant to the initial study from which the 
kidneys were scavenged (6). In the absence of this, a surrogate marker for increased serum 
osmolarity can be drawn from the significantly reduced ICP at 3 (p<0.05) and 4 hours 
(p<0.01) in mannitol treated animals compared to saline treated animals (6), although ideally, 
the availability of serum osmolarity as a direct correlate would be better. Animals were also 
given other medications as part of the anesthetics including intravenous thiopentone and 
ketamine, and inhalation of isoflurane. The histological effects of these agents on the renal 
tubular epithelium, if any, is not well documented in the literature so it is not known whether 
they could have impacted on the observed pathology. The current study is also limited by low 
numbers and further studies are warranted.  
 Mannitol was used as a substitute for glucose to induce hyperosmolarity and 
investigate whether the phenotypic features of Armanni-Ebstein lesions could be induced by 
an osmotic effect. Mannitol (C6H8(OH)6) is a six-carbon polyol (sugar alcohol) of the sugar 
mannose with a molecular mass of 182, and a chemical structure very similar to that of 
glucose and sorbitol (10,11). After intravenous injection, however, mannitol is metabolically 
inert, distributes almost entirely in the extracellular space, is filtered at the glomerulus and 





after a single dose of 0.5 to 0.71g/kg of mannitol varies widely in humans from 39 to 103 
minutes with a mean of 71 minutes (12). Due to its osmotic properties, intravenous mannitol 
has been used clinically to reduce intracranial and intraocular pressures, as a diuretic agent, 
for renal protection in transplant surgery, and for the prevention of nephrotoxic renal failure 
caused by radiocontrast, myoglobin, and cisplatin (10,11,13).  
 The glucose molecule (C6H12O6) is structurally similar to mannitol, and it is a key 
fuel for mammalian cells, as well as being an important metabolic substrate (14). In contrast 
to mannitol, approximately 90% of filtered glucose is reabsorbed in the proximal convoluted 
tubules via a low affinity, high capacity sodium glucose transporter, SGLT2, located on the 
apical membrane. Residual glucose is then absorbed by the high affinity and low capacity 
SGLT1 located in the proximal straight tubules (14,15). Two basolateral membrane glucose 
transporters, the low-affinity GLUT2 and high affinity GLUT1, then facilitate transcellular 
glucose transport (14,15). There is also evidence to suggest that there is increased expression 
of renal glucose transporters in diabetics (15), with hyperglycemia in diabetes leading to 
enhanced proximal tubular glucose reabsorption (16). Glucosuria only develops once the 
filtered glucose exceeds the renal threshold for reabsorption. Additionally, glucose molecules 
are metabolically active and induce a range of effects on proximal tubular cells, including 
increase synthesis and secretion of vasoactive hormones (e.g. angiotensin II), cytokines (e.g. 
transforming growth factor-β), and extracellular matrix proteins (16). Hyperglycemia has also 
been shown to increase the formation and accumulation of intracellular sorbitol via 
metabolism of glucose by aldose reductase (16). 
 In the present study, intravenous injection of 20% mannitol in sheep induced 
vacuolization of renal tubular epithelial cells in all ten cases with variable degrees of osmotic 





changes. Compared to the classical Armanni-Ebstein lesion, the membranes of the individual 
swollen and vacuolated epithelial cells were, however, less distinct, with variable nuclear 
changes ranging from normal appearing undisplaced nuclei to more characteristic peripherally 
displaced small dark nuclei. Mannitol-induced cytoplasmic clearing was also more commonly 
observed as a field effect with many adjacent tubules also affected; this is in contrast to 
traditional Armanni-Ebstein lesions in which the affected tubule is surrounded by normal 
unaffected tubules. PAS staining of affected tubules did not demonstrate any intravacuolar 
glycogen presumably because filtered mannitol is excreted and remains metabolically inert.  
 This study has demonstrated that the histological appearance of Armanni-Ebstein 
lesions can be reproduced by mannitol infusion, although no intravacuolar glycogen was 
present. This suggests that hyperosmolarity may contribute to the formation of Armanni-
Ebstein lesions, but that the accumulation of glycogen is more specific to the metabolic 
effects of the glucose molecule on renal tubular epithelial cells. Thus, when Armanni-Ebstein-
like tubules are seen on routine sections of the kidneys, a subsequent PAS stain should be 
conducted to demonstrate glycogen because of the possibility of these changes being induced 
by non-diabetic hyperosmolar conditions. Further controlled studies are warranted as the 
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FIG. 1-A section of kidney from an anesthetized sheep that was injected with 20% mannitol 
(11 mOsm/kg). There is non-specific uniform vacuolization of renal tubular epithelial cells 
consistent with osmotic nephrosis (Hematoxylin & eosin, H&E x 40). 
 
 
FIG. 2-A section of kidney from an anesthetized sheep that was injected with 20% mannitol 
(11 mOsm/kg). There is incomplete cytoplasmic clearing with undisplaced normal appearing 








FIG. 3-A section of kidney from an anesthetized sheep that was injected with 20% mannitol 
(11 mOsm/kg). There is complete cytoplasmic clearing with peripherally displaced small dark 
nuclei resembling the Armanni-Ebstein lesion (Hematoxylin & eosin, H&E x 40). 
 
 
FIG. 4-A section of kidney from an anesthetized sheep that was injected with 20% mannitol 
(11 mOsm/kg). No glycogen can be demonstrated within the vacuolated tubular cells (Period 






AN ISOLATED PERFUSED RAT KIDNEY MODEL FOR THE EVALUATION OF 





1. To develop an isolated perfused kidney model capable of reproducing renal tubular 
epithelial vacuolizations secondary to metabolic derangements. 
2. To utilize the isolated perfused kidney model to reproduce Armanni-Ebstein lesions. 
 
HYPOTHESES:  
1. That the isolated perfused kidney model is a viable ex-vivo model for the investigation 
of renal tubular epithelial vacuolizations 
2. That Armanni-Ebstein lesions are reproducible in an isolated perfused kidney model. 
 
COMMENTARY:  The isolated perfused kidney model has been used for pharmacologic 
investigations into drug metabolism and excretion, however, to our knowledge it has never 
been used for histologic studies. This model allows for a single rat kidney to be perfused with 
physiologic concentrations of electrolytes, with or without the addition of controlled 
concentrations of other substrates. Therefore, this model was tested to determine if it could be 
a viable means for the evaluation of renal tubular epithelial histology, and whether Armanni-







Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
 
CONCLUSIONS:  
1. The isolated perfused kidney model is a viable ex-vivo model for the investigation of 
renal tubular epithelial vacuolization. 
2. Armanni-Ebstein lesions were not reproduced in the isolated perfused kidney model, 
suggesting that this change requires more time to develop or involves factors in 
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ABSTRACT:  An isolated perfused kidney model was used to evaluate the effect of 
hyperglycemia on renal tubular epithelial cell morphology. Ten Sprague Dawley rat kidneys 
were perfused with Krebs Henseleit buffer containing 70mmol/l of glucose (5 for 1 hour, 5 for 
2 hours). Two control groups consisted of 10 kidneys perfused with Krebs Henseleit Buffer 
without hyperglycemia (5 for 1 hour, 5 for 2 hours), and 10 non-perfused contralateral 
kidneys placed in the same environment for the same duration. The hyperglycemia group had 
significantly increased renal tubular vacuolization (p<0.001) compared to both control groups 
at 1 and 2 hours. The isolated perfused kidney model recapitulates the renal tubular 
vacuolization phenotype found in hyperglycemia and may be a potential tool for the 
investigation of causal factors in renal histology. The full pattern of the Armanni-Ebstein 
phenomenon was not, however, reproduced, suggesting that this change requires more time or 
involves more complex factors. 
 
Keywords: Forensic science, Armanni Ebstein phenomenon, nephrotic syndrome, isolated 







 Identifying histologic changes in renal tubular cells is useful in a variety of clinical 
situations, such as in the diagnosis of calcineurin inhibitor nephrotoxicity (1) and acute 
tubular necrosis. In addition, it has been shown to be useful in a forensic context in the 
diagnosis of diabetic, alcoholic, and starvation ketoacidosis (2-4). Studies have reported the 
morphology, constituents, and associated metabolic conditions of various types of renal 
tubular epithelial changes, such as in Armanni-Ebstein lesions and basal lipid vacuolization; 
however, the pathogenesis of such lesions remains unclear. 
 The Armanni-Ebstein lesion appears as swollen epithelial cells with almost complete 
conversion of the cytoplasm into a single large vacuole filled with glycogen (2,5). Although 
these lesions appear in hyperglycemic states (2,6,7), it has remained uncertain whether 
elevated glucose levels alone can directly cause this change. Renal biopsies are not routinely 
undertaken in metabolic states such as diabetic ketoacidosis and hyperglycemic hyperosmolar 
nonketotic coma, since the outcomes would not affect patient management, thus making 
controlled studies difficult. Previous investigations have focused solely on in vivo or post-
mortem studies, thus the histological consequence of hyperglycemia in isolation on renal 
tubular epithelial cells is unknown.  
 The current study utilized an in vitro isolated perfused rat kidney model to directly 
control the duration and magnitude of hyperglycemia, in the absence of other confounding 
metabolic derangements (such as hyperlipidemia and ketoacidosis), to determine if a viable 
model could be established for linking physiological conditions to renal histological 
outcomes, and to evaluate whether Armanni-Ebstein lesions could be reproduced by high 






Materials and methods 
The use of scavenged Sprague Dawley rats for this study was approved by the local 
University Animal Ethics Committees at both SA Pathology and The University of Adelaide, 
South Australia. Animal studies were performed with approved protocols, in accordance with 
the guidelines established by the National Health and Medical Research Council (NHMRC). 
Dextran (MW = 48,000-90,000), bovine serum albumin (MW = 66,000), sodium 
chloride (NaCl), potassium chloride (KCl), sodium bicarbonate (NaHCO3), monopotassium 
phosphate (KH2PO4), magnesium sulfate (MgSO4), calcium chloride (CaCl2), L-cysteine 
(C3H7NO2S), glycine (C2H5NO2), L-glutamic acid (C5H9NO4), D-glucose (C6H12O6), and 
heparin sodium salt (50mg/ml) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
The isolated perfused kidney system and perfusion medium parameters were based on 
previously described methods (8). The perfusate for the control treatment group (n=10) 
consisted of Krebs-Henseleit buffer (pH 7.4) containing sodium chloride (118 mmol/l), 
potassium chloride (4.7 mmol/l), calcium chloride (1.25 mmol/l), magnesium sulfate (1.24 
mmol/l), monopotassium phosphate (1.2 mmol/l), sodium carbonate (25 mmol/l), D-glucose 
(5 mmol/l), L-cysteine (0.5 mmol/l), glycine (2.3 mmol/l), L-glutamic acid (0.5 mmol/l), 
bovine serum albumin (6.5 g/l), and dextran (36 g/l). The perfusate for the hyperglycemia 
treatment group (n=10) contained the above, with the addition of 70 mmol/l of D-glucose. 
1mg (200 units) of heparin sodium salt in 1ml was added to the perfusates at the beginning of 
each experiment. The perfusion media were filtered through 1.2 and 0.45 µm filters 
(Millipore, Bedford, MA, USA) prior to use and equilibrated with a mixture of moistened 
95% oxygen and 5% carbon dioxide for 1 hour before and during the kidney perfusion 





group placed in the same environment for the same duration of time without being connected 
to the recirculating perfusion system. 
Male and female Sprague Dawley rats >200g were euthanized individually using 
carbon dioxide (CO2) inhalation. The abdominal cavities were opened and the intestines and 
liver were ligated and removed. Retroperitoneal soft tissue was dissected to expose the vena 
cavae, abdominal aorta, and to free the kidneys (Figure 1). The renal artery was then 
cannulated through its ostia in the abdominal aorta with a 20 gauge intravenous cannula pre-
infused with perfusate including heparin (Figure 2). Both the cannulated kidney and the 
contralateral kidney were removed and immediately placed on a tray on ice for transportation 
to the isolated perfusion system.  
The kidneys were placed into a thermostatically controlled cabinet at 34-37.5°C. The 
cannulated kidney was connected to the recirculating system containing 180ml of perfusate, 
recycled using a peristaltic pump at approximately 32-38 ml/min with continuous adjustments 
as necessary to maintain renal artery perfusion pressure at 110 ± 20 mmHg, which was 
monitored using a manometer. The post-mortem interval between death and the initiation of 
perfusion was recorded for each case. Perfusion of the kidney was monitored by the 
macroscopic color change of the parenchyma from dark maroon to yellow/tan and the change 
in the perfusate color from dark red to clear as the residual red blood cells were flushed out. 
The temperature, flow rate, renal arterial pressure, and macroscopic color changes were 
routinely recorded at 5 minute intervals. After the designated perfusion time of 1-2 hours, 
both the perfused and non-perfused kidneys were bisected and immediately placed in 10% 
buffered formalin for overnight fixation. Kidneys were then routinely processed, embedded in 
paraffin wax, sectioned and stained with Hematoxylin and Eosin (H&E) and Period Acid-





remaining red blood cells within the vessels were considered to have been adequately 
perfused and were assessed histologically for vacuolization. 
Ten adjacent fields of each kidney were photographed at 400x magnification, and 
assessed for the degree of vacuolization using previously described methods (9) to determine 
the percentage area of unstained tissue. Differences between the high glucose concentration 
group and the two control groups were assessed by one-way ANOVA, followed by post hoc 
Tukey HSD test. To determine whether there were significant differences between the 
percentage area of vacuolization at 1 and 2 hours within each group, initial tests for the 
equality of variances were conducted using an F-test followed by the appropriate t-test (with 
or without equal variance).  
 
Results 
Control Treatment Group 
Ten Sprague Dawley rats, with a male to female ratio of 4:7, and whole animal 
weights ranging from 206 to 420g (mean=284.8g) were used in the perfused control group, in 
which kidneys were perfused with Krebs Henseleit Buffer without added glucose. Kidneys 
from five rats (3 male, 2 female; weight range from 226 to 350g (mean 293.5g) were perfused 
for 1 hour. Their post-mortem interval ranged from 20 to 30 minutes (mean = 27 minutes). 
During the perfusion, the temperature was maintained between 34°C to 37°C (mean = 
36.1°C), with a flow rate of 34 to 36 ml/min (mean = 35.2 ml/min) required to maintain a 
renal arterial pressure of 100 to 122 mmHg (mean 110.4 mmHg). The time required for the 
efferent perfusate to become clear and for the majority of the visible surface of the kidney to 





tubular epithelial vacuolizations were observed histologically, and the unstained area per high 
power field ranged from 3.14 to 10.59% (mean 5.73%). 
Kidneys from five female rats weighing from 206 to 320g (mean = 255g) and with a 
post-mortem interval ranging from 20 to 40mins (mean 26.6 minutes) were perfused for 2 
hours. Their temperatures were maintained between 34 to 37.5°C (mean = 36.8°C), with a 
flow rate of 33.4 to 35.8 ml/min (mean = 35.1 ml/min) required to maintain a perfusion 
pressure of 100 to 128 mmHg (mean = 111.1 mmHg). The time taken for efferent perfusate to 
clear ranged from 10 to 15 minutes (mean = 11 minutes), and the majority of the kidneys 
changed color in 2 to 10 minutes (mean = 8.4 minutes). Non-specific tubular vacuolizations 
(Figure 3) and occasional tubules with cytoplasmic clearing and normal nuclei were observed, 
with an unstained area ranging from 12.33 to 33.75% (mean 22.15%). 
 
Hyperglycemia Treatment Group 
Kidneys from ten female Sprague Dawley rats weighing between 202 to 260g (mean = 
234.7g) were perfused with Krebs Henseleit Buffer with 70 mmol/l of D-glucose. Five 
kidneys were perfused for 1 hour. In this group, whole animal weights ranged from 202 to 
247g (mean 226.4g), and the post-mortem intervals were 25 to 50 minutes (mean = 33 
minutes). During perfusion, temperature was maintained between 34°C to 37°C (mean = 
36.4°C), with a flow rate between 34 to 36.2 ml/min (mean = 35.1 ml/min) to maintain a renal 
arterial pressure of 102 to 126 mmHg (mean 112.7 mmHg). The time for the efferent 
perfusate to clear ranged from 5 to 15 minutes (mean 10.2 minutes) and the time for the 
majority of the kidney to change to yellow/tan ranged from 5 to 25 minutes (mean = 14.2 
minutes). Histologically, isometric fine vacuolizations of tubular epithelial cells consistent 





were seen, however PAS stain did not demonstrate any glycogen deposition. The percentage 
of unstained area per high power field ranged from 15.83 to 43.90% (mean 31.23%). 
Kidneys from five female rats weighing from 210 to 246g (mean = 243g) with a post-
mortem interval ranging from 20 to 25mins (mean 21.6 minutes) were perfused for 2 hours. 
Their temperatures were maintained between 34 to 37°C (mean = 36.6°C), with a flow rate of 
34 to 36.2 ml/min (mean = 35.5 ml/min) to maintain a perfusion pressure of 102 to 122 
mmHg (mean = 112.8 mmHg). The time taken for efferent perfusate to clear ranged from 3 to 
30 minutes (mean = 14 minutes), and the majority of the kidney changed color in 3 to 35 
minutes (mean = 15 minutes). Isometric vacuolizations of osmotic nephrosis were observed 
histologically (Figure 3), along with numerous tubules demonstrating cytoplasmic clearing 
with normal appearing nuclei surrounded by non-vacuolated tubules (Figure 4). PAS staining 
in all cases did not demonstrate any accumulated glycogen (Figure 5). The unstained areas 
ranged from 15.24 to 44.67% (mean 34.64%) per high power field. 
 
Non-perfused Group 
Ten contralateral kidneys from animals used in the control and hyperglycemia 
treatment groups were placed adjacent to their corresponding perfused kidney, in the same 
perfusion cabinet, with the same temperature and environment, for the same amount of time. 
Analyses of non-perfused kidneys in the 1 and 2 hour experiments showed a total cleared area 
ranging between 1.069 to 18.09% (mean 4.79%), and 0.92 to 23.30% (mean 5.57%) per high 
power field, respectively. In both groups, occasional small non-specific cytoplasmic vacuoles 
were observed; additionally, tubules with cytoplasmic clearing and pyknotic nuclei were 







Analysis via one-way ANOVA revealed a statistically significant difference in renal 
tubular epithelial vacuolization in the group infused with 70 mmol/l of glucose compared with 
both control groups at 1 (F(2,147)=697.47, p=<0.001) and 2 hours (F(2,147)=438.78, 
p=<0.001). Quantitative comparisons of epithelial cell vacuolization between the different 
study groups are summarized in Figure 6. 
The magnitude of the response correlated with glucose treatment. Post hoc 
comparisons using the Tukey HSD test revealed a significantly greater unstained area 
(p<0.001) in the high glucose group (M=31.23, SD=5.91) compared to the perfused control 
group (M=5.73, SD=1.53). The high glucose group also showed a significantly greater clear 
area than the non-perfused group (M=4.79, SD=3.34) after 1 hour. Similarly, after 2 hours, 
there was a significantly greater amount of cellular clearing in the high glucose group 
(M=34.64, SD=5.83), compared with the perfused control (M=22.15, SD 4.75), and non-
perfused control (M=5.57, SD=4.02) groups. There were no statistically significant 
differences between the perfused control treatment group and the non-perfused control groups 
at one hour.   
The F-tests indicated that the variances in the hyperglycemic groups (F=0.104, 
p<0.001) were not equivalent to those in the control groups (F=0.104, p<0.001). However, the 
variances for the 1 and 2 hour non-perfused kidneys (F=0.690, p=0.099) were not different. 
The magnitude of the response in the hyperglycemic groups correlated with the time 
of exposure. The F-test indicated no significant difference in variances between the kidneys 
perfused for 1 hour and those perfused for 2 hours with hyperglycemic perfusate (F=1.026, 
p=0.465). Subsequent two-sample t-test assuming equal variances showed that the mean 





31.23, SD=5.91) was significantly less than at 2 hours (M=34.64, SD=5.83), t(98)=-2.910, 
p=0.002. 
Similarly, kidneys perfused with non-hyperglycemic Krebs Henseleit Buffer for 1 
hour (M=5.73, SD=1.53) also showed significantly less clearing of tubules compared to the 2 
hour group (M=22.15, SD=4.75), t(59)=-23.275, p<0.001. There was no significant difference 
in vacuolization amongst the 1 hour (M=4.79, SD=3.34) and 2 hour (M=5.57, SD=4.02) non-
perfused kidneys, t(98)=-1.053, p=0.147. 
 
Discussion 
 The in vitro isolated perfused rat kidney model has been extensively utilized for 
investigating renal drug handling (8,10-12), and the effects of drugs and various substances 
on renal vasculature (13,14), glomerular function (15,16), renal cellular metabolism (17), and 
gluconeogenesis (18). However, the model has not been tested for the investigation of 
etiologic factors causing changes in renal histology. Rodents are appropriate candidates for 
establishing a new model for renal histological studies as histological abnormalities noted in 
human kidneys, including the Armanni-Ebstein phenomenon, have been demonstrated 
previously with in vivo studies in rats (7,19,20).  
 The current study perfused kidneys with Krebs Henseleit Buffer with and without 
70mmol/l of glucose. This concentration was chosen as it represents a ten-fold elevation in 
the threshold fasting glucose level of 7.0 mmol/l which is diagnostic for diabetes in humans 
(21). The degree of vacuolization after hyperglycemic treatment was significantly greater than 
that observed in two different control groups:  (i) a perfused group without excess glucose 
which controlled for any histological changes induced by the perfusion system; and (ii) a non-





autolysis. Results showed a statistically significant increase in renal tubular epithelial 
vacuolization in the group infused with 70 mmol/l of glucose compared to both control groups 
at 1 and 2 hours. Additionally, there was a significant increase in vacuolization among the 
kidneys perfused with high glucose for 2 hours compared to those perfused for 1 hour. This 
suggests that the isolated perfused kidney system is capable of inducing renal tubular 
epithelial vacuolizations that increase with perfusion time. The absence of accumulated 
glycogen (as determined by PAS staining) in the hyperglycemic treatment group may suggest 
that the pathogenesis of the Armanni-Ebstein lesion requires factors more complicated than 
simple exposure to hyperglycemia alone, or that cytoplasmic glycogen accumulation requires 
more than 2 hours of exposure to high glucose concentrations to develop.  
 Limitations of the system are the need to prevent thrombosis, and the limited duration 
of the treatment period that can be used to simulate a chronic disease condition (here not 
exceeding 2 hours). Prevention of thrombosis was addressed by the addition of 1mg (200 
units) of heparin to the perfusate in each experiment. This dose was based on previous studies 
injecting 100 units of heparin into the penile vein of rats weighing between 346-459g (8) or 
200 units injected into the renal vein (18). With sporadic thrombi, individual regions and 
tubules of the kidneys might have been perfused for less than the specified time. The reason 
why thrombi developed in some cases and not in others is unclear; perhaps more immediate 
delivery of heparin (e.g. antemortem) or a higher dose would facilitate better perfusion. While 
morphological changes that emulate human postmortem histology do develop in the ex vivo 
kidney model over time; the temporal limitation of this model is that the interpretation of 
vacuolization becomes increasingly more difficult with the onset of autolytic changes 





 To optimize the model, this study used dextran as an oncotic agent to substitute for a 
large portion of bovine serum albumin (BSA) in a ratio that has been shown previously to 
confer higher functional viability of the perfused kidney as compared with BSA alone; this 
was demonstrated by the preservation of the tubular reabsorption of water, glucose, and 
sodium (8). Dextran is preferred over BSA due to the significantly lower cost, and in 
pharmacokinetic investigations of drugs that are extensively bound to BSA (22). However, 
the histological consequences of this substitution are unclear.  
 The current study has demonstrated that the isolated perfused kidney model is a viable 
model for the study of renal tubular epithelial cell histology.  A significantly greater degree of 
vacuolization was observed after treatment with high glucose compared to both control 
groups, which also correlated with the duration of exposure. The morphological features of 
Armanni-Ebstein lesions (i.e. swelling and cytoplasmic clearing of renal tubular epithelial 
cells) were observed in the hyperglycemia treatment group, however, intravacuolar glycogen 
which is a defining feature of classical Armanni-Ebstein lesions, was not demonstrated.  
Therefore, further studies need to be conducted, perhaps with the addition of ketones and/or 
regulatory/counter-regulatory hormones (e.g. insulin and glucagon), and over longer periods 
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FIG. 3- Osmotic nephrosis in a rat kidney perfused with Krebs Henseleit Buffer and 70mmol/l 
of glucose for 2 hours (Hematoxylin and eosin x400). 
 
 
FIG. 4- Swelling and cytoplasmic clearing of renal tubules in a rat kidney perfused with 







FIG. 5- No glycogen within vacuolated tubular epithelial cells in a rat kidney perfused with 
Krebs Henseleit Buffer and 70mmol/l of glucose for 2 hours (Periodic Acid-Schiff x400). 
 
FIG. 6- Scatterplot histogram summarizing the degree of renal tubular vacuolization between 






THE ETIOLOGY OF BASAL VACUOLIZATIONS IN RENAL TUBULAR 




AIM: To utilize the isolated perfused kidney model to reproduce basal vacuolizations. 
 
HYPOTHESIS: That basal vacuolizations are reproducible in an isolated perfused kidney 
model. 
 
COMMENTARY:  Hyperlipidaermic conditions, such as nephrotic syndrome, have been 
associated with basal lipid vacuolizations but of a different morphology to those observed in 
ketoacidosis (see Chapter 2). Therefore, the isolated perfused kidney model was utilized to 
determine if basal vacuolizations could be reproduced by adding increased concentrations of 
triglycerides to the perfusate, and whether the morphology of these vacuoles changed with the 
addition of ketones. 
 
Literature review establishing the field of knowledge is discussed within the paper. This 
manuscript was written in American English to satisfy the publication requirements of the 
Journal of Forensic Sciences. 
 
CONCLUSION: Isolated hypertriglyceridemia can cause basal lipid vacuolizations in an 





ketoacidosis. The addition of ketones did not alter the morphology of the vacuoles, suggesting 
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ABSTRACT:  To determine whether basal lipid vacuolization characteristic of 
ketoacidosis could be induced with short-term hypertriglyceridemia, adult Sprague-Dawley 
rat kidneys were perfused in an isolated perfused kidney model with, and without, 11.3mmol/l 
(10g/l) of triglycerides in Krebs-Henseleit Buffer, for 1 and 2 hours (n=5/group). Additional 
treatments included perfusion with triglycerides with 20mmol/l of β-hydroxybutyrate and 
2mmol/l of acetoacetate (n=5); and perfusion with triglycerides with 70mmol/L of glucose 
(n=1). Basal vacuolization was produced in all groups, but differed in morphology to that 
reported in postmortem studies. There was no further increase in vacuolization after 2 hours 
of perfusion compared to 1 hour (p=0.24), and the addition of ketones did not alter the 
morphology or extent of vacuolization. This study using an ex-vivo model has confirmed that 
isolated hypertriglyceridemia is sufficient to cause basal lipid vacuolization in renal tubular 
epithelial cells, but with different morphology to vacuoles observed in lethal ketoacidosis at 
autopsy. 
 
Keywords: Forensic science, basal vacuolization, subnuclear vacuolization, isolated perfused 






 Renal tubular epithelial cells respond to metabolic insults with a variety of 
distinctive patterns of vacuolization, as is seen in osmotic nephrosis secondary to 
hyperosmolarity (1), the Armanni-Ebstein phenomenon secondary to hyperglycemia (2), 
hypokalemia with coarse irregular vacuolization (3), and calcineurin-inhibitor toxicity with 
secondary isometric vacuolization (4). Basal vacuolization, characterized by a row of 
subnuclear vacuoles in close proximity to the basement membrane, has been reported in 
postmortem samples from subjects with diabetic (5,6), alcoholic (7), septic (8) and starvation 
(9) ketoacidosis. Basal vacuolization of a different morphology, appearing as numerous 
circular vacuoles which begins basally and then spreads to involve the entire cell, has also 
been observed in cases of pediatric nephrotic syndrome (10). A consistent feature in all these 
conditions has been the demonstration of intravacuolar lipids with Oil Red O staining and by 
electron microscopy (5,9,10), suggesting that the etiology of the pathological phenotypes is 
linked to hyperlipidemia (5). However, all studies to date have involved post-mortem tissues, 
which have made the determination of a direct association between basal vacuolization and 
hyperlipidemia in isolation challenging.  The use of a perfused kidney model has allowed 
separation of possible causal factors, with minimization of other confounding metabolic 
abnormalities that are often present in these conditions in vivo (11).  
 
Materials and methods 
This use of scavenged Sprague Dawley rats for this study was approved by the Animal 
Ethics Committees of SA Pathology and The University of Adelaide, South Australia. Animal 
studies were performed according to the guidelines established by the National Health and 





The isolated perfused kidney system and perfusion medium composition were based 
on previously described methods (12). The perfusate consisted of Krebs-Henseleit buffer (pH 
7.4) containing 118mmol/l of sodium chloride (NaCl), 4.70mmol/l of potassium chloride 
(KCl), 1.25mmol/l of calcium chloride (CaCl2), 1.24mmol/l of magnesium sulphate (MgSO4), 
1.20mmol/l of monopotassium phosphate (KH2PO4), 25mmol/l of sodium bicarbonate 
(NaHCO3), 5mmol/l of D-glucose (C6H12O6), 0.5mmol/l of L-cysteine (C3H7NO2S), 
2.3mmol/l of glycine (C2H5NO2), 0.5mmol/l of L-glutamic acid (C5H9NO4), 6.5g/l of bovine 
serum albumin (MW = 66,000), and 36g/l of dextran (MW = 48,000-90,000) (Sigma-Aldrich, 
St. Louis, MO, USA). Intralipid 20% (Fresenius Kabi AB, Sweden), which contains 
triglyceride 20%, phospholipid 1.2%, and glycerol 2.2%, was added to the perfusate medium 
to achieve a triglyceride concentration of 11.3mmol/l (10g/l) (n=10).  An additional treatment 
group (n=5), used to simulate concurrent ketoacidosis, was exposed to perfusate containing 
20mmol/l of β-hydroxybutyric acid (C4H8O3) and 2mmol/l methyl acetoacetate (C5H8O3). A 
pilot treatment assay (n=1) used to simulate concurrent hyperglycemia contained 70mmol/l of 
D-glucose instead of the standard 5mmol/l in the perfusate medium. 1mg (200 units) of 
heparin sodium salt in 1ml was added to the perfusate solutions at the beginning of each 
experiment. The perfusion media were successively filtered through 1.2 and 0.45 µm filters 
(Millipore, Bedford, MA, USA) prior to use and equilibrated with a gaseous mixture of 
moistened 95% oxygen and 5% carbon dioxide for 1 hour before and throughout the kidney 
perfusion.  
Adult Sprague Dawley rats (>200g each) were euthanized using carbon dioxide (CO2) 
inhalation. The kidneys were subsequently cannulated through the renal artery via the 
previously described dissection techniques (11) and placed into a thermostatically controlled 





containing 180ml of perfusate pumped using a peristaltic pump at approximately 32-38 
ml/min with continuous adjustments as necessary to maintain renal artery perfusion pressure 
at 110 ± 20 mmHg. The post-mortem interval between time of death and the initiation of 
perfusion was recorded for each case. Renal perfusion was monitored via macroscopic color 
change from dark maroon to yellow/tan and a change in the efferent perfusate from dark red 
to clear as red blood cells within the kidney were flushed. The temperature, flow rate, renal 
arterial pressure, and macroscopic color changes were routinely recorded at 5 minute 
intervals. After perfusion for the designated time of 1-2 hours, a small portion of the kidney 
was excised and immediately placed in gluteraldehyde for fixation. The remainder of the 
kidney was bisected and placed in 10% buffered formalin for overnight fixation. Kidneys 
were then routinely processed, embedded in paraffin wax, sectioned and stained with 
Hematoxylin and Eosin (H&E) for histological assessment of basal vacuolization. Only 
perfused areas of the kidney (those with a microscopic absence of red blood cells) were 
assessed for vacuolization area and morphology. 
The average area of vacuolization per high power field was assessed by photographing 
ten consecutive fields of each kidney at 40x magnification and calculating the percentage of 
negative staining in ImageJ using previously described methods (13). Analysis of statistically 
significant differences between the means of all the treatment groups began with a 
preliminary test for the equality of variances (F-test), and followed by the appropriate two-
tailed t-test which either assumes or does not assume equal variances. 
 






 The control group was taken from a previous study using the same perfusion system 
with the same concentration of constituents making up the Krebs-Henseleit buffer (11). This 
consisted of ten Sprague Dawley rats, with body weights ranging from 206 to 420g (mean 
284.8g) which were perfused for one and two hours with Krebs-Henseleit buffer in the 
absence of added triglycerides or ketones. Non-specific tubular epithelial vacuolizations 
consistent with osmotic nephrosis were observed in all cases, with the unstained area per high 
power field ranging from 3.14 to 10.59% (mean 5.73%) in the kidneys perfused for 1 hour, 
and 12.33 to 33.75% (mean 22.15%) in the kidneys perfused for 2 hours. Separation of 
tubules from the basement membrane was focally observed in some cases, but no discrete 
subnuclear vacuolizations were present (11). 
 
Hypertriglyceridemia in isolation 
Ten Sprague Dawley rats, with body weights ranging from 210 to 342g (mean 270.2g) 
were used in the groups perfused with hypertriglyceridemia alone, at one and two hours. Five 
rats weighing between 210 to 246g (mean 225.2g) were perfused for 1 hour. Their post-
mortem interval ranged from 25 to 35 minutes (mean 30 minutes). Perfusion temperature was 
maintained between 34°C to 37°C (mean 36.0°C), and a flow rate of 33.2 to 37.2 ml/min 
(mean 34.9 ml/min) was required to maintain a renal arterial pressure of 100 to 130 mmHg 
(mean 111.6 mmHg). The time for the efferent perfusate drops to become clear and for the 
majority of the kidney to change to a yellow/tan color ranged from 1 to 15 minutes (mean 
11.2 minutes), and 1 to 20 minutes (mean 9.6 minutes), respectively. Subnuclear 
vacuolizations were observed histologically in all cases, and the mean unstained area ranged 





Five rats weighing from 292 to 342g (mean 315.2g) and with a post-mortem interval 
ranging from 15 to 20mins (mean 18.4 minutes) were perfused for 2 hours. Environmental 
temperature was maintained between 35 to 37.5°C (mean 36.8°C), and a flow rate of 33.6 to 
36 ml/min (mean 35.3 ml/min) was required to maintain a perfusion pressure of 100 to 120 
mmHg (mean 110.6 mmHg). The time taken for efferent perfusate to clear and the change in 
kidney color to occur ranged from 10 to 20 minutes with a mean of 17 and 15 minutes 
respectively. Subnuclear vacuolizations of renal tubular epithelial cells were observed in all 
cases, with a mean unstained area ranging from 15.9 to 22.3% (mean 19.7%). 
 
Hypertriglyceridemia with concurrent ketoacidosis 
Kidneys from five Sprague Dawley rats weighing between 280 to 380g (mean 323g) 
were perfused with added triglycerides and ketones for 2 hours. Their post-mortem interval 
ranged from 15 to 30 minutes (mean 19.6 minutes), and the perfusion temperature was 
maintained between 34°C to 37°C (mean 36.7°C). A flow rate of 32 to 36 ml/min (mean 34.9 
ml/min) was required to maintain a renal arterial pressure of 100 to 120 mmHg (mean 110.4 
mmHg). The time for the efferent perfusate drops to clear and the time for the majority of the 
kidneys to change to yellow/tan ranged from 10 to 20 minutes with a mean of 17 and 15 
minutes, respectively. Histologically, subnuclear vacuolizations of similar morphology to the 
ones observed in the hypertriglyceridemia in isolation group were seen in all cases. The mean 
percentage of unstained area ranged from 19.4 to 24.8% (mean 22.0%). 
 
Hypertriglyceridemia with concurrent hyperglycemia 
One kidney from a Sprague Dawley rat with a weight of 316g and a post-mortem 





perfusion temperature was maintained between 35-37°C (mean 36.8°C) and a flow rate of 
34.8 to 35.6 ml/min (mean 35.3 ml/min) was required to maintain renal arterial pressure 
between 104 to 117 mmHg (mean 111.2 mmHg). Efferent perfusate drops cleared in 20 
minutes, and the vast majority of the kidney changed color to yellow/tan in 15 minutes. 




 Subnuclear vacuolizations of similar morphology were observed in all study 
groups (Figures 1 and 2). The dominant pattern of vacuolization appeared as a single vacuole 
in contact with and beneath normal appearing nuclei but not in contact with the basement 
membrane (Figure 1). As these vacuoles enlarged, they displaced nuclei luminally, and also 
engulfed the nucleus and involved the entire cell, giving the appearance of cellular 
cytoplasmic clearing (Figure 3). Occasional focal subnuclear vacuoles in contact with the 
basement membranes were also observed (Figure 4), and in a few cases, these vacuoles were 
seen to simultaneously affect the same tubules as the other subnuclear vacuoles (Figure 5). 
The addition of ketones into the perfusate did not change the overall morphology of the basal 
vacuolization. Electron microscopy was undertaken on one kidney from the 
hypertriglyceridemia in isolation group perfused for 1 hour, and one kidney from the 
hypertriglyceridemia with concurrent ketoacidosis group. Both kidneys showed 
intracytoplasmic lipids within vacuoles which were in contact with the nucleus but not with 







F-tests for the equality of variances showed no statistically significant difference in 
variances between the 1 and 2 hour hyperlipidemia in isolation group (F=0.39, p=0.19), nor 
between the 2 hour hyperlipidemia and hyperlipidemia with concurrent ketoacidosis groups 
(F=1.49, p=0.35). Quantitative comparisons of areas of epithelial vacuolization in the 
different treatment conditions are summarized in Figure 7. T-tests assuming equal variances 
showed no statistically significant differences in the mean unstained areas of the kidneys 
perfused with added triglycerides for 1 hour (M=17.65, SD=1.92) and 2 hours (M=19.69, SD 
= 3.06), t(8)=-1.26, p=0.24. Similarly, the degree of vacuolization in the kidneys perfused for 
2 hours with elevated triglycerides alone (M=19.69, SD=3.06) as compared to those perfused 
with elevated triglycerides and ketones (M=21.95, SD=2.51) were not statistically different 
[t(8)=-1.28, p=0.24].  
  
Discussion 
 An ex-vivo isolated perfused rat kidney model was used in this study to 
investigate the etiology of basal vacuolizations as it allows for control of a single metabolic 
derangement (e.g. hypertriglyceridemia in isolation), and the addition of other known 
derangements (e.g. ketosis). This is difficult to investigate with post-mortem material as 
individuals with ketoacidosis can often have other known or unknown co-occurring metabolic 
abnormalities. This model has previously been validated for the investigation of drug effects 
on glomerular function (14,15), renal vasculature (16,17), cellular metabolism (18), and 
gluconeogenesis (19). A recent study has also shown that it is a viable model for the 
investigation of renal tubular epithelial histology, showing the induction of osmotic nephrosis 
subsequent to hyperglycemic perfusate with a statistically significant increase in vacuolization 





 In the current study, hyperlipidemia was induced by the addition of triglycerides, 
following on studies by Nielsen and colleagues that demonstrated triglycerides as the major 
constituent of the basal vacuolizations in diabetic ketoacidosis (20). Hypertriglyceridemia is 
also a feature of nephrotic syndrome; however, the hyperlipidemia seen in nephrotic 
syndrome usually consists of both elevated cholesterol as well as triglycerides (21). The dual 
effect is thought to result from proteinuria and subsequent hypoalbuminemia, leading to 
decreased plasma oncotic pressure, and stimulation of hepatic apoprotein B gene transcription 
that in turn mediates a compensatory increase in hepatic lipoprotein synthesis (22). The 
absence of hypercholesterolemia within the perfusate may, therefore, explain the difference in 
morphology of the subnuclear vacuoles that were observed compared to basal vacuoles in 
nephrotic syndrome.  
 Hypertriglyceridemia commonly occurs in diabetic ketoacidosis. For example, a 
study of 46 patients hospitalized with diabetic ketosis and ketoacidosis showed that 64% had 
moderate hypertriglyceridemia with levels above the 95th percentile; 28% had severe 
hypertriglyceridemia (>5.65mmol/l) including 6 patients (13%) with triglyceride levels 
>11.29mmol/l (23). Treatment of the ketoacidosis was also usually associated with a rapid 
decrease in plasma triglyceride levels. Hypercholesterolemia was less frequent, with 36% of 
patients having values above the 95th percentile (23). In a study of plasma endogenous 
triglycerides in 74 patients with different types of diabetes, the highest rates of triglyceride 
synthesis were recorded in those with ketoacidotic diabetes (24). Hypertriglyceridemia in 
diabetic ketoacidosis occurs because insulin deficiency activates lipolysis in adipose tissue, 
thus releasing free fatty acids (FFA) which stimulate hepatic production of very low density 
lipoprotein (VLDL) (24,25). Insulin deficiency also increases the esterification of FFAs, and 





in adipose tissue (24,26). It has been suggested that co-existing genetic abnormalities such as 
mutations on the lipoprotein lipase gene, may play a role in ketoacidotic hypertriglyceridemia 
(26); however, a study of 15 patients with ketosis and severe hypertriglyceridemia of 
>11.3mmol/l showed that at least 10 and perhaps 12 of these patients did not have an 
underlying genetic abnormality (27). There are no reports in the current literature on lipid 
levels in alcoholic, starvation, or septic ketoacidosis, but Fulop and Eder reported that only 11 
of their 15 patients with ketosis and severe hypertriglyceridemia (>11.3mmol/l) had definite 
or probable insulin-dependent diabetes mellitus (27), implying that other causes of 
ketoacidosis can also be associated with significant derangements in serum triglycerides. 
 The current study used a hyperlipidemic perfusate with the addition of 11.3mmol/l 
(10g/L) of triglycerides. This concentration was chosen as it represents double the threshold 
concentration for the highest tier of hypertriglyceridemia (“Very high”; 500mg/dL) as set by 
the American Heart Association guidelines (28). β-hydroxybutyrate and acetoacetate are the 
main ketones in ketoacidosis, and they have a ratio of 1:1 in normal circulating blood. In 
diabetic ketoacidosis, this ketone body ratio is initially 3:1 or greater, but can be as high as 
10:1 as a result of the highly reduced state of hepatic mitochondria (29). Similarly, a high 
ratio (7:1 to 10:1) of β-hydroxybutyrate to acetoacetate is seen in alcoholic ketoacidosis (30). 
The concentration of 20mmol/l of β-hydroxybutyrate was chosen as this reflected the highest 
observed range seen in autopsy studies (31), and 2mmol/l of acetoacetate was chosen to 
reflect a 10:1 ratio of ketone derangement seen in severe ketoacidosis.  
 The predominant pattern of basal vacuolization observed in this study differed 
from that seen in autopsy cases of ketoacidosis, as vacuoles did not abut the basement 
membrane unless they had expanded to involve the entire cell. Additionally, basal 





unaffected tubules. In contrast, subnuclear vacuoles in post-mortem cases of ketoacidosis 
were often observed as a diffuse effect which could occur with β-hydroxybutyrate levels less 
than 20mmol/l (7). A possible shortcoming of this study is that the concentration of 
triglycerides was insufficient to cause diffuse basal vacuolization, however, more marked 
basal vacuolization with clusters of tubules affected has been noted in nephrotic syndrome 
cases with lower levels of hypertriglyceridemia (<9.92mmol/l)(10). This may suggest that a 
perfusion time of greater than 2 hours is required for more widespread changes to develop. It 
may also suggest that additional factors or other concurrent metabolic derangements, such as 
hypercholesterolemia, might be required to cause the morphological changes and extent of 
basal vacuolization seen in ketoacidosis. The basal vacuoles which were in contact with the 
basement membrane (Figure 5) also appeared morphologically different to basal vacuoles in 
ketoacidosis in that they were elongated perpendicular to the basement membrane, and were 
frequently confluent, as opposed to discrete and circular. No demonstrable lipids were present 
within these vacuoles on electron microscopy, therefore, it is likely that these vacuoles may 
represent a non-specific early autolytic change with separation from the basement membrane. 
 The study is also limited by the low numbers of animals in each treatment group. 
To maximize utility and preserve animal usage, experiments in the hypertriglyceridemia 
treatment group was limited to ten kidneys, and the hypertriglyceridemia with ketosis 
treatment group was limited to five kidneys as they all demonstrated the same pattern of 
subnuclear vacuolization (Figure 1), and it was thought further experiments in the same group 
was unlikely to yield different results. However, larger studies would add more statistical 
significance to these findings. The single kidney perfused with added glucose was intended to 
be a pilot study, which did not demonstrate a difference in the pattern of vacuolization, 





 The current study has demonstrated that hypertriglyceridemia in isolation is able 
to cause subnuclear lipid vacuolization in renal tubular epithelial cells, however, the 
morphology of these vacuoles differs from those observed in post mortem tissues that have 
been exposed to ketoacidosis in vivo (2,7-9). This may suggest that a longer duration of 
exposure (> 2 hours) or metabolic derangements other than hypertriglyceridemia, ketosis, and 
hyperglycemia, are involved in the pathogenesis of ketoacidotic basal vacuoles. Further 
studies will be required to determine the precise contribution of each metabolic derangement, 
in isolation and also synergistically, to the renal phenotype characteristically observed in 
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FIG. 1- Subnuclear vacuolization in a kidney perfused with 11.3mmol/l triglycerides for 2 
hours (Hematoxylin and eosin x400). 
 
 
FIG. 2- Subnuclear vacuolization in a kidney perfused with 11.3mmol/l triglycerides, 







FIG. 3- Subnuclear vacuolization with focal expansion of vacuoles to involve entire cells in a 
kidney perfused with 11.3mmol/l triglycerides, 20mmol/l β-hydroxybutyrate and 2mmol/l 
acetoacetate for 2 hours (Hematoxylin and eosin x400). 
 
 
FIG. 4- Basal vacuolization with vacuoles in contact with the basement membrane in a kidney 






FIG. 5- Two concurrent patterns of subnuclear vacuolization in a kidney perfused with 
11.3mmol/l triglycerides for 1 hour (Hematoxylin and eosin x400). 
 
 
FIG. 6- Intravacuolar lipid on electron microscopy within the cytoplasm of a renal tubular 






FIG. 7- Scatterplot histogram summarizing the mean % area of renal tubular vacuolization 








Chapter 1: Clarification of terminology 
1. Armanni-Ebstein lesions and basal vacuolizations represent two distinct histologic 
changes in renal tubular epithelial cells and are associated with different metabolic 
derangements which overlap in diabetic ketoacidosis.  
 
Chapter 2: Histopathological studies to confirm or refute associations between 
histomorphology and pathologic conditions 
2. Basal vacuolizations in renal tubular epithelial cells are caused by alcoholic 
ketoacidosis. 
3. Basal vacuolizations in renal tubular epithelial cells are caused by septic ketoacidosis. 
4. Basal lipid vacuolizations in renal tubular epithelial cells are caused by 
hyperlipidaemic conditions such as nephrotic syndrome, however, the vacuoles appear 
to be of a different morphology to those observed in ketoacidotic states. 
5. Basal vacuolizations in renal tubular epithelial cells can be seen in deaths due to 
hypothermia, but the aetiology in some cases may be a manifestation of underlying 
metabolic derangements predisposing to the development of hypothermia, rather than 
to the hypothermia on its own. 
6. Macroscopic renal cortical pallor is a useful marker for significant metabolic 
derangements and the underlying spectrum of histologic changes includes basal 
vacuolization, Armanni-Ebstein lesions, and osmotic nephrosis. Therefore, it’s 






7. Formalin pigment deposition in a characteristic basal distribution is a useful surrogate 
marker for basal vacuolization, especially in cases where significant putrefaction or 
autolysis precludes accurate morphologic assessment of vacuoles. 
 
Chapter 3: Determining incidence and further defining diagnostic utility 
8. Armanni-Ebstein lesions are present in 38% of cases with terminal hyperglycaemia 
(≥11.1 mmol/l). 
9. There is no significant difference in vitreous glucose levels between cases with and 
without Armanni-Ebstein lesions. 
10. Cases with Armanni-Ebstein lesions have a significantly higher level of β-
hydroxybutyrate compared to cases without, suggesting that ketoacidosis may 
facilitate the development of Armanni-Ebstein lesions. 
11. Basal vacuolizations in renal tubular epithelial cells are present in 43% of cases with 
terminal ketoacidosis (>1mmol/l). 
12. Basal vacuolizations are associated with ketoacidosis, and their incidence increases 
with the degree of ketone elevation. 
13. Basal vacuolizations are not associated with hyperglycaemia. 
 
Chapter 4: Establishing and utilizing animal models to facilitate further investigation 
14. Basal vacuolizations in renal tubular epithelial cells are not associated with terminal 
hypothermia in an animal model. 
15. Armanni-Ebstein lesions were not reproducible by simulating the osmotic effects of 






16. The isolated perfused kidney model is a viable ex-vivo model for the investigation of 
renal tubular epithelial vacuolization. 
17. Armanni-Ebstein lesions were not reproduced in the isolated perfused kidney model, 
suggesting that this change requires more time to develop or involves factors in 
addition to hyperglycaemia. 
18. Isolated hypertriglyceridemia can cause basal lipid vacuolizations in an isolated 
perfused kidney model, but of a different morphology to those observed in 
ketoacidosis. The addition of ketones did not alter the morphology of the vacuoles, 





























































































































































































































































































































































ADDITIONAL FIGURES OF ISOLATED PERFUSED KIDNEY MODEL 
 
 






FIG. 2-Photograph inside the thermostatically controlled perfusion cabinet used in the 







FIG. 3-Rat kidney being perfused in the isolated perfused kidney system. The kidney sits on 
top of the mesh platform and is perfused with filtered and oxygenated perfusate. After passing 







FIG. 4-Sprague Dawley rat kidney being perfused via a cannula inserted through the renal 
artery. The non-perfused contralateral kidney is placed adjacent to the perfused kidney as a 
control. Kidneys are covered with thin plastic wrap to prevent surface dehydration. 
 
 






FIG. 6-Paired perfused (left) and non-perfused (right) kidneys of the same rat after cessation 
of the experiment. The perfused kidney is homogenously yellow/tan, and appears plump and 
moist. In contrast, the non-perfused kidney is dark maroon, and appears smaller and 
shrunken with crinkling and drying of the renal capsule. 
 
 
FIG. 7-Coronal section through both kidneys demonstrate a lighter colour of the perfused 
kidney (left) due to an absence of red blood cells within the parenchyma following successful 
perfusion. The non-perfused kidney appears dark maroon due to the presence of red blood 
cells. 
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